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Abstracts From the 26th Annual Health Care Systems
Research Network Conference, April 8–10, 2020
The Health Care Systems Research Network (HCSRN) is made up of communitybased care delivery systems with a shared mission to improve health and health care
through research. The network’s annual conference serves as a forum for attendees
to disseminate study findings, stimulate collaborations, and share insights about
conducting research in real-world care settings. Although this year’s live conference
was cancelled to help slow the spread of COVID-19, the oral and poster abstracts
accepted for presentation at HCSRN 2020 are published in this open access
supplement of Journal of Patient-Centered Research and Reviews, the official
scientific journal of the conference. J Patient Cent Res Rev. 2020;7(1):64-137.

LATE-BREAKING RESEARCH
OA5.03
The NIA IMPACT Collaboratory: Transforming
Dementia Care Through Embedded Pragmatic
Clinical Trials
Leah Hanson,1 Leah Tuzzio,2 James Fraser,2 Eric
Larson2
HealthPartners, Bloomington, MN; 2Kaiser Permanente
Washington, Seattle, WA
1

Background: More than 5 million Americans are living
with Alzheimer’s disease or a related dementia, and that
number is expected to triple in the next three decades. People
with dementia (PWD) have higher rates of hospital stays,
emergency room visits, skilled nursing facility stays, and
overall health care utilization. Caregivers of PWD experience
increased anxiety, depression, and stress. It is imperative that
health systems address this large and growing unmet need
to improve symptom management for PWD and minimize
caregiver strain. A disconnect between research evidence
showing that nonpharmacologic interventions improve
outcomes for PWD and their caregivers and real-world
health care systems has stymied the adoption of promising
interventions. Embedded pragmatic clinical trials (ePCTs)
have the potential to accelerate the translation of evidencebased interventions into clinical practice.
Methods: The mission of the National Institute on Aging
(NIA) IMPACT Collaboratory is to build the nation’s capacity
to conduct pragmatic clinical trials of nonpharmacologic
interventions embedded within health care systems for
PWD and their caregivers. Through 6 administrative and
management teams and 10 working group cores, IMPACT
aims to develop and disseminate best practice research
64
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methods, support the design and conduct of pragmatic
trials (including funding of pilot studies), build investigator
capacity through training and knowledge generation, catalyze
collaboration among stakeholders including health care
providers and investigators, and ensure culturally tailored
interventions and engagement of people from diverse and
underrepresented backgrounds.
Results: Leveraging the success of the collaboratory,
IMPACT will develop the necessary support and resources
specific to the unique needs of PWD and their caregivers.
People living with dementia receive care across a spectrum
of settings, including not just medical systems but their places
of residence and programs to support remaining at home.
Each of these settings has its own challenges to implementing
ePCTs in this population.
Conclusion: The NIA IMPACT health care systems core
is building a national resource devoted to the intersections
between ePCTs for persons with dementia and the settings in
which they receive health care. Our group seeks to engage
investigators and sites within the HCSRN and other health
systems to establish a collaborative to support and facilitate
the conduct of ePCTs among PWD and their caregivers.
OA5.04
Testing of a Prototype Clinical Decision Support
Tool to Combat Clinical Inertia at the Point of Care:
Identifying and Closing Health and Care Gaps for
Patients With Cardiometabolic Conditions
Hannah Husby,1 Jake Delatorre-Reimer,1 Farah Refai,1
Xiaowei (Sherry) Yan,1 Karen MacDonald,2 J.B. Jones,1
Madina Gbotoe,1 Kevin Knobel1
Sutter Health, Walnut Creek, CA; 2AstraZeneca, San
Francisco, CA
1

Supplement

Background: Clinical inertia, defined as the failure to modify
therapy when clinically indicated, is a key contributing factor
for why patients do not meet guideline-recommended goals
and for poorly controlled health outcomes. In a previous
investigation, we developed an algorithm to identify
patients who potentially require new or escalated treatment
using electronic health record (EHR) data for patients with
cardiometabolic conditions (ie, diabetes, hypertension, and
dyslipidemia). We refined the algorithm for point-of-care
delivery with clinician feedback. Herein, we describe our
experience field-testing the prototype clinical decision support
algorithm and its presentation in a real-world clinical setting.
Methods: The algorithm, derived based on EHR structured
fields (ie, disease diagnosis, lab values, and medication order
and adherence), identifies a patient’s unmet goals and the
need for gap-related action based on biometric values and
treatment guidelines (ie, health gap), and compares these to
medication orders and adherence (ie, care gap). Research
staff completed chart reviews of patients the day before their
scheduled office visit with pilot clinicians. A paper report was
generated based on the assessment and given to the clinician
prior to them entering the exam room with the patient.
Clinicians made decisions on how to best act on the presented
data and proceeded to share feedback with the research team
on how to improve the algorithm and presentation.
Results: To date, 81 patients of 2 primary care clinicians
were assessed. Of the 81 patients, 48 (59%) were identified as
having a health and/or care gap, and clinicians agreed with 36
(75%) of these assessments. Pilot clinicians reported that the
algorithm output helped set an agenda for the encounter and led
to more direct data-driven conversations with patients about
their condition(s). Reasons why alerts were not applicable/
not acted on included individual patient characteristics and
history, age, and higher-priority topics.
Conclusion: Initial testing of this algorithm shows promise
that clinicians are receptive to using clinical decision support
tools that help deliver guideline-based care. Additional testing
is needed to further refine the algorithm and presentation,
and to determine its potential impact on clinician workflow
efficiency and patient health outcomes.
P1.07
Development, Feasibility, and Preliminary Validation
of a Spanish-Language Version of the TAPS Tool
Katherine Sanchez

1

Baylor Scott & White Health, Dallas, TX

1

Background: The TAPS Tool is a validated 2-stage screening
and brief assessment in primary care for unhealthy substance
use. We report on the development of a Spanish-language
version of the TAPS Tool and its preliminary evaluation in a
Spanish-speaking, NIH-designated health disparity population
seen in community health centers. This project involved the
adaptation of the TAPS Tool into Spanish, its development
Supplement

on a self-administered mobile/tablet technology platform,
and an empirical pilot study of its feasibility, acceptability,
and preliminary validity in a Spanish-speaking primary care
sample.
Methods: Participants were adult primary care patients, age
18 years or older, with Spanish as their primary language
(N=10 for development/refinement using qualitative
cognitive interviewing; N=100 for the preliminary validation
study). The Spanish-language TAPS Tool was administered
in both interviewer- and self-administered format (in random
order). We examined disclosure of substance use on TAPS
by administration format and compared it with established
measures (modified Composite International Diagnostic
Interview [CIDI]; World Health Organization’s Alcohol,
Smoking and Substance Involvement Screening Test
[ASSIST]) for identifying substance use and substance use
disorders.
Results: The Spanish-language TAPS was feasible to use,
and participants reported high levels of acceptability. The
sample had low rates of past 12-month substance use (11%
tobacco, 28% risky alcohol, 4% illicit drugs, 1% nonmedical
prescription drugs) and use disorders (7% tobacco, 2%
alcohol, 1% other substances). The self-administered TAPS
elicited 1, 3, and 1 additional disclosures of tobacco, risky
alcohol, and marijuana use, respectively, as compared to
the interviewer-administered TAPS. Rates of disclosure on
TAPS were similar to those on established measures for past
12-month and 3-month time frames.
Conclusion: Deployment of linguistically accurate and
culturally relevant screening and assessment in primary care
could improve detection of substance use problems in Spanishspeaking patients and open new opportunities for delivering
primary care-based behavioral interventions and referrals to
specialty treatment when clinically indicated. The current
study represents a starting point for expanding the availability
of the TAPS Tool beyond its original English-language
version into Spanish. The Spanish-language TAPS Tool could
expand options for substance use screening in primary care
settings with Spanish-dominant/preferred populations.
P3.05
Assessing Heart Disease in a Large Population of
Adults With Down Syndrome, 1991–2019
Veronica Fitzpatrick,1 Anne Rivelli,1 Brian Chicoine2
Advocate Health Care, Park Ridge, IL; 2Advocate
Medical Group, Park Ridge, IL
1

Background: Down syndrome (DS) is characterized by
intellectual disabilities, dysmorphic features, and comorbid
conditions that result from increased genetic material of the
21st chromosome. As recently as 1983, an adult with DS
was only expected to live until age 25, but with advances in
medicine, many individuals with DS are currently living up
to 60 years. This poses new challenges for the individual,
www.aurora.org/jpcrr
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families, and clinical care teams, particularly the prevention
and treatment of aging-related conditions. Research into the
clinical trajectory of adults with DS is warranted to improve
the health of adults with DS and update current health care
guidelines. The purpose of this study was to 1) describe
demographic factors and calculate prevalence of clinical
conditions related to heart disease among the adult DS sample
population, and 2) compare demographic and clinical heart
disease conditions between the DS sample population and the
general population.
Methods: Utilizing a retrospective, descriptive-cohort study
design, analyses were based on 28 years of data collected on
the patient population of Advocate Health Care’s Adult Down
Syndrome Center. Prevalence of disease and risk conditions
are reported as counts (and percentages) with corresponding
odds ratio (OR) indicating odds of diagnosis among the DS
sample compared to the general population. Corresponding
Pearson chi-squared P-values were calculated to represent
statistically significant differences between prevalence
of diagnoses in the DS sample compared to the general
population. In cases where prevalence was low (<5), Fisher’s
exact test P-values were calculated.
Results: Overall, adults with DS had significantly lower
odds of coronary heart disease (OR: 0.432, P<0.0001),
angina (OR: 0.047. P<0.0001), and myocardial infarction
(OR: 0.012, P<0.0001), with lower odds of the heart
disease risk factors diabetes mellitus (OR: 0.535, P<0.0001)
and hypertension (OR: 0.071, P<0.0001). Adults in the
DS sample have greater odds of heart failure (OR: 1.48,
P<0.0001), stroke (OR: 1.259, P<0.166), being overweight
(OR: 1.219, P<0.0002) and being obese (OR: 1.324,
P<0.0001) as compared to the general population.
Conclusion: Targeted clinical care pathways focus on reducing
risk factors for heart disease conditions and events; however,
our prevalence findings suggest that typical risk factors and
heart-related conditions look very different in a DS population.
Therefore, clinical care guidelines should more accurately
reflect the conditions most prevalent in the DS population.
P3.06
Control of Risk Factors for the Secondary
Prevention of Cardiovascular Disease
Nicole Glowacki,1 Rasha Khatib1
Advocate Research Institute, Advocate Health Care,
Oak Lawn, IL
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documented, especially in primary care where most of these
patients are managed.
Methods: To describe real-world control of cardiovascular
risk factors in patients diagnosed with hypertension and free
cardiovascular disease in primary care, we retrospectively
analyzed electronic medical record data from a large health
care system in Illinois. Data were collected on patients with
at least 2 primary care encounters in 2018 and who were
diagnosed with hypertension for at least 6 months based
on ICD-10 codes. Patients diagnosed with coronary artery
disease, stroke, heart failure, or chronic kidney disease were
excluded. Clinical practice guidelines recommend a blood
pressure goal of <150/90 mmHg in patients 60 years of age
or older and <140/90 mmHg in diabetic patients or those
younger than age 60, a low-density lipoprotein cholesterol
(LDL-C) goal of <100 mg/dl, glycemic control (defined as
hemoglobin A1c of <7%), and not smoking. The last available
measurement during the study period was used to assess
control of each cardiovascular risk factor.
Results: A total of 4595 patients managed in primary care
and diagnosed with hypertension were included in the
analysis. Mean age was 61 ± 13.7 years, 65.9% were females,
49.9% were Caucasian, and 95.1% reported English as a first
language. Blood pressure goals were achieved in 73.4% of
the population. LDL-C goals were achieved in 47.9% of
patients. Glycemic control was achieved in 94.2% of patients,
and 89.6% were not smokers. Overall, 31.4% of patients with
hypertension achieved control across the 4 risk factors.
Conclusion: A significant proportion of patients diagnosed
with hypertension and managed in primary care failed to
achieve targets for 4 major modifiable cardiovascular risk
factors in clinical practice. New approaches to achieve
optimal secondary prevention treatment goals are required to
translate evidence into practice.
P5.10
Ejection Fraction Extraction From Echocardiography
Reports With an Application of Computerized
Algorithm
Xiangyi Xu,1 Wendi Knapp,1 Souvik Das,1 Anthony
Sturzu,1 Kimberly Buss,1 Kelly Miller,1 Erica Weirich,1
Kaartiga Sivanesan,1 John Smucny,1 Margaret
MacMillan,1 Xiaowei (Sherry) Yan1
Sutter Health, Walnut Creek, CA

1

1

Background: Cardiovascular disease is a leading cause of
death and disability worldwide and is particularly prevalent
among patients with hypertension. Clinical practice guidelines
recommend controlling multiple risk factors to reduce
cardiovascular events in these patients. Lifestyle interventions
and pharmacotherapy aimed at controlling risk factors show
effectiveness in randomized controlled trials. The level of
risk factor control in clinical real-world practice is not well

Background: Left ventricular ejection fraction (LVEF) is an
important diagnostic indicator for the classification of heart
failure and is used in determining clinical treatment. However,
LVEF is documented in free-text reports with considerable
variations among how and where it is reported, which hinders
the utilization of LVEF. We developed a regular-expressionbased algorithm to automatically extract ejection fraction
(EF) values from echocardiographic reports and conducted
comprehensive validation.
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Methods: We conducted a 2-phase study in the algorithm
development and validation. The outcomes of the study
included EF value and EF quality, which refers to domains
from where EF was extracted. At the first phase, a regularexpression-based algorithm was developed by comparing
outcomes derived from the algorithm with those manually
reviewed by an experienced physician on 112 randomly
selected reports. The refined algorithm was further validated
in the second phase. At the second phase, 512 reports
were randomly selected from all available data spanning
January 1, 2017–December 31, 2018, stratified by clinical
departments, and manually reviewed by 7 physicians. Each
report was reviewed by 2 physicians. We evaluated the interreviewer agreement on both outcomes and also compared the
algorithm-derived values with the “gold standard,” defined as
the agreed-on EF value between 2 reviewers.
Results: Our algorithm was initially developed using a list of
keywords, including left ventricular ejection fraction, LVEF,
EF, LV systolic function, and variants of those expressions,
created based on mining from 13,681 echocardiographic
reports. At the first phase, both the physician and the algorithm
identified EF values from 88 of 112 reports (78.6%), showing
100% consistency of identification fidelity. Among those 88
reports, the accuracy of EF value extracted by the algorithm
was 97.5%. In phase 2, the interreviewer consistency was
93.9% for EF value and 82.5% for EF quality. Compared to
gold standard on 499 reports, the algorithm accuracy of EF
value was 97.2%, consistent with phase 1 validation.
Conclusion: Cardiovascular domain knowledge is the key in
developing highly accurate natural language process algorithms
for extracting EF from free texts. The 2-phase validation has
ensured the accuracy and validity of the algorithm before
implementing it throughout the health care system.
P6.03
Prescription Opioid Distribution Trends After the
Legalization of Recreational Marijuana in Colorado,
2007–2017
Amalie Kropp Lopez,1 Stephanie Nichols,2 Daniel
Chung1 Kenneth McCall,2 Brian Piper1
Geisinger Commonwealth School of Medicine,
Scranton, PA; 2University of New England, Portland, ME
1

Background: Opioid-related overdoses and overprescribing
continue to be an issue within the United States. Further
consideration of nonopioid alternatives as a substitute to
treat chronic noncancer pain and in the treatment of opioid
use disorders (OUD) is warranted. We aimed to examine
the association between the legalization of Colorado’s
recreational marijuana and prescription opioid distribution
trends. Two states that have not legalized recreational cannabis
were selected for comparison.
Methods: The U.S. Drug Enforcement Administration’s
Automation of Report and Consolidated Orders System
Supplement

(ARCOS) was used to examine 9 pain medications —
oxycodone, fentanyl, morphine, hydrocodone, hydromorphone,
oxymorphone, tapentadol, codeine, and meperidine — and 2
OUD medications — methadone and buprenorphine — from
2007 to 2017 in Colorado, Utah, and Maryland. Drug weights
were extracted, examined, and graphed. Medications were
converted to their oral morphine milligram equivalents
(MME) using standard conversion factors.
Results: Colorado reached a peak of pain MME weight in
2012 and had a -11.66% reduction from 2007 to 2017. Utah
had a +9.64% increase in pain medication distribution, and
Maryland had a -6.02% reduction. As for medications used
for OUD, Colorado, Utah, and Maryland saw a +19.42%
increase, a -31.45% reduction, and a +66.56% increase,
respectively, from 2007 to 2017. Analysis of the interval
pre- (2007–2009) versus post-marijuana legalization (2013–
2017) was completed. Statistically significant changes for
pain medications were observed for Colorado (P=0.033)
and Maryland (P=0.007) but not Utah (P=0.659). Analysis
of the OUD medications identified significant changes for
Colorado (P=0.0003) and Maryland (P=0.0001) but not Utah
(P=0.0935). Over the decade, Colorado’s opioid distribution
was predominantly (72.49%) for pain with one-quarter
(27.51%) for an OUD. Utah distributed 61.00% for pain
and 39.00% for OUD. However, Maryland was one-third
(37.89%) for pain and over three-fifths (62.11%) for an OUD.
Conclusion: This study found that there has been a
significant decrease in prescription opioid distribution after
the legalization of marijuana in Colorado. Colorado had a
larger decrease in opioid distribution after 2012 than Utah
or Maryland. Therefore, marijuana should be considered as
an alternative treatment for chronic pain and reducing use of
opioids. Also, when combined with other research reviewed in
this study, marijuana use may reduce the overdose death rate.
Additional research with more comparison states is ongoing.
P6.04
Impact of Sustained Weight Loss on Incident Type
2 Diabetes
Craig Wood,1 Lisa Bailey-Davis,1 Abhilasha Ramasamy,2
Neeraj Iyer,2 Gabriel Smolarz,2 Jacob Mowery,1 Adam
Cook,1 Peter Benotti,1 Christopher Still1
Geisinger Health, Danville, PA; 2Novo Nordisk USA,
Plainsboro, NJ
1

Background: The risk of developing type 2 diabetes (T2D)
increases in direct proportion with higher body weight and
decreases with body weight loss. However, the success of
achieving clinically meaningful weight loss is highly variable,
and the impact of sustained weight loss versus weight stability
or weight regain on future T2D risk is unclear.
Methods: Adult primary care patients with body mass index
(BMI) of >27 kg/m2 were retrospectively evaluated over
a 2-year referent period occurring between 2002 and 2018.
www.aurora.org/jpcrr
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Those with baseline weight, 1-year weight, and 2-year weight
measured during the referent period were categorized into
overweight/obesity maintainers (OM, maintained weight
within 3% of baseline), weight loss maintainers (WLM, lost
≥5% weight in first year and maintained ≥80% of weight
loss by the end of second year), and weight loss rebounders
(WLR, lost ≥5% weight in first year and regained >20%
of weight loss by the end of second year). The postreferent
period (up to 10 years, ending in 2018) was reviewed to
identify incident T2D. Cox regression adjusted for age, sex,
and baseline BMI was used to compare the time until incident
T2D between the weight change group and by the overall
magnitude of maintained weight loss within the WLM group.
Results: The 49,327 qualifying patients comprised 57%
females, a mean age of 49.8 years (SD: 15.2), a mean BMI of
34.9 (SD: 5.2), and a median follow-up of 6.4 years. Weight
change groups included 67% OM (n=33,260), 20% WLR
(n=9630), and 13% WLM (n=6437). Overall incidence of
T2D for the overall population was 6.3% at 3 years, 10.1%
at 5 years, and 18.9% at 10 years. As compared to the OM
group, incident T2D was lowest for the WLM group (adjusted
hazard ratio [aHR]: 0.67, 95% CI: 0.61–0.73, P<0.0001) but
was not reduced in the WLR group (aHR: 0.95, 95% CI: 0.89–
1.02, P=0.163). Within the WLM group, the magnitude of
maintained weight loss was associated with a lower incident
T2D (aHR: 0.72 for each additional 5% of maintained weight
loss, 95% CI: 0.64–0.81, P<0.0001).
Conclusion: Weight loss is most effective at reducing risk
of future T2D when weight loss is maintained and weight
regain is minimized. T2D risk reduction was directly related
to the magnitude of sustained weight loss.
P14.06
AHRQ EPC Program Initiatives to Improve Utility of
Evidence Reviews for Health Systems
Celia Fiordalisi,1 Kelly Vander Ley,1 Amanda Borsky,2
Cathy Gordon,1 Stephanie Chang2
Scientific Resource Center, Agency of Healthcare
Research and Quality, Portland, OR; 2Evidencebased Practice Center Program, Agency of Healthcare
Research and Quality, Rockville, MD
1

Background: The Agency for Healthcare Research and
Quality (AHRQ) Evidence-based Practice Center (EPC)
program has been producing comprehensive systematic
evidence reviews of health care literature for over two
decades, traditionally serving needs of clinical practice
guideline developers and professional societies. Recently,
AHRQ has worked to speed the adoption of evidence
into the practices of learning health systems. The ongoing
evolution of EPC products to address questions of usability,
implementation, applicability, relevance, and timeliness is a
major component of this effort.
Methods: The AHRQ EPC program has engaged health
68

JPCRR • Volume 7, Issue 1 • Winter 2020

systems through a variety of methods. Information on the
improvement of evidence reviews has been gathered through
the AHRQ-convened ACTION Network Learning Health
Systems panel, qualitative interviews with health systems
operational leadership, and sessions at clinical conferences.
Results: Engagement with health system leaders has resulted
in several EPC program efforts to adapt the existing framework
for presenting systematic reviews and explore alternative
evidence products that can be completed on a shorter timeline.
The identified need to make information accessible has led to
a revised evidence summary emphasizing actionable findings
and visual representations of data. Customizable interactive
data visualization techniques also are being developed to
provide health systems with the ability to start with higherlevel summary statements with optional deeper data dives.
Health systems underscored the importance of including
contextual factors for implementation and applicability in
the evidence synthesis. To address this need, the program
is actively discussing the reformulation of the traditional
hierarchy of evidence to place more value on evidence
from pragmatic trials and observational studies that provide
information on factors like implementation considerations,
studied populations, and settings.
Conclusion: Each subsequent initiative has expanded and
built upon the last. Collectively, they are reframing the
presentation and methodologic approach of EPC reports to
address the evidence needs of learning health systems. Current
efforts range from expanding the breadth of considered
evidence to developing data visualization solutions for
making evidence more accessible for its intended use. We
encourage collaboration with health systems of all sizes and
hope HCSRN members will nominate review topics and
provide input to make AHRQ EPC products most useful to
their systems.

CARDIOVASCULAR DISEASE
OA1.01
Prevalence of Apparent Treatment-Resistant
Hypertension in a U.S. Integrated Health Care
System
Jaejin An,1 John Sim,1 Ran Liu,1 Rong Wei,1 Hui Zhou,1
Kristi Reynolds1
Kaiser Permanente Southern California, Pasadena, CA

1

Background: The 2017 American College of Cardiology/
American Heart Association (ACC/AHA) blood pressure
(BP) guideline lowered BP treatment goals from <140/90
mmHg to <130/80 mmHg for most adults with hypertension.
We compared prevalence of apparent treatment-resistant
hypertension (aTRH) according to the seventh report of the
Joint National Committee (JNC 7) or the 2017 ACC/AHA
guideline in an integrated health care delivery system.
Supplement

Methods: We identified individuals ≥18 years old with
hypertension from the Kaiser Permanente Southern California
hypertension registry between July 1, 2014, and June 30,
2015. aTRH was defined as either BP above goal while taking
3 or more classes of antihypertensive medication or taking 4
or more classes of antihypertensive medication regardless of
BP level. We used the lowest BP measurement from the first
outpatient visit encounter after exposure to 3 or more classes
of antihypertensive medication concurrently. A secondary
analysis was conducted requiring use of a thiazide diuretic
for the definition of aTRH. Patient clinical characteristics
and antihypertensive medication use were described using
electronic health records.
Results: We included 469,509 patients with treated
hypertension (mean age: 65 years [SD: 12 years]; race: 46%
white, 26% Hispanic, 13% black, and 12% Asian). Prevalence
of aTRH was 16.9% and 21.8% according to the JNC 7 and
2017 ACC/AHA guidelines, respectively (Δ: 4.9% [95%
CI: 4.7%–5.0%]). The newly classified patients with aTRH
according to the 2017 ACC/AHA guideline were younger and
had fewer comorbidities compared with patients with aTRH
per JNC 7. By requiring a thiazide diuretic to be considered
as aTRH, the prevalence of aTRH decreased to 10.4% and
13.8% according to JNC 7 and 2017 ACC/AHA guidelines,
respectively. The most frequent 3-drug antihypertensive
combination was an angiotensin-converting enzyme inhibitor
(or angiotensin receptor blocker), beta blocker, and thiazide
diuretic. Among patients with aTRH, 1.9% received a longacting thiazide-like diuretic (chlorthalidone or indapamide),
and 5.6% received a mineralocorticoid receptor blocker
(spironolactone or eplerenone).
Conclusion: As expected, the prevalence of aTRH increased
using the more stringent BP goals of the 2017 ACC/AHA
guideline. The use of recommended long-acting thiazide-like
diuretics and mineralocorticoid receptor blockers for aTRH
was suboptimal. Future studies may be necessary promoting
the use of effective pharmacotherapy in aTRH.
OA1.02
Providers’ Prescribing Behavior for Lipid-Lowering
Therapy After Receiving Patients’ Positive Genetic
Test for Familial Hypercholesterolemia
Jing Hao,1 Nan Chen,1 Dina Hassen,1 Tracey Klinger,1
Megan McMinn,1 Dustin N. Hartzel,1 David Veenstra,2
Scott Spencer,2 Marc S. Williams,1 Susan R. Snyder,3
Josh F. Peterson,4 Victoria Schlieder,1 Laney K. Jones1
Geisinger Health, Danville, PA; University of
Washington, Seattle, WA; 3Georgia State University,
Atlanta, GA; 4Vanderbilt University, Nashville, TN
1

2

Background: Familial hypercholesterolemia is an inherited
condition causing significant lifelong elevation in low-density
lipoprotein cholesterol (LDL-C), which results in increased
risk of premature cardiovascular disease. The MyCode
Supplement

initiative is a precision medicine program at Geisinger that
returns medically actionable results from exome sequencing.
Our objective was to evaluate providers’ prescribing behavior
for lipid-lowering therapies (LLT) after receiving patients’
positive genetic result for familial hypercholesterolemia.
Methods: We conducted a retrospective study on MyCode
participants who received familial hypercholesterolemia
results. The observation period was from 2 years prior to
the patient receiving a positive genetic result for familial
hypercholesterolemia to January 16, 2019. Patients’ health
records, including LLT prescriptions and LDL-C values, were
obtained from the electronic health record supplemented
by chart review. Descriptive analysis was conducted to
demonstrate changes in patients’ LLT management and
LDL-C level before and after genetic result disclosure.
Results: In preliminary analysis, we analyzed 98 MyCode
patients who received positive familial hypercholesterolemia
results; 76 were already on LLT and 22 were not on any LLT
before disclosure. After receiving genetic results of familial
hypercholesterolemia, 30 patients received more intensive
treatment, 34 patients had no change in their LLT, and 34
patients were not on LLT at the end of our observation period
(15 discontinued LLT and 19 continued not to receive LLT).
We found that 8 patients were at LDL-C goal (of either <100
mg/dL for primary prevention or <70 mg/dL for secondary
prevention) before disclosure; 3 of them were no longer at
goal after disclosure. Among the 50 patients who were not at
goal before disclosure, 34 experienced improvements in their
LDL-C level (11 patients met goal), 9 patients’ LDL-C level
increased, and 7 patients had no change after disclosure. The
remaining 40 patients did not have sufficient LDL-C data
for classification.
Conclusion: Among patients receiving genetic diagnosis
of familial hypercholesterolemia, one-third had increased
intensity in LLT and about 35% experienced improvements
in their LDL-C level. However, after receiving genetic results
of familial hypercholesterolemia, an increased number of
patients were not on LLT and most patients were still not
on goal. Further study is needed to understand the factors
impacting treatment.
OA1.03
Randomized Controlled Trial Comparing SelfGuided Versus Dietitian-Led Approach Using
Web-Based Tools to Lower Blood Pressure: Study
Design and Rationale
Alex Chang,1 Heather Bonaparte,1 Christina Yule,1
Allison Naylor,1 Sara Kwiecien,1 Mohamed Taher,1
Andrea Nale,1 Stephen Juraschek,1 Charlotte Collins,1
Lisa Bailey-Davis1
Geisinger Health, Danville, PA

1

Background: Weight loss, consumption of a Dietary
Approaches to Stop Hypertension (DASH) dietary pattern,
www.aurora.org/jpcrr
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reduced sodium intake, and increased physical activity have
been shown to lower systolic blood pressure (SBP). Use of
website- or smartphone-based tools could be potentially
scalable solutions to improve lifestyle behaviors and lower
SBP, but little data exist to support their use in clinical practice.
Methods: In an ongoing 2-arm randomized controlled trial in
the Geisinger system, we compare the efficacy of a dietitianguided approach to a self-guided approach in lowering 24hour ambulatory blood pressure (ABP) in overweight/obese
patients with 24-hour SBP of 120–160 mmHg and on 0–1 blood
pressure medication. As part of standard of care, participants
with outpatient SBP of ≥130 mmHg are identified using
Geisinger electronic health record and health plan wellness
data, then invited to complete 24-hour ABP. Qualifying
participants are invited to complete a web-based questionnaire
(Viocare®) that provides personalized recommendations to
improve dietary quality, access to a comprehensive weight
management program (www.bmiq.com), and a smartphone
app (Lose It!). Participants are then randomized 1:1 to a selfguided arm or a dietitian-led arm, which additionally receives
weekly telephone calls from registered dietitian nutritionists
trained in motivational interviewing. Primary outcome is
3-month change in 24-hour SBP.
Results: Out of 210 patients who have thus far completed
ABP, 140 were eligible for the trial, 85 consented for the trial,
and 81 were randomized after completing the run-in period.
In a preplanned interim analysis of the first 34 randomized
patients, 28 (82%) completed the 3-month study visit. Mean
(SD) changes from baseline to 3 months were -8.0 mmHg
(9.9) for 24-hour SBP, -5.4 kg (4.5) for weight, -6.1 cm (7.4)
for waist circumference, and 11.2 units (12.0) for Healthy
Eating Index score.
Conclusion: Confirmation of elevated blood pressure using
ABP may provide an opportunity to engage patients in making
lifestyle modifications, as 58% of eligible patients after 24hour ABP screening have been successfully randomized
with strong preliminary results. Completion of the study is
expected by the end of 2020 and will determine the efficacy
of a self-directed vs dietitian-led approach to lower 24-hour
SBP using web-based tools in an integrated health system.
OA1.04
Utilizing
Core
Electronic
Health
Record
Functionalities to Prevent Cardiovascular Disease
Among Underserved Patients
Christopher Rogers1
Seton Hall University, South Orange, NJ

1

Background: Preventable cardiovascular disease (CVD)
disproportionately affects low-income Medicaid-eligible
populations. Electronic health record (EHR) use has been
proved to increase the likelihood of receiving recommended
primary preventive care for CVD. Several studies have shown
that EHRs integrated with clinical decision support functions
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help physicians to use alerts, reminders, and shared health
information to proactively prevent chronic conditions in
high-risk safety-net patients. Despite these important findings
highlighting the role of EHRs in preventing chronic diseases
in high-risk patients, the literature remains mixed on whether
EHRs can be instrumental in improving CVD outcomes.
Methods: Utilizing a nationally representative survey
of ambulatory care visits by patients at risk for CVD
in 2014 and 2015, binary logistic regression models
examined differences in the associations between core
EHR functionalities for public and population health, care
coordination, patient engagement, and quality improvement
on the provision of recommended CVD-preventive health
services provided at primary care visits for adults at risk for
CVD who had Medicaid and those with private insurance.
Results: Primary care providers caring for at-risk patients
with Medicaid were significantly less likely to adopt
fully functional certified EHR technology compared to
PCPs caring for private insurance patients (75% vs 82%,
P<0.01). Overall Medicaid and private insurance patients,
respectively, had low rates of diet/nutrition counseling,
exercise counseling, hemoglobin A1c test, lipids/cholesterol
screening, and weight reduction counseling. Medicaid
patients were significantly less likely to receive recommended
blood pressure screening compared to private insurance
patients (95% CI: 0.205–0.931). Among preventive visits for
Medicaid patients at risk for CVD, significant associations
were found between select recommended CVD-preventive
services and public and population health management, care
coordination, and patient engagement.
Conclusion: Study findings demonstrate concerns about
the rates of recommended CVD-preventive services at
primary care visits for Medicaid patients at risk for CVD,
which imply gaps in their care. Increased physician
adoption of fully functional certified EHR technology
may facilitate recommended preventive CVD screening
for low-income, underserved patients with Medicaid.
P3.01
Direct Oral Anticoagulant Use in Patients With
Atrial Fibrillation at Extreme Body Weight: What Is
the Scope of the Problem?
Stephen Voyce,1 Patrick Roman,1 Joseph Chronowski,1
Eric Wright,1 Michael Gionfriddo,1 Eric Kowalek,1
Danielle Kuhn,1 Amanda Boyer1
Geisinger Health, Danville, PA

1

Background: Multiple medical society guidelines recommend
direct oral anticoagulants (DOACs) over vitamin K antagonists
(warfarin) for use in patients with atrial fibrillation. These
agents are dosed according to renal function, but there is no
alteration in dose for increased body weight or body mass
index. Limited pharmacokinetic and pharmacodynamics
data suggest that patients at the upper extremes of body
Supplement

weight (UEBW) (>120 kg and/or body mass index of
>40 kg/m2) have decreased drug exposures, reduced peak
concentrations, and shorter half-lives, which raises concerns
about underdosing the population that falls under UEBW.
Previous trials have looked at clinical efficacy based on posthoc analyses, and no study has described the demographics
or the prescribing patterns of DOACs in UEBW patients.
Methods: We utilized a retrospective review of the Geisinger
Pharmacy and Epic electronic medical record database from
2010 to 2018 for patients with atrial fibrillation who were in
the UEBW category. Diagnosis, medication profile, duration
of therapy, efficacy, and safety results are to be analyzed.
Results: Of the 10,140 patients with atrial fibrillation
prescribed DOACs, we identified 1763 (17.4%) who fell
under the UEBW category. Over the duration of the study,
the number of patients treated with DOACs increased, but the
percentage of UEBW patients prescribed DOACs remained
stable. A higher percentage of UEBW men were treated with
DOACs as compared to UEBW women (18.8% vs 15.6%).
Conclusion: 17.4% of individuals with atrial fibrillation
treated with DOACs are UEBW. The number of UEBW
patients treated with DOACs has increased over time. Men
at UEBW are more likely to be treated with DOACs than
women in the same category. As the study progresses, we will
be looking to understand the clinical efficacy and safety of
DOACs in UEBW patients.
P3.02
Assessing Anticoagulation Management and
Shared Decision-Making Documentation From
Providers Participating in the SUPPORT-AF Study
Laboni Hoque,1 Azraa Amroze,1 Vinit Gilvaz,1 Sonu
Abraham,1 Amos Lal,2 Ajay Mishra,3 Sybil Crawford,1
Kathleen M. Mazor,1 David McManus,1 Alok Kapoor1
Reliant Medical Group/University of Massachusetts
Medical School/Fallon Health, Worcester, MA; 2Mayo
Clinic, Rochester, MN; 3St. Vincent Hospital, Worcester,
MA
1

Background: We previously tested an intervention featuring
educational outreach with modified academic detailing (AD) to
increase anticoagulation use in patients with atrial fibrillation.
Currently, we compare providers receiving and not receiving
AD in terms of inclusion of our AD educational topics and
shared decision-making elements in documentation.
Methods: Physicians reviewed themes discussed with
providers during AD and evaluated charts for evidence of
shared decision-making. We then compared frequency of
documentation of individual items for providers receiving
AD compared with non-AD providers. To understand
baseline documentation practices of AD providers, we also
randomly selected encounters of AD providers before their
AD participation.
Results: There were 113 eligible encounters in the 4
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months after AD — 36 from AD providers and 77 from
non-AD providers. We also identified 35 encounters from
AD providers before participating in the intervention.
Providers infrequently documented many reviewed items (%
documenting): anticoagulation mentioned (44%); multiple
options for anticoagulation (5%); CHA2DS2-VASc score
(11%); and bleeding risk factors (2%). Compared with nonAD providers, AD providers had statistically significant
higher percentages for the following items: mention of
anticoagulation (64% vs 35%); stroke risk (11% vs 0%);
anticoagulation benefits (8% vs 0%); and patient involvement
(70% vs 0%). There was no improvement, however, for AD
providers compared with baseline documentation percentages.
Conclusion: Providers infrequently documented important
items in anticoagulation management and shared decisionmaking. AD participation did not improve documentation.
Improving adoption of AD educational items may require
more prolonged interaction with providers. Improving shared
decision-making may require an intervention more focused
on it and its documentation.
P3.03
Nurse-Driven Multidisciplinary Rounds to Decrease
30-Day All-Cause Readmission Rate for Heart
Failure
J. Patrick Quiambao,1 Lillian Clowers,1 Dianna CurrierKirby,1 Maryam Jamshidi1
Kaiser Permanente Northwest, Portland, OR

1

Background: Patients with heart failure are at a higher risk
for 30-day all-cause hospital readmissions, and nurses play a
critical role in reducing readmission rates.
Methods: During an 11-month period, the nurses of an acute
care medical unit were provided with additional education
and resources on heart failure, tools for educating patients
with heart failure, and guidelines for multidisciplinary
rounding. The team participating in rounding include the unit
nurse manager, a nursing professional development educator,
an acute care pharmacist or pharmacy intern, and the
primary nurse. Physicians were included via text messages.
Over the last 11 months, 30-day all-cause readmission
rates were compared to rates prior to implementation of the
multidisciplinary rounds.
Results: The spring 2019 readmission rate was 19.9%,
5.1% below the target rate of 25%. Nursing documentation
of heart failure education provided to patients rose from less
than 40% to more than 90%.
Conclusion: Nurse-driven multidisciplinary rounds had a
direct impact on the 30-day all-cause hospital readmission
rate in spring 2019. Heart failure rounds resulted in patients
receiving more consistent heart failure education and
medication management per American Heart Association
guidelines. Nursing-driven heart failure rounds resulted in
improved patient heart failure education and increased nurse
www.aurora.org/jpcrr
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interaction with patients. These measures have contributed
to the improved patient readmission rate. One can draw the
conclusion that readmission rates will continue to improve
as the program and processes become more hard-wired with
nursing staff and other disciplines.
P3.04
Accuracy
of
Computer-Interpreted
Electrocardiographic
Diagnosis
of
Prior
Anteroseptal Myocardial Infarction
Stephen Voyce,1 Humera Mohammmad,1
Gilhooley,1 Jason Lewis,1 Kathleen Cope1

Sean

Geisinger Health, Danville, PA

1

Background: Electrocardiograms (ECG) are commonplace
in the treatment of patients. Of the millions of ECG performed
annually, the majority are analyzed and interpreted by
computer programs. Previous studies have analyzed some
of the benefits and limitations of these computer programs.
Special attention has not been paid to the diagnosis of
previous anterior, septal, and anteroseptal infarction (ASMI).
Although current computer algorithms use strict criteria in
their interpretation, the accuracy of computer-interpreted
ECG (CIE) diagnosis of prior ASMI and subsequent impact
on the utilization of medical resources is unknown.
Methods: We performed a retrospective analysis of ECG
performed from April 1, 2018, to April 30, 2019. Data was
extracted from MUSE using a CIE keyword of ASMI. We
excluded serial ECG. The CIE+ diagnoses were compared
to physician-interpreted ECG (PIE). PIE and CIE were
correlated with imaging (echocardiograms and/or nuclear)
studies performed within 6 months of the ECG. A numerical
analysis was conducted.
Results: A total of 2007 ECG were performed; 422 were
ASMI; 125 were excluded. A total of 297 ECG (15.8%)
were CIE+ for prior ASMI; 168 of the 297 (56.6%) had
imaging studies. Physicians (PIE+) only agreed with 47.1%
of CIE+. Physicians (PIE-) altered 52.9% of CIE+; 12 of
168 CIE+ with imaging confirmed ASMI (7.1%); 12 of 100
PIE+ studies with imaging confirmed ASMI (12%). In all 68
PIE-/CIE+, imaging was negative for ASMI.
Conclusion: ECG interpretation for prior ASMI by both
physician and computer requires improvement. CIE for ASMI
carries a high false-positive rate (92.9%). In 68 PIE-/CIE+
ECG, imaging confirmed the absence of ASMI. Studies with
a larger pool of data will be conducted to examine the trends
identified. Further evaluation will be conducted to determine
whether the false-positive CIE led to delays in surgical
procedures, referrals for cardiology evaluation, additional
testing, or undue patient emotional distress. Analysis of
these ECG interpretation differences with modern artificial
intelligence and machine learning techniques may lead to
improved CIE algorithms.

72

JPCRR • Volume 7, Issue 1 • Winter 2020

IMPLEMENTATION SCIENCE AND
EMBEDDED RESEARCH
OA2.01
A Review of Reviews to Advance Understanding
and Identify Strategies for Sustaining EvidenceBased Practices
Sarah Birken,1 Emily Haines,1 Soohyun Hwang,1 David
Chambers,2 Alicia Bunger,3 Michael Harrison,4 Per Nilsen5
University of North Carolina at Chapel Hill, Chapel Hill,
NC; 2National Cancer Institute, Bethesda, MD; 3Ohio
State University, Columbus, OH; 4Agency for Healthcare
Research and Quality, Rockville, MD; 5Linköping
University, Linköping, Sweden
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Background: Declining use of evidence-based practices
(EBPs) following implementation is well documented.
Sustained EBP use is critical for maintaining these practices’
benefits over time; yet, understanding of EBP sustainment
is limited. Limited understanding of sustainment may relate
in part to lack of an agreed-on theory, model, or framework
(TMF) to conceptualize sustainment. A highly relevant
TMF could advance understanding and identify strategies
for sustaining EBPs in health care systems. To identify
potentially relevant sustainment TMFs, we evaluated the
extent to which TMFs have been used, how TMFs have been
used, and the relevance of the TMFs that have been used in
extant sustainment research.
Methods: We drew upon recently published reviews of
sustainment studies, evaluating 1) the frequency with which
included articles used a TMF for conceptualizing sustainment,
and 2) the relevance of TMFs for understanding sustainment
using the Theory, Model, and Framework Comparison and
Selection Tool, a user-friendly tool to help select TMFs used
in implementation research.
Results: The 607 studies included across the 9 reviews cited
57 TMFs. Only 12 TMFs were used by more than 1 study.
Of these, just 3 TMFs explicitly included sustainment as
the outcome of interest; 9 offered face-valid explanations of
proposed relationships; and 6 identified mechanisms through
which included constructs influence sustainment. Only 3
TMFs (institutional theory, normalization process theory,
organizational learning) performed adequately with respect
to all these criteria.
Conclusion: TMFs are seldom used in extant sustainment
studies. Of those that were used in sustainment studies,
most TMFs were only used once, contributing to fractured
understanding of sustainment. Of the more consistently
used TMFs, few proposed face-valid relationships between
included constructs and sustainment, limiting their ability
to advance our understanding. Future research is needed to
explore the TMFs that we identified as potentially relevant, as
well as TMFs not identified in our study that have the potential
to advance understanding of sustainment and identification of
strategies for sustaining EBPs in health care systems.
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OA2.02
Challenges of and Strategies Toward Optimal
Implementation of Patient-Reported Outcome
Measures for Clinical Care
Jeanette Y. Ziegenfuss,1 Leif I. Solberg,1 Steve E.
Asche,1 Elizabeth Grossman,1 Christine K. Norton1
HealthPartners, Bloomington, MN

1

Background: While patient-reported outcome measures
(PROMs) have a history of use for public quality reporting,
their use in the course/process of clinical care delivery at the
individual patient level is newer and as such brings its own set
of challenges. Clinical integration requires both that patients
complete the measures and that providers use the data in the
care of patients. Taking advantage of these data for research
means facing the same challenges. If data are not addressed for
a given patient due to either patient nonresponse or clinician
nonuse, it detracts from future patient participation and
diminishes researchers’ ability to evaluate impact. Orthopedic
centers in our care delivery system have been systematically
collecting PROMs since spring 2017. The data has been
available in Epic for use by clinicians since summer 2019.
Methods: In this work we describe current response rates to
orthopedic PROMs in our care delivery system and use rates
by clinicians. We describe efforts led by a multidisciplinary
team with representation across research and clinical
leadership to increase both patient response as well as
clinicians’ use of these data and the impact of these efforts.
Results: Patient methods to improve response rates include
introduction of additional modes of survey delivery and
introduction of measures developed with patient input.
Clinician efforts included awareness building, staff support
for use, and reporting of comparative use rates among
clinicians. Preintervention patient response rates average
about 60% depending on surgery type and time point.
Preintervention clinician use rates were less than 2%,
suggesting a critical need for improvement. Early outcomes
of these efforts, unavailable now, will be reported.
Conclusion: The use of PROMs to study and improve
care delivery is dependent on high levels of engagement
by both patients and clinicians. Working with operational
care system leaders and patients, we identified and tested
strategies to improve their use and value.
OA2.03
Implementation of an Opioid Withdrawal Clinical
Pathway: A Health System Quality Improvement
Initiative to Screen and Treat Medical Inpatients
Kimberly Williams, Beverly Wilson, Claudine Jurkovitz,
Jo Melson,1 Jeffrey Reitz,1 Carmen Pal,1 Sherry
Hausman,1 Erin Booker,1 Linda Lang,1 Terry Horton1
1

ChristianaCare, Wilmington, DE
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Background: Opioid-related inpatient hospital stays are
increasing at alarming rates. Unidentified and poorly treated
opioid withdrawal may be associated with inpatients leaving
against medical advice and increased health care utilization.
To address these concerns, we developed and implemented
an opioid withdrawal clinical pathway to screen and treat
medical service inpatients. This study aimed to evaluate the
implementation and sustainability of this pathway in our
health care system.
Methods: The pathway process included administration of
a 2-item universal screening instrument to identify opioid
withdrawal risk (ie, Opioid Withdrawal Risk Assessment
[OWRA]), use of the validated Clinical Opiate Withdrawal
Scale (COWS) to monitor opioid withdrawal symptoms
and severity, and a 72-hour buprenorphine/naloxonebased treatment protocol. Process measures monitored our
implementation outcomes, including adoption, fidelity, and
sustainability of this new pathway model. To assess if there
were changes in the knowledge, perceptions, and attitudes
of participating nursing staff, a survey was administered
to 4 hospital medical units before and after pathway
implementation.
Results: Between December 2016 and December 2018,
72.4% (77,483 of 107,071) of admitted patients received
the OWRA screening tool. Of those, 3.0% (2347 of 77,483)
were identified as at risk for opioid withdrawal. Of those
2347 patients, 2178 (92.8%) were assessed with COWS,
and 29.6% of those (645 of 2178) were found to be in active
withdrawal. Nearly half of patients in withdrawal (319 of
645, 49.5%) were treated with buprenorphine/naloxone.
More than half of nurses (83 of 145, 57.2%) completed both
the initial and follow-up surveys in February and December
2016, respectively. Pairs analysis of the pre/post survey data
revealed that nurse respondents were significantly more
confident in their ability to determine which patients are at
risk for withdrawal (P=0.01) and had increased confidence
in their ability to identify patients currently experiencing
withdrawal (P=0.008).
Conclusion: Our study demonstrates a process for successfully
implementing and sustaining a clinical pathway to screen
and treat medical service inpatients for opioid withdrawal
within the health care system. Standardizing care delivery
for patients in opioid withdrawal also can improve nursing
confidence when working with this complex population.
OA2.04
Where Do I Store My Guns Until I’m Feeling Better?
Evaluation of Outreach Methods for a Safe Storage
Web-Based Decision Aid: Lock to Live
Jennifer M. Boggs,1 LeeAnn M. Quintana,1 Arne Beck,1
Samuel B. Clinich,1 Laura Richardson,1 Amy Conley,1
James T. Hardee,1 Marian Betz2
Kaiser Permanente Colorado, Denver, CO; 2University
of Colorado, Aurora, CO
1

www.aurora.org/jpcrr

73

Background: Safe storage of lethal means, such as firearms,
medications, and other potentially dangerous household
items, is a highly recommended suicide prevention practice.
However, many patients with suicide risk are not counseled
on lethal means safety in both medical and mental health
settings. “Lock to Live” is an anonymously delivered webbased decision aid that incorporates patients’ values and
preferences into recommendations for safe storage of lethal
means, specifically firearms. “Lock to Live” was designed
with input from 60 stakeholders, including medical/mental
health providers, public health researchers, and the firearm
community, and had high acceptability in pilot testing.
However, achieving adequate patient engagement is a
major barrier for most web-based prevention strategies. We
compared use of “Lock to Live” through a variety of delivery
approaches (eg, email, mail) on website visit rates, with
messaging that emphasizes anonymity.
Methods: Adult members of a large integrated health care
system (Kaiser Permanente Colorado) who reported suicide
risk on the Personal Health Questionnaire-9 depression
screener, administered during mental health and medical
visits, were invited to visit “Lock to Live.” Invitation
messages emphasized anonymity, and were co-designed
with input from clinicians, public health researchers, and
members of the Colorado Firearm Safety Coalition. Several
different delivery method approaches were piloted: mail,
text, email, patient medical record message, and providerdelivered. Two weeks after receiving an invitation to “Lock
to Live,” patients will receive a web-based survey to evaluate
satisfaction, delivery method preferences, perceptions of
privacy, ease of use, and safe storage behavior.
Results: Approximately 2500 patients will be invited to visit
“Lock to Live” and complete a follow-up survey (500 per
delivery method). Outreach started in October 2019 and will
finish in March 2020. “Lock to Live” visit rates and survey
data for each outreach approach will be reported.
Conclusion: Findings will be used to develop an implementation
guide for “Lock to Live” that highlights advantages/
disadvantages for each delivery approach. Next steps are
implementation of a large hybrid randomized effectiveness/
implementation trial of “Lock to Live” using 1 or more delivery
approaches that are determined most acceptable to patients and
feasible for implementation on a large scale.
OA7.01
Consequences of Using an Automated Electronic
Health Record Tool to Screen and Enroll
Participants in a Pragmatic Cluster-Randomized
Hypertension Trial
Karen L. Margolis,1 A. Lauren Crain,1 Beverly B.
Green,2 Patrick J. O’Connor,1 Leif I. Solberg,1 Mary Sue
Beran,1 Anna Bergdall,1 Pamala A. Pawloski,1 Jeanette
Y. Ziegenfuss,1 Amy Kodet,1 Daniel Rehrauer,1 Zeke
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HealthPartners, Bloomington, MN; 2Kaiser Permanente
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Background: Pragmatic trials are desirable to demonstrate
the efficacy of clinical interventions in real-world settings.
They often apply minimal exclusion criteria to broadly
accrue patients from usual care settings. However, these
features may present challenges to intervention fidelity and
adherence.
Methods: We enrolled patients into this clinic-randomized
trial of clinic-based vs pharmacist-led telehealth-based blood
pressure (BP) management using electronic health record
(EHR) algorithms triggered by BP entry during primary
care encounters. Algorithms applied the following criteria
to screen patients for eligibility: 1) age 18–85 years; 2) >2
hypertension diagnostic codes in 24 months; 3) an encounter
with primary care provider in 12 months; 4) BP of >150/95
mmHg on two consecutive occasions; and 5) no identified
pregnancy, end-stage renal disease, or hospice/nursing
home residence. If eligible, a best-practice alert prompted
rooming staff to pend a hypertension follow-up referral order,
defaulted to nurse BP check in clinic-based and a pharmacist
in telehealth-based clinics. Clinicians subsequently accepted,
changed, or dismissed the order at their discretion. Patients
were considered an enrolled participant when that order was
signed, with a goal of 2000 enrollees.
Results: Of 222,134 patients screened over 18 months in
21 study clinics, 3796 (1.7%) were eligible and 3072 (1.4%,
81% of eligible) were enrolled. Enrollees (mean age: 60
years; sex: 47% male; race: 69% white; mean BP: 164/94
mmHg) differed slightly from eligible patients without
signed follow-up orders (mean age: 63 years; sex: 51% male;
race: 77% white; mean BP: 164/92 mmHg). Within 6 weeks
of enrollment, 55% of clinic-based and 63% of telehealthbased enrollees attended hypertension follow-up, but only
32% of clinic-based and 27% of telehealth-based enrollees
attended follow-up consistent with their randomized clinic
assignment. Among the telehealth care subjects who saw the
pharmacist, 86% agreed to home BP monitoring and 94% of
those sent in at least 1 home BP measurement.
Conclusion: Automated EHR mechanisms to screen and
enroll a high proportion of eligible patients into a pragmatic
trial exceeded study enrollment goals. However, intervention
exposure was lower than anticipated, particularly for
subjects in telehealth-based clinics. The negative impact
on intervention exposure and fidelity will potentially dilute
intent-to-treat BP outcomes but will be assessed using a
complementary per-protocol analysis.
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OA7.02
SUPPORT-AF II: A Cluster Randomized Study of
Electronic Profiling and Messaging Combined
With Academic Detailing for Providers Making
Decisions About Anticoagulation in Patients With
Atrial Fibrillation

Conclusion: Our electronic messaging and academic detailing
intervention was feasible but did not increase anticoagulation
use. Patient-directed interventions or provider interventions
targeting patients declining anticoagulation may be necessary
to raise the rate of anticoagulation.
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Evaluation in a Continuously Learning Health
System: Findings From a Critical Access Hospital
Telemedicine Program
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and Women's Hospital, Harvard Medical School, Boston,
MA; 6Massachusetts General Hospital, Boston, MA;
7
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Background: Previous provider-directed electronic
messaging interventions have not by themselves improved
anticoagulation use in patients with atrial fibrillation (AF).
Direct engagement with providers using academic detailing
coupled with electronic messaging may overcome the
limitations of the prior interventions.
Methods: We randomized outpatient providers affiliated with
our health system in a 2.5:1 ratio to our electronic profiling/
messaging combined with academic detailing intervention.
In the intervention, we emailed providers monthly reports of
their anticoagulation percentage relative to peers for patients
with AF who had elevated stroke risk (CHA2DS2-VASc score
of ≥2). We also sent electronic medical record-based messages
shortly before an appointment with an anticoagulationeligible but untreated AF patient. Providers had the option to
send responses with explanations for prescribing decisions.
We also offered to meet with intervention providers using an
academic detailing approach developed based on knowledge
gaps discussed in provider focus groups. To assess feasibility,
we tracked provider review of our messages. To assess
effectiveness, we measured the change in anticoagulation for
patients of intervention providers relative to controls.
Results: We identified 85 intervention and 34 control
providers taking care of 3591 and 1908 patients, respectively;
33 intervention providers participated in academic detailing.
More than 80% of intervention providers read our emails, and
98% of the time a provider reviewed our in-basket messages.
Replies to messages identified patient refusal as the most
common reason for patients not being on anticoagulation
(11.2%). For the group of patients not on anticoagulation at
baseline assigned to an intervention vs control provider, the
adjusted percentage increase in the use of anticoagulation
over 6 months was 5.2% vs 7.4%, respectively (P=0.21).
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Background: Rigorous evaluation of novel clinical programs
is a central tenant of continuously learning health systems. The
triangulation of administrative health systems data and more
traditional evaluation methods (eg, stakeholder surveys) is key
in these efforts. The purpose of this work is to present findings
from a robust evaluation of a new telemedicine program
delivered in one health system’s critical access hospitals.
The specific evaluation presented herein tests the impact of
telemedicine on stakeholder experience and clinical outcomes.
Methods: This telemedicine program was designed to
facilitate real-time overnight clinical care at critical access
hospitals with an onsite care team and remote hospitalists via
a hub-and-spoke model. Using a prospective pragmatic pre/
post evaluation design, administrative data (from electronic
health records) was collected to measure clinical processes
and outcome measures. Patient, hospitalist, and nurse surveys
were collected throughout and after program implementation
to understand impact on experience and make program
improvements. Differences in clinical process measures were
tested via chi-squared tests and logistic regression with a
noninferiority test was used to compare longer-term clinical
outcomes for telemedicine and usual care.
Results: Findings show that patients, nurses, and hospitalists
would recommend the program and perceived a high quality
of care, offering feasible recommendations to enhance
communication. On average, lengths of hospital stay were
shorter (P<0.01), and a higher proportion of care was
delivered at night postimplementation (P=0.02). Telemedicine
was demonstrated to be no worse than usual care in terms
of hospital transfers (odds ratio: 0.73; 95% CI: 0.54–1.00),
but the evaluation was not able to demonstrate the same for
other clinical outcomes.
Conclusion: This presentation will discuss how these
evaluation findings were disseminated and used to strengthen
this novel telemedicine program within the context of a
learning health system. For example, these results were used to
make practical improvements in program implementation and
strengthen the case for future reimbursement of telemedicine
in rural acute care.
www.aurora.org/jpcrr
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Results From a Randomized Trial Comparing
Strategies for Helping Community Clinics Implement
Guideline-Concordant Cardioprotective Care
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Background: Statins can reduce cardiovascular disease
risk in patients with diabetes mellitus, but statin prescribing
lags behind current recommendations. We compared how
3 increasingly intensive implementation support strategies
impacted community health centers’ (CHCs) adoption of
electronic health record (EHR) clinical decision support tools
targeting guideline-concordant statin prescribing in diabetes
mellitus. The tools (the “CVD Bundle”) were adapted from a
previously successful intervention.
Methods: In this mixed-methods, pragmatic comparative
effectiveness trial, we randomized 29 CHCs with a shared
EHR to 3 arms, which received varying implementation
support: 1) implementation toolkit (CVD Bundle
instructions, quality improvement techniques); 2) toolkit +
in-person training with follow-up webinars; or 3) toolkit,
training, webinars + offered practice facilitation. All study
CHCs identified a champion to oversee research activities.
Statin prescribing rates were compared across arms, and with
those in 137 nonrandomized CHCs (a comparison group).
We compared change in statin prescribing from 12 months
preintervention through 36 months postintervention using
adjusted Poisson regressions. We collected qualitative data
using diverse methods (eg, interviews, observations).
Results: Statin prescribing increased preintervention to
postintervention for all arms, although not in the hypothesized
additive pattern. Arms 1 and 2 improved prescribing rates
significantly (by 7% and 8%, respectively) relative to
comparison CHCs (3%). Qualitative analysis identified
interconnected clinic- and intervention-level factors
underlying these results: 1) Problems with the EHR tools
reduced their utility; 2) High staff turnover was a barrier
to providing the planned implementation support; 3) The
influence of study champions varied greatly; and 4) The
provided support could not be adapted to each clinic’s
specific needs. Overall improvements in statin outcomes were
likely influenced by a secular trend in awareness of statin
prescribing guidelines and study participation bias.
Conclusion: The implementation strategies utilized were
associated with small improvements in guideline-concordant
statin prescribing. CHCs that received more intensive
implementation support did not have greater improvements
in prescribing rates. Efforts to implement care guidelines
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should ensure adaptability when providing implementation
support and use early evaluations to determine the optimal
form of such support for a given clinic. More research is
needed on supporting change implementation, especially in
underresourced settings like CHCs.
P10.01
Validating Results From a Coincidence Analysis
Using Diverse Stakeholders’ Perspectives on
Survivorship Care Plan Implementation in Complex
Health Systems
Sarah Birken,1 Soohyun Hwang,1 Rebecca Whitaker,2
Burcu Bozkurt,1 Sarah Asad,1 Tamara Huson,1 Ted
James,3 Lawrence Shulman,4 Deborah Mayer1
University of North Carolina at Chapel Hill, Chapel
Hill, NC; 2Duke-Margolis Center for Health Policy,
Duke University, Durham, NC; 3Beth Israel Deaconess
Medical Center, Boston, MA; 4Abramson Cancer
Center, University of Pennsylvania, Philadelphia, PA
1

Background: Achieving desired intervention outcomes
requires
successful
implementation.
Successful
implementation
requires
identifying
high-leverage
strategies. Identifying high-leverage strategies in health
systems is complicated because 1) multiple paths to
successful implementation likely exist, and 2) perceptions
of implementation success likely vary across stakeholders.
These challenges can be addressed with coincidence analysis
(CNA). CNA combines within-case and logic-based crosscase analysis to identify multiple “recipes” for successful
implementation. Herein, we report a method for validating
CNA results using the perspectives of the kinds of diverse
stakeholders who characterize complex health systems. We
use the example of applying CNA to identify strategies for the
successful implementation of survivorship care plans (SCP),
documents recommended to improve survivorship care.
Methods: We used data from in-depth, semi-structured
interviews with 42 providers/staff in 39 cancer programs
and 23 breast cancer survivors who received care in 15 of
the 39 programs regarding SCP implementation success and
strategies. We transformed codes from qualitative analyses
into dichotomous or multivalue factors for use in CNA. We
then created 2 datasets — 1 using the perspective of providers/
staff to define SCP implementation success and 1 using the
perspective of survivors. We will analyze the 2 datasets
independently using the R-package “can” function. Our final
step will be to assess whether strategies for successful SCP
implementation vary based on provider/staff vs survivor
definitions of SCP implementation success.
Results: Four investigators analyzed data from 65 interviews
over 5 weeks, representing more than 200 combined personhours of coding. Reconciling qualitative coding approaches
to ensure intercoder reliability required 4 meetings before
independent coding. Transforming qualitative codes into
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values for analysis in CNA effectively doubled the time
required for coding. Similarly, CNA programming was
required for 2 models, doubling the time typically required for
analysis. We are concurrently comparing the model results.
Conclusion: If different perspectives on implementation
success require divergent strategies, CNA’s usefulness
may be limited for achieving the goals of the diverse
stakeholders who characterize complex health systems.
However, if similar strategies predict outcomes from
diverse perspectives, we would have strong evidence
of CNA’s reliability and thus its importance as a tool for
identifying strategies for health systems change.
P10.02
Applying User-Centered Design to Enhance the
Usability and Usefulness of Patient-Reported
Outcome Measures: A Case Example in Adolescent
and Young Adult Oncology
Emily Haines,1 Alex Dopp,2 Byron Powell,3 Angela
Stover,1 Andrew Smitherman,1 Lauren Lux,1 Sarah
Birken1
University of North Carolina at Chapel Hill, Chapel
Hill, NC; 2RAND Corporation, Santa Monica, CA;
3
Washington University in St. Louis, St. Louis, MO
1

Background: The National Cancer Institute, National
Institutes of Health, and others increasingly advocate for
the use of patient-reported outcome measures (PROMs)
in practice to better address needs of patients with cancer.
However, PROMs are unlikely to address patient needs if
they lack usability (ie, patients/providers find them difficult
to use) or if they are not linked to available services/resources
that will address identified needs (ie, have low usefulness).
To facilitate the delivery of services/resources to address
the unmet needs of adolescents and young adults (AYAs)
with cancer, we developed the Needs Assessment & Service
Bridge (NA-SB). To optimize the usability and usefulness
of NA-SB, we leveraged user-centered design, an iterative
process for intervention development based on prospective
user engagement.
Methods: We solicited input from a design team of users and
researchers throughout the project. We used mixed-methods
usability testing to collect data on user interactions with an
existing PROM, including an online survey and cognitive
interviews with AYAs and concept mapping with providers,
to map PROM-identified needs onto services/resources.
We then used ethnographic methods with prospective users
to identify contextual factors to consider in the design and
implementation of NA-SB; we analyzed ethnographic data
using template analysis. Finally, through two design team
workshops, we designed a useful and usable NA-SB prototype
and implementation plan.
Results: We will report descriptive statistics on users as well
as usability testing and ethnography results. We will describe
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how we collaborated with the design team to produce an
NA-SB prototype and implementation plan as well as
discuss the viability of user-centered design for optimizing
PROM usability and usefulness in other disease contexts.
Conclusion: PROMs are unlikely to be implemented
if users find them difficult to use or irrelevant. Even if
implemented successfully, a PROM’s usefulness will be
limited without an explicit link between PROM-identified
needs and available services/resources to address their
needs. In this case example, we leveraged user-centered
design to enhance an existing PROM’s usability and
usefulness, accounting for context to promote its receptivity
and anticipate needed implementation strategies — in effect,
harmonizing intervention, context, and implementation to
promote NA-SB’s implementation and effectiveness. Future
efforts should apply user-centered design to enhance the role
of PROMs in improving patient outcomes.
P10.03
CM-SHARE Spread: Scaling Up a Digital Health
Research Pilot
Hannah Husby,1 Jake Delatorre-Reimer,1 Farah Refai,1
Xiaowei (Sherry) Yan,1 J.B. Jones1
Sutter Health, Walnut Creek, CA
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Background: Digital health tools have the potential to play an
integral role in transforming health care. Health care systems
are uniquely positioned to understand how to implement
these tools in real-world settings, although the path from
pilot tests to systemwide dissemination remains challenging.
We describe our experience with CM-SHARE, a web-based
digital health application designed to help physicians and
patients manage cardiometabolic (CM) conditions. In its
pilot, CM-SHARE demonstrated successful adoption and
led to statistically significant improvements in measures of
physician efficiency. Our objective was to then spread CMSHARE across our health care system.
Methods: We conducted a nonsystematic assessment of
available toolkits for dissemination and selected 3 sets
of strategies that addressed anticipated challenges in our
system. Our people strategies included engaging the right
level of leadership to endorse and support the spread effort
and identifying local champions for day-to-day support. Our
communications strategies included identifying the relevant
meetings to engage and inform future users and creating
training and informational materials. Our resources strategies
focused on ensuring appropriate technical modifications
were made to the pilot and making sure day-to-day support
was available in individual clinics. We are testing these
methods in a stepwise fashion and will modify based on
learnings before expanding to other medical foundations
and the rest of the system.
Results: We identified 2 quality leaders to endorse the
systemwide spread effort. We partnered with a physician
www.aurora.org/jpcrr
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champion during an 8-month “pre” period to garner support
among Sutter Health leaders across stakeholder groups.
Sutter’s electronic health record trainers provide side-byside support to practicing clinicians. This train-the-trainer
approach allows for a level of day-to-day support beyond
what research could provide alone. We developed training
materials and flyers to communicate about the purpose,
value, and availability of the tool. Feedback from users
is systematically collected by the trainer, and appropriate
modifications will be communicated to users. Our poster will
describe adoption rates among new users, effective methods
and strategies of communication, and key physician feedback.
Conclusion: By engaging physician champions and
leadership, the research team has successfully initiated a
systemwide dissemination effort for a new digital health
tool. Findings will be applied to future spread sites.
P10.04
Testing the Effectiveness of an Employee-Offered
Behavioral Weight-Loss Program in a Learning
Health System: Study Design and Baseline Results
Meghan JaKa,1 Jennifer Dinh,1 Rachael Rivard,1
Stephen Herrmann,2 Nico Pronk,1 Jeanette Y.
Ziegenfuss,1 Joel Spoonheim1
HealthPartners, Bloomington, MN; 2Sanford Health,
Sioux Falls, SD
1

Background: Obesity is a leading cause of the most
expensive chronic health conditions faced by employers. As
such, learning health systems aim to test and offer effective
weight-loss programs as a part of well-being incentive
programs. This presentation reports one health plan’s efforts
to pilot and test the effectiveness of an evidence-based
behavioral weight-loss program among its employees,
providing a unique opportunity to combine employeereported, claims, and programmatic data.
Methods: This pragmatic pre/post evaluation measures
fidelity, outcomes (psychosocial, lifestyle, workplace, health,
well-being), and incentive program preferences via survey,
claims, and programmatic data. Employees/dependents with
insurance through a large health system in the Midwest
were offered “Profile by Sanford” at a discounted rate.
Profile includes coaching, meal replacement offerings, and
regular self-monitoring (food journals and self-weighing).
Profile participants were recruited to the study immediately
following enrollment. Surveys are completed at baseline, 3, 6,
and 12 months, and claims data are pulled for the year before
and after enrollment. Descriptive statistics will be presented
for measured baseline outcomes. Designed intent-to-treat and
per-protocol analysis plans also will be presented.
Results: Of the 354 employees/dependents enrolled in
Profile, 41% provided consent for the study and completed
baseline measures. Study participants (mean age: 50 ± 10
years; mean body mass index: 33 ± 6 kg/m2) were primarily
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female (90%) and of non-Hispanic white race (95%) and
had at least some college education (80%). Nearly all (96%)
reported prior weight-loss attempts. Baseline life and job
satisfaction was high (81% and 93%, respectively, said 7+ on a
10-point scale), with more moderate levels of healthy weightrelated behaviors (64% avoid sugar-sweetened beverages,
21% eat 5+ fruits/vegetables daily, 12% with 5+ days/week
of vigorous activity). Preliminary fidelity results indicate
initial satisfaction with Profile was high (n=42 provided
unprompted positive feedback in open-ended questions), with
some offering opportunities for improvement (eg, related to
technology, coaching).
Conclusion: Findings suggest the feasibility of implementing
and evaluating a weight-loss program offered to employers
as an incentivized health and well-being offering. The results
of this study will be discussed in the context of other weightrelated offerings and will be used to make programmatic
improvements and informed health plan decisions, following
best practice in learning health systems.
P10.05
Utilizing Dissemination Strategies to Implement a
Systemwide Initiative in a Large Health Care System
Farah Refai,1 Xiaowei (Sherry) Yan,1 Zijun Shen,1
William Isenberg,1 Mitesh Patel,2 Amol Navathe,2 Kit
Delgado,2 Rebecca Pepe,2 Joshua Liao3
Sutter Health, Walnut Creek, CA; 2University of
Pennsylvania, Philadelphia, PA; 3University of
Washington, Seattle, WA
1

Background: Systemwide interventions are challenging to
disseminate effectively across large health care systems.
Sutter Health, a large health care system in Northern
California, in collaboration with University of Pennsylvania
and University of Washington, implemented a 6-month
quality improvement initiative across all emergency
departments (EDs) and urgent care clinics (UCs) to reduce
opioid prescriptions. We describe our experience using
dissemination strategy and communication methods to
navigate and successfully implement this intervention in all
21 EDs and 27 UCs across Sutter.
Methods: We assessed strategies available from
dissemination science and selected 2 sets that directly
addressed anticipated challenges disseminating in both UCs
and EDs. We focused on communications and people. Our
top-down communications approach comprised establishing
3 primary levels of communication to engage Sutter leaders
and use their influence to enroll clinicians to the initiative
— first level: CEOs; second level: physician leadership; and
third level: medical directors. Our people strategy centered
on engaging influential stakeholders to support and endorse
systemwide dissemination. We tested these strategies in a
pilot phase involving 6 clinicians and implemented them in
all EDs and UCs after successful results.
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Results: Every ED and UC in the system, which included 451
eligible clinicians, was successfully enrolled in the initiative.
Our team found that EDs and UCs are managed very
differently at Sutter, and as such the top-down communications
strategy worked best for EDs and the people strategy for
UCs. Structurally, all Sutter ED leaders and sites are managed
by the system ED leadership group, and endorsement from
the chair and group is key to successful dissemination to
all sites. In contrast, Sutter UCs practice independently
from one another. UCs required significant time and effort
communicating directly with each medical director and
developing site-specific presentations to obtain support. Our
poster will describe effective strategies of communication and
key learnings for UC and ED dissemination.
Conclusion: Reliable communication methods and
leadership buy-in are key for universal, systemwide
dissemination efforts. An understanding of work culture
and identification of key stakeholders and gatekeepers is
crucial for efficient and successful dissemination.
P10.06
Using Practice-Based Evidence to Optimize
Survivorship Care: Results From a Pilot Test of
Supporting Transitions AfteR Treatment (START)
Sarah Birken, Burcu Bozkurt, Octavia Gladden,
MaryBeth Grewe,1 Emily Haines,1 Soohyun Hwang,1
Ann Jackson,2 Darren DeWalt,3 Deborah Mayer,1 Morris
Weinberger,1 Sarah Nikolich,1 Karen Kimel-Scott,1
Jennifer Leeman1
1

1

1

University of North Carolina at Chapel Hill, Chapel Hill,
NC; 2lead patient partner; 3UNC School of Medicine,
Chapel Hill, NC
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Background: After completing treatment, many low-risk
breast cancer survivors receive follow-up care from oncology
providers despite the benefits of receiving follow-up care
from primary care providers (PCPs). Interventions intended
to promote survivors’ transitions from oncology providers to
PCPs exist, but their effectiveness is limited. We addressed the
limitations of extant interventions by developing Supporting
Transitions AfteR Treatment (START), a 3-step, low-intensity
intervention specifically targeting the multilevel barriers to
transitioning survivors to primary care.
Methods: In this study, we describe refining START based on
the demands of a complex practice environment, pilot testing
it in a tertiary academic comprehensive cancer program
with the objectives of integrating START into existing clinic
processes. Currently, we are conducting interviews with
oncology providers, survivors, and PCPs regarding START’s
appropriateness, acceptability, and feasibility.
Results: The oncology provider enrolled in the pilot study
identified several opportunities to refine START based on the
demands of a complex practice environment. Refinements
included increasing the flexibility of oncology provider
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education, reminding oncology providers of upcoming
visits for potentially eligible survivors, and using an existing
clinic form to deliver START content. In preparation for
implementing the refined START intervention, we identified
6 potentially eligible survivors (14%) among 43 scheduled
patients across 5 clinic days.
Conclusion: Our careful attention to incorporating lessons
from efforts to change clinical practice in the context of
complex practice environments into START distinguishes
our intervention from extant survivorship care improvement
interventions, which have largely been based on expert
consensus and have not been refined to reflect the challenges
of implementation in the context of complex practice
environments and thus have had substantial difficulty with
implementation. By incorporating practice-based evidence
into START, this study meaningfully contributes by generating
practice-based evidence regarding an intervention intended to
optimize survivorship care.
P10.07
Approaches Used to Develop a Clinic-Based
Medication Disposal Program Targeting OpioidNaïve Patients
Lorraine Tusing,1 Jove Graham,1 Alanna Kulchak
Rahm,1 Eric Wright1
Geisinger Health, Danville, PA
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Background: Opioid-related drug overdose deaths continue
to rise, with unused prescription opioids being a primary
entry point. Evidence suggests that education by providers
and access to disposal items improves disposal rates among
patients with unused opioids but is not widely implemented.
The goal of our larger project is to develop and evaluate the
effectiveness and scalability of a clinic-based medication
disposal program for patients newly prescribed opioid
medications utilizing the RE-AIM framework to guide
implementation planning and evaluation. Herein, we describe
the processes used to develop the program and the impact of
these approaches on the pragmatic nature of the study.
Methods: The initial medication disposal program was
developed by the study team, inclusive of a literature search,
informal discussion with clinic leadership, and institutional
experience with implementing programs into primary care.
This program design was reviewed and critiqued through
1:1 unstructured interviews with system leaders, clinicians,
embedded service line best practice team representatives,
information technology support leaders, and clinical
informaticians. The PRagmatic Explanatory Continuum
Indicator Summary (PRECIS-2) was used to evaluate the
pragmatic level of the larger evaluation study design before
and after adjustments based on stakeholder feedback.
Results: 13 primary care clinics were identified for
participation. Initial design involved physicians providing
both written and verbal education, along with physical
www.aurora.org/jpcrr
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disposal items (eg, a mail-back disposal bag) at the clinic visit,
but stakeholders expressed concerns over poor adoption of
and fidelity to this process. Following input from stakeholder
interviews, program design was revised to remove the physical
supply of written education materials and disposal items from
the clinic to a centralized location and the mailing of materials
directly to the patient by the study team. This resulted in a
slightly less pragmatic design (driven by the movement of
organization from very pragmatic to rather pragmatic due to
the insertion of a centralized mail process). The PRECIS-2
results for the finalized overall study design in each category
ranged from rather pragmatic (4) to very pragmatic (5).
Conclusion: Following interviews with clinical and system
leadership, the medication disposal program to be implemented
and evaluated remained pragmatic and is expected to reduce
barriers to effective implementation.
P10.08
Evaluation of a Pilot Implementation of PopulationBased Risk Assessment for Breast Cancer
Screening and Prevention

Geisinger facilities without the implementation during the
same time period. The comparison cohort will be obtained
by matching using a 1:1 ratio on the bases of age, breast
density, Gail score, and comorbidities. We will measure the
percentage of increased-risk women identified. Descriptive
analysis will be conducted to compare the two cohorts on
referral to HRBC and their postmammography guidelinerecommended preventive screening and prevention
services at 1-year preimplementation and at 1-year
postimplementation. Difference-in-differences will be
applied to evaluate these initial outcomes of risk assessment
implementation.
Results: Preliminary data show that during the first year
of implementation, about 7400 women underwent routine
screening mammography with risk assessment. Using data
from the first few weeks postimplementation, about 65% of
women were identified as being at increased risk for breast
cancer.
Conclusion: Study findings on the initial impact of the risk
assessment pilot are expected to demonstrate its effectiveness
and areas for improvement for achieving personalized breast
cancer screening and prevention.

Dina Hassen1 Alanna Kulchak Rahm,1 Susan R.
Snyder,2 Mallory Snyder,1 Brianna Maciejewski,1
Serena Tripp,1 Jason Brown,1 Rosemary Leeming,1
Aalpen Patel1 Jing Hao1

P10.09
Barriers and Facilitators to Genetic Testing for
Familial Hypercholesterolemia in the United States

Geisinger Health, Danville, PA;
University, Atlanta, GA

Rachele Hendricks-Sturrup,1 Kathleen M. Mazor,2
Amy Sturm,3 Christine Y. Lu1
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Georgia State
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Background: Risk stratification is increasingly recommended
as the new standard of care to identify and offer appropriate
breast cancer screening and prevention services. Beginning
in May 2018, Geisinger Medical Center in Danville,
Pennsylvania, implemented a pilot population-based
risk assessment strategy for all women receiving routine
screening mammograms in Radiology. Language identifying
patients’ risk of either “increased” or “not increased over
that of other women your age” was incorporated into
mammography reports. A recommendation for referral to
the High-Risk Breast Clinic (HRBC) for more personalized
risk evaluation and appropriate risk-based preventive care
management was placed in the mammography report for
women identified at increased risk. The study objective is to
evaluate the initial outcomes of this pilot implementation to
determine if it impacted referral and use of evidence-based
services.
Methods: We conducted a retrospective analysis on
women who underwent routine screening mammography
at Geisinger Medical Center and identified as at increased
risk during the first 6 months of the risk assessment pilot
implementation. The patients’ risk-level category was
identified using chart review, and health care utilization
was obtained from the electronic health record. We will
identify retrospectively a comparison cohort of women
who underwent routine screening mammography at other
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Harvard Pilgrim Health Care, Boston, MA; 2Reliant
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Background: Familial hypercholesterolemia (FH) is an
underdiagnosed condition in the United States and globally. It
is a genetic risk factor for premature cardiovascular disease, is
responsible for an estimated 600,000 to 1.2 million preventable
vascular events, and affects an estimated 1 in 250 individuals
in the United States. FH genetic testing can identify a causal
gene variant in 60% to 80% of clinically suspected FH cases.
Clinical FH genetic testing, however, is underutilized in the
United States for reasons that are poorly understood.
Methods: We searched the PubMed/MEDLINE database and
7 peer-reviewed journals to identify potential barriers and
facilitators to FH genetic testing in the United States. After
filtering 2340 articles based on our inclusion criteria, we
selected 9 commentaries or expert opinions and 8 empirical
studies reported from January 2014 to March 2019 for
inclusion.
Results: After applying the Consolidated Framework for
Implementation Research (CFIR) to understand the nature of
these potential barriers and facilitators, we identified a total of
26 potential barriers and 15 potential facilitators (estimated
barrier-to-facilitator ratio of 1.73). We estimated ratios of
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potential barriers to facilitators were calculated for each CFIR
domain (characteristics of intervention, outer setting, inner
setting, characteristics of individuals, and process).
Conclusion: Findings derived from our systematic approach
to the literature and calculations of estimated baseline ratios
of barriers and facilitators can be used to inform future
research on understanding implementation of genetic testing
for familial hypercholesterolemia in the United States.

Most patients found it easy to use and were able to complete
the tool quickly. While some patients felt the tool made
the visit more efficient, other patients felt that it created
unnecessary work. Helpful features included the ability to
visually see their list as well as the ability to add and remove
medications, which patients felt improved the accuracy of
their medication list.
Conclusion: A web-based tool to facilitate medication
reconciliation was well received by patients.

ELECTRONIC HEALTH RECORDS,
TECHNOLOGY, AND DIGITAL HEALTH

OA3.02
Leveraging Electronic Health Record Data and
Partnerships to Enhance Latent Tuberculosis
Infection Surveillance

OA3.01
Patient Perceptions of a Web-Based Medication
Reconciliation Tool
Michael Gionfriddo,1 Vanessa Duboski,1 Melissa Kern,1
Eric Wright1
Geisinger Health, Danville, PA

1

Background: Despite routine review of medication lists
during patient encounters, patients’ medication lists remain
incomplete and not reflective of actual medication use.
Reconciling medication use from existing health records,
along with external locations (eg, pharmacies, other
provider/hospital records and care facilities) remains a
large challenge. Advances in interoperability and digital
connections provide a foundation for integration of these
once-disparate information sources. We developed a webbased tool (MedTrue™) that facilitates the reconciliation
of these varying sources of information and places it into
the use of patients and providers through direct electronic
health record integration. We report on patient satisfaction,
usability, and acceptability of the tool.
Methods: We conducted a mixed-methods study of patient
experiences with MedTrue through a patient-facing survey
and through semi-structured interviews. The survey assessed
patient satisfaction with the tool and consisted of 5 questions.
A study team member conducted semi-structured interviews
with a convenience sampling of patients following clinic
encounters at which MedTrue was used. The interviews
lasted up to 30 minutes, and patients were offered a $10
gift card for participating. Interviews continued until it was
decided that data saturation had been met. Interviews were
transcribed verbatim and thematically analyzed.
Results: MedTrue was used by 7341 patients; 1450
(20%) completed the optional patient satisfaction survey
at the conclusion of MedTrue. Patients were satisfied
with MedTrue, giving it an average rating of 8 out of 10.
Additionally, 88% agreed or strongly agreed that it was easy
to use, and 85% agreed or strongly agreed that it helped
them create a more accurate medication list. We recruited
14 patients (and 1 spouse) for semi-structured interviews.
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Background: Eliminating tuberculosis (TB) in the United
States requires correctly identifying and treating patients with
latent tuberculosis infection (LTBI). Appropriate screening
and interventions require a robust surveillance system
capable of measuring screening, treatment, and risk factors,
particularly in primary care settings. Community health
centers are instrumental, as they see a large proportion of
people who may be at higher risk for LTBI.
Methods: We conducted secondary data analysis utilizing
Big Data from a large U.S.-based electronic health
record (EHR) network with clinics in 20 states. Initial
epidemiological exploration of LTBI/TB cascade of care
will inform future interventions using EHR tools to identify
and treat patients with LTBI/TB. The population studied
included 2,190,686 low-income and underserved patients
seen in approximately 700 safety-net clinics between
January 1, 2012, and December 31, 2016.
Results: This study calculates the proportions of patients
screened for LTBI/TB using 3 separate TB screening
tests: tuberculin skin tests (TST), QuantiFERON-TB
Gold (QFT), and T-SPOT.TB. Among the study cohort,
151,195 (6.9%) unique patients had a total of 185,854 TB
screening tests. Most screening tests were TST, with a total
of 139,561 (75.1%), followed by 45,567 (24.5%) QFT and
726 T-SPOT.TB (0.4%).
Conclusion: Using Big Data systems for TB surveillance
is challenging, especially finding and normalizing pertinent
lab data for LTBI and TB and highly variable medicationdispensing data. Many opportunities exist to improve data
collection in primary care setting in order to enhance LTBI
and TB surveillance. Next steps include adapting data
extraction techniques to be utilized in The National PatientCentered Clinical Research Network (PCORnet®).
www.aurora.org/jpcrr
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Predicting Sepsis Using Machine Learning: Impact
of Design Decisions on Assessment of Predictive
Performance
Sylvia Sudat, Philippe Boileau, Shruti Vaidya, Ridhima
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Background: Machine learning-based predictive modeling
has been increasingly explored and implemented for
various health-related applications. In these settings,
premodeling design decisions may be complex and heavily
influence both a model’s performance and its potential
clinical utility. Traditionally, little attention is paid to
the possible impact of these design decisions. Sepsis has
been a focus of early identification efforts using predictive
modeling. Sepsis is also difficult to define — its clinical
definition is changing over time — and those who meet
clinical criteria may or may not ultimately develop sepsis.
It can be nearly impossible to distinguish appropriate
identifications (sepsis averted due to clinical intervention)
from true false positives. Sepsis treatment is also highly
time-sensitive, making the choices regarding handling of
time-dependent data, such as lab results and vital signs,
very important in terms of the model’s utility. We present
the results of a project using machine learning to predict
onset of sepsis and describe the impact of modeling design
decisions on assessed performance.
Methods: We studied 768,955 adult hospitalizations from
2014 to 2018 at 23 acute care hospitals within Sutter Health,
a large health system in northern California that offers
hospital-based and ambulatory care. We used data during
hospitalization, prior-year comorbidities, and preadmission
clinical/utilization data over prior 2 weeks. We applied
machine learning methods to predict sepsis using standard
clinical criteria and plan to further assess alternate definitions
of sepsis onset and the predictive utility of preadmission data.
Results: Early results predicting sepsis onset using the first
2 hours of hospitalization data produced areas under the
receiving operating curve of 0.877, 0.855, and 0.843 for
developing sepsis within the subsequent 2, 4, and 6 hours,
respectively. More than 70% of those meeting sepsis criteria
did not have a sepsis discharge diagnosis, and future analyses
will explore how the decision to treat these individuals as true
or false positives influences model performance and utility.
Conclusion: Machine learning-based predictive modeling
is an increasingly attractive way to utilize large amounts
of electronic health record data to identify individuals
with increased risk or need for health care services.
Careful attention must be paid not only to standard model
performance measures, but also to the impact of premodeling
design decisions.
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Background: Safety surveillance is difficult for medical
devices, partly because unlike medications that can be
tracked on insurance claims via National Drug Code
numbers, no similar system has existed for devices until
recently. In 2014, the U.S. Food and Drug Administration
(FDA) began requiring manufacturers to label medical
devices with unique device identifiers (including device
identifiers [DIs]). In advance of expected 2020 regulations
that would add DIs to claims, Partners HealthCare, Blue
Cross Blue Shield of Massachusetts, and Geisinger Health
collaborated to demonstrate feasibility of transmitting DIs
from catheterization laboratories to insurance claims, then
analyzed the resulting claims.
Methods: At Partners, devices were scanned and DIs
transferred to billing via the electronic health record (EHR)
using an extension rule to write to the claim when appropriate.
At Geisinger, DIs were sent by inventory management
software to billing, then mapped to the claim form. We
examined claims from 2017 to 2019 to categorize devices by
FDA product code and analyzed 90-day outcomes, including
all-cause readmissions, emergency department visits,
myocardial infarction, revascularization, renal failure, and
bleeding. We stratified results by whether the hospitalization
occurred within the same or a different health system than
where the initial procedure was performed, an important
information advantage of insurance claims.
Results: At Geisinger, 1493 devices for 489 patients were
transmitted to claims; at Partners, 888 devices for 463 patients
were transmitted. The most frequently used implants were
coronary drug-eluting stents (n=213 patients). Of these 213
drug-eluting stent patients, 45 (21%) had a 90-day hospital
readmission, 26 (58%) of which occurred outside the initial
health system and therefore appeared in claims but would not
have appeared in the original hospital’s EHR.
Conclusion: Generating insurance claims with DIs in two
health systems provided proof of concept of the feasibility
of adding DIs to claims with minimal work beyond what
is required for other routine information system updates.
Claims provide meaningful advantages to EHRs in that
they capture out-of-system postprocedure events. For health
system analysts and researchers who use claims data, having
detailed information on the manufacturer and model of
implanted devices that can be linked to patient outcomes will
be a significant step forward toward improved device safety.
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P16.01
Evaluation of Implementing Electronic Prior
Authorization for Medications in a Large Health
Care System
Cheryl Stults,1 Xiaowei (Sherry) Yan,1 Satish
Mudiganti,1 Mengdong He,2 Lisa Dean-Gilley,1
Luke Forster-Broten,3 Nicholas Webber,3 Julie
Lauffenburger,2 Michael Fischer2
Sutter Health, Walnut Creek, CA; 2Brigham and Women's
Hospital, Boston, MA; 3Surescripts, Arlington, VA
1

Background: Prior authorization is intended to manage
prescription drug use and spending by channeling medication
use to patients who meet prespecified criteria to receive
selected medication. However, in practice, prior authorization
is not only imposing substantial administrative burden
to physicians, it also is leading to delays in prescription
filling that may delay patients from receiving potentially
beneficial medications. Electronic prior authorization (ePA)
is an electronic solution that automates the process of prior
authorizations in real time by contacting the pharmacy benefit
manager (PBM). We discuss the implementation and impact
of an ePA application embedded into the Epic electronic
health record in a large health care delivery system.
Methods: Sutter Health is an integrated health care system
in Northern California serving more than 3 million patients
annually. Sutter implemented ePA in a staggered roll-out
from March 2018 to November 2018. Summary statistics
were conducted to understand how ePA is utilized following
full implementation. “Resolved” status means that ePA was
approved or denied by the PBM.
Results: From December 1, 2018, to June 30, 2019, ePA
was queried 59,394 times. Of these, 23,953 (40.33%) were
resolved with an approved (n=15,494) or denied (n=8459)
status. The departments with the most ePA-resolved
requests were family medicine (n=9823), internal medicine
(n=4568), dermatology (n=1380), rheumatology (n=1136),
and endocrinology (n=840). The 5 most common therapeutic
classes with resolved ePA were dermatological/anorectal/
mouth-throat/dental/ophthalmic/otic (n=5559), analgesic/
anti-inflammatory/migraine/gout
agents/anesthetics
(n=4273), cardiovascular agents (n=2679), endocrine and
metabolic agents (n=2094), and antihistamines/nasal agents/
cough & cold/respiratory/miscellaneous (n=1982). The
average time between ePA initiation and resolved was 44.47
hours (median: 14.23 hours), with a range of 0 to 5106.63
hours. The therapeutic subclass with the shortest time to
resolved was dermatological/anorectal/mouth-throat/dental/
ophthalmic/otic (mean: 38.96 hours, median: 8.42 hours), and
the longest was cardiovascular agents (mean: 56.61 hours,
median: 18.08 hours).
Conclusion: To our knowledge, this is the first academic
report on the evaluation of ePA in real-world practice settings.
Initial results suggest that most resolved ePAs were from
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family and internal medicine departments and from the
therapeutic classes of dermatological/anorectal/mouth-throat/
dental/ophthalmic/otic and analgesic/anti-inflammatory/
migraine/gout agents/anesthetics. Further coordination is
necessary to work with PBMs to improve the resolution rate.
P16.02
Exploring Healthy Eating and Digital Health Care
Support in an Overweight Sample of Working
Rural Women
Sharon S. Laing1
University of Washington Tacoma, Tacoma, WA

1

Background: Residents in rural communities in the United
States have increased probability of being obese. Research
show barriers to healthy eating. Technology, including
mobile-based tools, can provide healthy eating coaching
and social connection to disperse communities. This study
explored healthy eating and technology practices related
to preventive care behaviors in a sample of working rural
women who self-identify as overweight/obese.
Methods: 60 women completed a 32-item survey that
assessed Centers for Disease Control and Prevention (CDC)recommended fruit and vegetable (F/V) intake, barriers to
healthy eating, support for healthy eating, and access/use of
technology. Eligibility criteria were 1) English-speaking, 2)
40+ years of age, 3) owned or had access to a smartphone, and
4) self-identify as overweight or obese. Descriptive statistics
characterized healthy eating engagement, support for healthy
eating, and technology access/use. Chi-squared analyses
described the relationship between healthy eating support
and likelihood of using health information technology.
Results: Mean age of respondents was 53 years with mean
body mass index of 32.2. Only 25% adhered to CDCrecommended F/V consumption guideline, and individuals
earning up to $76,000 per year were most likely to follow
the F/V guideline. Those with a high school education or
higher reported adhering to the recommended guideline more
so than individuals with less education (28% vs 11%). More
than half (57%) of respondents experienced healthy eating
barriers, and 52% reported support from family or friends.
Most respondents used their personal computers (92%) and
mobile devices (82%) to look up health information. Almost
two-thirds (62%) reported a likelihood of using online
health information to support healthy eating engagement.
Chi-squared analyses (χ2) revealed a significant relationship
between healthy eating support and likelihood of using online
health information tools, χ2(2, n=60): 7.69, P=0.021).
Conclusion: Working rural women with lower income
and less than a high school education require support to
eat healthy and are less likely to follow recommended F/V
guidelines. Web- and mobile-based technologies can promote
healthy behaviors, and our rural sample appears willing to
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engage in digital health care management. Technologists
should consider sociodemographic factors in the design/
development of innovations to ensure a tailored intervention
for rural women.
P16.03
A New Midwestern Virtual Data Warehouse From
SSM Health and Saint Louis University Health
Care Systems
Leslie Hinyard,1 Jeffrey Scherrer1
Saint Louis University, St. Louis, MO

1

Background: HCSRN membership can lead to transformative
growth in research collaboration and funding. Saint Louis
University (SLU) has funded the development of a virtual
data warehouse (VDW) containing electronic health record
data from more than 2 million patients who have received
care in SLU's academic medical practice or its partner SSM
Health, with the goal of joining the HCSRN and filling the
gap of HCSRN members located in the Midwest. Herein,
we describe the development of a unique comprehensive
VDW encompassing data from two organizationally distinct
collaborative entities.
Methods: A merged instance of Epic between SSM
Health and SLUCare medical practice provided a unique
opportunity for the development of an SSM-SLU VDW.
Working collaboratively with both medical organizations,
SLU researchers obtained a data use agreement for shared data
use across the institutions. SLU researchers consulted with
leadership and collaborators within the HCSRN to inform a
business plan intended to self-sustain the VDW within 4 years.
Upon obtaining institutional support for the project, we recruited
an experienced HCSRN VDW developer and established a
phase 1 goal to extract a limited data set with monthly updates
by June 2020. Phase 2 extends sources of data to new patientreported outcomes, wearables, and geospatial measures.
Results: This unique academic-private health system
collaboration began after data use agreement completion.
The SSM-SLU VDW will include 23 hospitals, nearly 300
ambulatory care sites, and more than 2 million patients who
receive care in Missouri, Illinois, Oklahoma, and Wisconsin.
Patient demographics include sufficient samples of poor
African American and white as well as urban- and ruralbased patients to offer a unique resource for health disparities
research. Publications are expected by the end of 2019, and
application to HCSRN membership will be made in 2020.
Conclusion: The SSM Health-SLU partnership allows for
novel health services and outcomes research comparing
academic to private sector delivery of care. Bridging two
independent organizations with shared data resources
presents both challenges and advantages during resource
development. Early VDW-user research areas include mental
health, infection, asthma, breast cancer, and type 2 diabetes.
Investigators have a successful track record of HCSRN
84
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collaboration, which should enhance our potential to become
members of this national resource.
P16.04
A Web-Based Medication Reconciliation Tool
Reduced Medication Discrepancies in a Primary
Care Population
Michael Gionfriddo,1 Vanessa Duboski,1 Melissa Kern,1
Bhumika Maddineni,1 Yirui Hu,1 Eric Wright1
Geisinger Health, Danville, PA

1

Background: Having an accurate medication list is a wellrecognized patient safety issue. Unfortunately, patients’
medication lists are often inaccurate. We developed a
web-based medication reconciliation tool (MedTrue™) to
facilitate the collection of accurate medication lists through
integration of patient-collected, electronic health record,
and administrative claim medication information and a
display that integrates within the electronic health record.
Effectiveness of this tool in improving the accuracy of
medication lists is not known.
Methods: We conducted a cluster randomized trial within
6 primary care clinics within an integrated health delivery
system. Sites were selected in collaboration with clinic
leadership and randomized in a 1:1 fashion to intervention
(MedTrue) or usual care using a random number generator.
Patients were eligible for inclusion if they were seen at a
participating clinic for a visit with their primary care provider,
if they were 18 years of age or older, if they spoke English, and
if, in the intervention arm, both the patient and a health care
provider were exposed to MedTrue. After an eligible visit,
patients were approached by a trained pharmacist, obtained
consent, and performed a best possible medication history. Our
primary outcome was the rate of medication discrepancies,
defined as a composite rate of medication additions, removals,
or modifications (change in dose, frequency, etc). Continuous
outcomes are reported using mean and standard deviation,
and a zero-inflated Poisson regression model was used to
evaluate the impact of MedTrue.
Results: Overall, 224 patients were recruited and underwent
a best possible medication history with the pharmacist (118
usual care, 106 MedTrue). The most common discrepancies
identified were modifications, with a mean of 2.68
modifications identified per patient in usual care and 1.54
modifications per patient identified among those who used
the tool. For the primary composite outcome, after adjusting
for age, sex, and Charlson comorbidity index, patients in
MedTrue had a lower rate of medication discrepancies
compared to usual care (rate ratio: 0.84, 95% CI: 0.74–0.94;
P=0.0025).
Conclusion: MedTrue reduced the rate of medication list
discrepancies among a population of patients seen in primary
care. Future studies should assess how best to implement the
tool in primary care practices.
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P16.05
The Dreem Headband as an Alternative to
Polysomnography
for
Electroencephalogram
Signal Acquisition and Sleep Staging
Pierrick Arnal,1 Valetin Thorey,1 Michael Ballard,1 Albert
Bou Hernandez,1 Antoine Guillot,1 Hugo Jourde,2
Mason Harris,1 Mathias Guillard,2 Pascal Van Beers,2
Mounir Chennaoui,2 Fabien Sauvet2
Dreem, New York, NY; 2Fatigue and Vigilance Unit,
French Armed Forces Biomedical Research Institute
(IRBA), Paris, France
1

Background: Despite the central role of sleep in our
lives and the high prevalence of sleep disorders, sleep is
still poorly understood. The development of ambulatory
technologies capable of monitoring brain activity
during sleep longitudinally is critical to advancing
sleep science and facilitating the diagnosis of sleep
disorders. We introduced the Dreem headband (DH) as
an affordable, comfortable, and user-friendly alternative
to polysomnography (PSG). The purpose of this study
was to assess the signal acquisition of the DH and the
performance of its embedded automatic sleep-staging
algorithms compared to the gold-standard clinical PSG
scored by 5 sleep experts.
Methods: 31 subjects completed an overnight sleep study
at a sleep center while wearing both a PSG and the DH
simultaneously. We assessed 1) the electroencephalogram
(EEG) signal quality between the DH and the PSG; 2)
the heart rate, breathing frequency, and respiration rate
variability (RRV) agreement between the DH and the
PSG; and 3) the performance of the DH’s automatic
sleep staging according to American Academy of Sleep
Medicine guidelines vs PSG sleep experts’ manual
scoring.
Results: Results demonstrate a strong correlation
between the EEG signals acquired by the DH and those
from the PSG, and the signals acquired by the DH enable
monitoring of alpha (r: 0.71 ± 0.13), beta (r: 0.71 ±
0.18), delta (r: 0.76 ± 0.14), and theta (r: 0.61 ± 0.12)
frequencies during sleep. Mean absolute error for heart
rate, breathing frequency, and RRV was 1.2 ± 0.5 bpm,
0.3 ± 0.2 cpm, and 3.2% ± 0.6%, respectively. Automatic
sleep staging reached an overall accuracy of 83.5% ±
6.4% (F1 score : 83.8 ± 6.3) for the DH, compared with
an average of 86.4% ± 8.0% (F1 score: 86.3 ± 7.4) for the
5 sleep experts.
Conclusion: These results demonstrate the capacity of the
DH to both precisely monitor sleep-related physiological
signals and process them accurately into sleep stages.
This device paves the way for high-quality, large-scale,
longitudinal sleep studies.
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P16.06
Mixed-Methods Evaluation of Parents’ Unmet
Needs and Experiences Regarding Behavioral
Intervention Technologies for Common Behavioral
Health Problems
Sean O'Dell,1 Heidi Fisher,1 Victoria Schlieder,1 Tracey
Klinger,1 Rachel Kininger,1 McKenna Corlis,1 Amanda
Ferriola1
Geisinger Health, Danville, PA

1

Background: Behavioral intervention technologies (BITs) are
an emerging modality for electronic behavioral innovations
across a wide range of behavioral, emotional, and cognitive
outcomes. However, few BITs have been tested with parents in
real-world settings. We conducted a mixed-methods evaluation
of unmet needs to inform subsequent iterative user testing.
Methods: An exploratory sequential design was used, in
which focus group interviews were conducted with primary
care and behavioral health stakeholders. Then, analysis of
these data was used to inform a parent survey that included
17 selected behavioral health topics corresponding to the
American Academy of Pediatrics’ Bright Futures modules.
Results: Qualitative results are collected, transcribed,
coded, and will be further analyzed using Atlas.ti. Survey
results were implemented using Qualtrics, have been
cleaned, and await analysis once qualitative results are
finalized (anticipated December 2019). Preliminary results
show several preferred BIT domains addressing both current
and future concerns for their children.
Conclusion: We found unique advantages to this mixedmethods approach that will inform design and evaluation
functions as the project enters the design, evaluation, and
sustainability phases. Implementation and partnership
challenges will be discussed, as will systems-level factors that
support and constrain design for dissemination in our setting.

MENTAL HEALTH AND SUBSTANCE USE
DISORDERS/ADDICTION
OA4.01
Accuracy of an Opioid Withdrawal Risk Assessment
Screening Tool for Hospital Patients
Kimberly Williams,1 Claudine Jurkovitz,1 Richard
Caplan,1 Beverly Wilson,1 Alexa Meinhardt,1 Bayo
Gbadebo,1 Terry Horton1
ChristianaCare, Wilmington, DE

1

Background: Opioid use disorder and withdrawal may go
undetected among patients admitted for general medical
reasons, raising the risk of withdrawal during hospitalization.
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To address this, we implemented a standardized method to
screen and treat opioid withdrawal in the hospital, including
the development of an Opioid Withdrawal Risk Assessment
(OWRA) tool for universal screening. This study aimed to
evaluate the accuracy of the OWRA in identifying patients at
risk for opioid withdrawal.
Methods: We evaluated adult patients who were administered
the OWRA from 2016 to 2017. A retrospective analysis
compared OWRA results to the Clinical Opiate Withdrawal
Scale (COWS), the gold standard used to assess opioid
withdrawal symptoms and evaluate withdrawal severity.
Admitted patients were asked: 1) Have you used heroin or
prescription pain medicines other than prescribed in the
last week? and 2) Do you get sick if you can't use heroin,
methadone, or prescription pain medications? Patients who
answered “Yes” to either OWRA question were considered a
positive screen and administered COWS. A positive COWS
(score of ≥8) triggered evaluation and treatment for opioid
withdrawal. A sample of patients who screened negative on
the OWRA (ie, “No” to both questions) were administered
COWS to evaluate the OWRA’s accuracy. We used a Bayesian
approach to estimate the prevalence of opioid withdrawal as
well as OWRA’s sensitivity, specificity, positive predictive
value (PPV), and negative predictive value (NPV).
Results: Of 22,441 patients, 21,935 (97.7%) screened
negative on the OWRA and 506 (2.3%) screened positive.
Of patients with a positive OWRA, 28.1% had a positive
COWS. We administered COWS to a sample of 646
patients with a negative OWRA. Of the 646 OWRAnegative patients, 2 (0.31%) had a positive COWS. The
estimated opioid withdrawal prevalence was 1.15%
(standard deviation: 0.26%). The OWRA’ s sensitivity was
57.3% (95% CI: 35.6%–81.1%), specificity 98.4% (95%
CI: 98.3%–98.4%), PPV 31.7% (95% CI: 27.8%–35.7%),
and NPV 99.5% (95% CI: 98.8%–99.9%).
Conclusion: Given its high specificity and NPV, the OWRA
tool may effectively exclude patients not at risk for opioid
withdrawal, successfully limiting the instance of false-positive
assessments and ensuring that treatment is administered
appropriately. Additional research is needed to further assess
factors that may affect the OWRA’s sensitivity and PPV.
OA4.02
Instrumental Variable Analysis of Lethal Means
Assessment in Patients Reporting Suicide Ideation
and Subsequent Risk for Suicide Outcomes
Jennifer M. Boggs,1 Arne Beck,1 Debra P. Ritzwoller,1
Catherine Battaglia,2 Heather D. Anderson,2 Richard C.
Lindrooth2
Kaiser Permanente Colorado, Denver, CO; 2University
of Colorado, Aurora, CO
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with suicide risk, but there are no formal evaluations of
its impact in real-world settings. We evaluated the impact
of lethal means assessment delivered during medical and
mental health visits on suicide outcomes. Randomized
trials would not be ethical to answer this question, and
there is high likelihood for confounding with traditional
regression adjustment. We implemented a cohort design
using an instrumental variable to address this confounding.
Methods: The sample included adult patients of Kaiser
Permanente Colorado who endorsed suicide ideation on
the Personal Health Questionnaire-9 (PHQ-9) depression
screener during medical and mental health visits from
2010 to 2016. Provider documentation of lethal means
assessment in clinical notes was collected using a validated
natural language processing program. The instrument was
the practice-level rate of lethal means assessment, which
had substantial variation by location, department, and
provider specialty visited. The instrument helped adjust
for unmeasured patient characteristics from clinical
interviews that influence provider decisions to ask about
lethal means. The main outcomes included any ICD-9 or
ICD-10 code for self-inflicted injury/death within 180 days
of index PHQ-9. Demographic, diagnostic, and treatment
co-variates were included in a 2-stage residual inclusion
model to evaluate the impact of lethal means assessment
on suicide outcomes.
Results: We found 33% of patients with suicide ideation
reported on the PHQ-9 were exposed to lethal means
assessment in the 30 days following risk identification.
Lethal means assessment reduced the risk of a suicide
attempt or death within 180 days from 3.3% to 0.83%, with
a relative risk of 0.25 (P=0.034, 95% CI: 0.069–0.9).
Conclusion: The reduction in suicide risk that we
detected may be due to lethal means assessment as well
as unmeasured suicide prevention strategies that may
co-occur with it. Instrumental variable approaches are
an important and underutilized tool for detecting effects
with research questions that are unethical to pose with
randomized trials. Mental health providers should expand
the use of counseling on access to lethal means, along with
co-occurring safety planning practices, to all patients who
report suicide ideation.
OA4.03
Measuring Quantitative Traits of Alcohol Use
Disorder Using the Alcohol Use Disorders
Identification Test
Patrick Asdell,1 Donielle Beiler,1 Stephanie Ranck,1
Vanessa Troiani1
Geisinger Health, Danville, PA

1

1

Background: Counseling on access to lethal means (ie,
firearms, medications) is highly recommended for patients

Background: Alcohol use disorder (AUD) is a common,
devastating substance use disorder (SUD), with typical
onset in adolescence or young adulthood and a chronic
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relapsing course of illness, resulting in disability, billions
of dollars lost in economic activity, and greater than 3-fold
increased mortality. It is estimated that persons of European
ancestry have a lifetime prevalence of severe AUD of 15.8%,
although AUD is underdiagnosed in most health systems.
Herein, we assess the utility of using patient portal messaging
to obtain alcohol use information from patients.
Methods: We report data from 680 patients who enrolled
in our study and completed the Alcohol Use Disorders
Identification Test (AUDIT) via a patient messaging portal
at Geisinger. Education and monitoring processes were
implemented for patients who 1) scored above threshold
on the AUDIT, indicating probable AUD, and 2) requested
that their AUDIT score be sent to their medical provider. We
also examine patients’ willingness to share the scores of this
screener with their physician, patient awareness of alcohol
treatment options within the health system, and the impact
of online learning materials regarding excessive alcohol use.
Recruitment is ongoing.
Results: Of patients that use alcohol, 25% were at some
risk of AUD based on AUDIT scores. A majority of patients
(59%) requested that their AUDIT scores be forwarded to
their physicians, while a substantial portion (36%) were
unaware that medication-assisted treatment is an option for
AUD. Outcome monitoring is ongoing but presently indicates
that multiple individuals have been referred to social work,
medication-assisted treatment, and inpatient substance use
disorder treatment. Other patients have reported reduction
in alcohol consumption since completing the survey and/or
have had a discussion with their primary care physician about
alcohol use, following enrollment in this study.
Conclusion: These results suggest that use of patient portal
messaging for substance use disorder screeners may be a
productive method that fosters communication between
patients and providers, stratifies patients based on the level
of treatment needed, and records quantitative substance
use disorder data on individual patients using a mechanism
amenable to scaling for high throughput data collection.
OA4.04
Long-Term Effectiveness of Online MindfulnessBased Cognitive Therapy for Reducing Residual
Depressive Symptoms: A Randomized Pragmatic
Trial
Arne Beck,1 Zindel Segal,2 Sona Dimidjian,3 Jennifer
M. Boggs,1 Rachel Vanderkruik,3 Christina Metcalf,3
Robert Gallop,4 Jennifer Felder,5 Joseph Levy3
Kaiser Permanente Colorado, Denver, CO; 2University
of Toronto, Toronto, Canada; 3University of Colorado
Boulder, Boulder, CO; 4West Chester University, West
Chester, PA; 5University of California, San Francisco,
San Francisco, CA
1
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Background: Patients with residual depressive symptoms
experience functional impairments and increased risk for
recurrence of major depressive disorder (MDD). They also
face a “care gap,” as few resources are available to manage
the lingering effects of their illness. The objective of this
study was to evaluate the effectiveness for treating residual
depressive symptoms with Mindful Mood Balance (MMB),
a web-based application that delivers mindfulness-based
cognitive therapy.
Methods: A 2-group randomized pragmatic trial was
conducted at Kaiser Permanente Colorado, recruiting
adults with residual depressive symptoms (ie, Personal
Health Questionnaire-9 [PHQ-9] scores between 5 and
9) and 1 or more prior episodes of major depressive
disorder. Participants were recruited from behavioral
health and primary care clinics between March 2015 and
November 2018. Both groups received usual depression
care (UDC), and the MMB group also received 8 sessions
delivered online over 3 months plus minimal phone/email
coaching support. Primary outcomes were reduction in
PHQ-9 scores, rates of depressive relapse (PHQ-9 of
>15), and rates of remission (PHQ-9 < 5). Secondary
outcomes included depression free days (DFD), anxiety
symptoms (per the 7-item Generalized Anxiety Disorder
[GAD-7] scale), and functional status (per the SF-12 patient
questionnaire). Outcomes were assessed over a 15-month
period, comprising a 3-month intervention interval and a
12-month follow-up.
Results: Among 460 randomized participants (230
per group), data were analyzed for the intent to treat
sample. Participants had a mean age of 48 years, and
76% were women. Those who received MMB+UDC
had significantly greater mean reductions in residual
depressive symptoms than those receiving UDC
alone (P<0.02). A significantly greater proportion of
patients achieved remission in MMB+UDC relative
to UDC (P<0.01), and rates of depressive relapse
also were significantly lower in MMB+UDC relative
to UDC (hazard ratio: 0.61, 95% CI: 0.39–0.95,
P<0.03). Secondary outcomes indicated an additional
34 depression-free days for MMB+UDC relative to
UDC (P<0.02), mean decreases in anxiety (P<0.004),
and improved mental functioning (P<0.0003), but not
physical functioning.
Conclusion: In the largest online treatment trial of residual
depressive symptoms, MMB resulted in significant
improvement in depression and functional outcomes
compared to routine depression care. MMB may offer
a scalable approach for the management of residual
depressive symptoms.
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P1.01
Agent-Specific Analysis of Opioid Distribution
Trends in U.S. Hospitals From 2000 to 2018
Sarah Eidbo,1 Varkey Mathew,1 Daniel Kaufman,1
Stephanie Nichols,2 Kenneth McCall,2 Brian Piper1
Geisinger Health, Danville, PA; 2Department of
Pharmacy Practice, University of New England,
Portland, ME
1

Background: The United States is currently enduring
a devastating opioid crisis. More than 130 people die
every day from opioid overdoses, and in 2017 alone,
47,000 Americans died from an opioid overdose. The
U.S. Department of Health and Human Services estimates
that 40% of opioid overdose deaths involve a prescription
opioid. The purpose of this project was to analyze trends
in use and distribution of opioid compounds by hospitals
in the United States from 2000 to 2018. The Automation
of Reports and Consolidated Orders System (ARCOS) is
a drug reporting system for substances controlled for by
the Drug Enforcement Administration, which reports on an
array of opioids and opioid derivatives. Opioids monitored
included buprenorphine, codeine, fentanyl, hydrocodone,
hydromorphone, meperidine, methadone, morphine,
oxycodone, oxymorphone, powdered opium, remifentanil,
and tapentadol.
Methods: Data from ARCOS Report 5 and Report 7 from
2000 to 2018 were utilized for an observational study on
hospital opioid distribution in the United States, excluding
U.S. territories. The programs GraphPad Prism and Excel
were used to graph total weights of the studied opioids.
The morphine milligram equivalent (MME) was calculated
using oral conversion factors for each opioid. A paired t-test
was run on the MME per person per state to compare 2012,
the year with the highest U.S. MME total, and 2018, the year
of the most recent ARCOS data release.
Results: Hospital opioid use in the United States has
seen a statistically significant 31.1% net decrease from
2012 to 2017. When totals were calculated correcting for
the opioids no longer reported on in 2018, a statistically
significant decrease of 42.24% was seen between 2009
and 2018. Codeine and meperidine have seen overall
decreases in hospital use from 2000 to 2018. Buprenorphine
has seen overall increases in hospital use from 2000 to
2018. Tapentadol has been declining in use since 2017.
Oxycodone, hydromorphone, hydrocodone, methadone,
morphine, powdered opium, oxymorphone, and fentanyl
are experiencing a slow decline in hospital use.
Conclusion: Despite the opioid crisis continuing to ravage
communities throughout the United States, hospitals are
steadily decreasing their overall opioid use.
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P1.02
A Randomized Controlled Pilot of a Clinical
Decision Support Tool to Improve Primary Care of
Opioid Use Disorder
Rebecca Rossom,1 JoAnn Sperl-Hillen,1 Patrick J.
O'Connor,1 A. Lauren Crain,1 Laurel Nightingale,1 Anne
Pylkas,1 Kristen Huntley,2 Gavin Bart3
HealthPartners, Bloomington, MN; 2National Institutes
of Health, Bethesda, MD; 3University of Minnesota,
Minneapolis, MN
1

Background: Despite an opioid epidemic, most Americans
with opioid use disorder (OUD) do not receive medical
care for their OUD. A clinical decision support (CDS)
tool designed for primary care providers (PCP) could
improve this treatment gap. The primary objective of this
study was to build and pilot test an OUD-CDS tool with
PCPs. Secondary objectives were to achieve high use rates,
improve PCP confidence in assessing and treating OUD,
and achieve high PCP approval rates.
Methods: Design: 55 PCPs in a Midwestern health
care system participated. PCPs waivered to prescribe
buprenorphine (n=8) were assigned to the intervention.
Nonwaivered PCPs (n=47) were randomized to the
intervention (n=24) or control (n=23) group. Intervention:
Intervention PCPs received access to the OUD-CDS
alerting them to high-risk patients. The OUD-CDS included
modules for screening and diagnosis, treatment selection,
treatment guidance, and other recommended care. Control
PCPs provided care as usual.
Results: Testing in the electronic health record using
simulated and real patients determined the OUD-CDS was
functional and accurate. PCPs used the OUD-CDS in 5% of
targeted encounters, less than the goal of 60%. Intervention
PCPs reported increased confidence in screening for
OUD following the pilot, whereas control PCPs did not.
Confidence in diagnosing OUD increased in nonwaivered
intervention PCPs but not in waivered intervention or
control PCPs. Most intervention PCPs would recommend
the OUD-CDS to a colleague and found it helpful with
screening for OUD, discussing and prescribing medications
for OUD, and prescribing naloxone.
Conclusion: The OUD-CDS improved PCP confidence
in screening and diagnosing OUD despite low use rates.
Qualitative data are guiding development of modifications
to increase CDS use rates.
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P1.03
Validation of a DSM-5 Opioid Use Disorder Severity
Score Derived From Health Record Review
Anthony Seiwell,1 Sarah Palumbo,2 Alexia Perrin,1
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Hoffman,1
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Adamson,1
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Pennsylvania, Philadelphia, PA
1

Background: Opioid use disorder (OUD) is ideally diagnosed
based on a clinician interview that determines severity based on
DSM-5 criteria, resulting in a severity score. However, many
patients are prescribed opioids without undergoing such an
interview, and thus may not be diagnosed with OUD, despite
meeting criteria. Thus, it would be advantageous to have a
quantitative scoring algorithm that can determine a DSM-5
OUD severity score based on existing health record data.
Methods: We conducted in-depth chart review of 600
patients; 400 patients were used to develop a proxy DSM5 risk score to predict severity of OUD (200 at high risk
of OUD and 200 at low risk). We then validated this
proxy DSM-5 score in 200 additional patients who have
confirmation of OUD diagnostic status and a self-reported
questionnaire that assesses DSM-5 criteria for OUD.
Results: We used our proxy DSM-5 scoring criteria to predict
OUD severity among opioid-using patients. In the high-risk
patients, there was a high prevalence of moderate to severe
OUD, with 94 patients (47%) meeting the criteria for severe
OUD and 50 patients (25%) meeting the criteria for moderate
OUD. Validation chart review of an independent sample of
patients with confirmed diagnosis is ongoing.
Conclusion: These results indicate that many DSM-5 criteria
for OUD can be determined via in-depth chart review.
Following a validation review on an independent sample
of patients with confirmed OUD and quantitative scores for
DSM-5 OUD criteria, we will determine whether the same
criteria can be extracted via automated methods using
discrete electronic health record variables.
P1.04
Degree of Bystander-Patient Relationship and
Prehospital Care for Opioid Overdose
Molly McCann, Todd Jusko, Courtney Jones,
Christopher Seplaki,2 Jeremy Cushman2
1

2

2

Henry Ford Health System, Detroit, MI; 2University of
Rochester Medical Center, Rochester, NY
1

Supplement

Background: Across the spectrum of patient care for opioid
overdose, an important yet frequently overlooked feature is the
bystander. For other acute medical events, such as cardiac arrest
and stroke, research supports that the presence of a bystander
is associated with better outcomes. Despite the similarities,
however, this well-established conceptual framework has yet to
be applied in the context of overdose. Our objective was to assess
whether the degree of bystander-patient relationship is associated
with prehospital care for the treatment of opioid overdose.
Methods: A retrospective cohort study was conducted among
adults who received naloxone administration in the prehospital
setting for suspected opioid overdose. Patients were identified
using a preexisting longitudinal registry documenting all
prehospital administrations of naloxone by first responders in
a midsized community in New York. Individuals who received
at least 1 administration for a suspected opioid overdose from
June 1, 2016, to July 31, 2018, with available emergency medical
services and medical record data were eligible for study inclusion.
Bystander type was defined as Close (spouse/family), Proximal
(friends), and Distal (no relation to patient). The association
between bystander type and prehospital patient care outcomes
were estimated using logistic and linear regression models.
Results: A total of 610 opioid overdose encounters, equating
to 545 unique patients, were identified from the registry.
The sample makeup was predominately male (67.2%),
white (73.6%), and 25–34 years of age (34.9%). Among
patients who had Proximal-related bystanders during their
encounter, the time to naloxone administration was decreased
by 2.40 minutes, compared to Distal-related, after adjusting
for covariates (95% CI: -4.6 to -0.2). Overdose encounters
with 911 dispatch codes more indicative of opioid overdose
(ie, “overdose/poisoning” vs “unconscious/fainting”) were
associated with having a Close/Proximal bystander present
relative to a Distal bystander (odds ratio: 1.9, 95% CI: 1.1 to
3.4 for Close; odds ratio: 3.7, 95% CI: 1.9 to 7.3 for Proximal).
Conclusion: We found that having a Proximal bystander
during an overdose event is associated with dispatch codes
indicative of an overdose and shorter time to naloxone
administration. These findings offer an alternative focal point
for interventions aimed at spreading overdose awareness and
harm reduction strategies.
P1.05
Degree of Bystander-Patient Relationship and Its
Association With Repeated Opioid Overdose Events
Molly McCann,1 Todd Jusko,2 Courtney Jones,2
Christopher Seplaki,2 Jeremy Cushman2
Henry Ford Health System, Detroit, MI; 2University of
Rochester, Rochester, NY
1

Background: Across the spectrum of patient care for opioid
overdose, an important yet frequently overlooked feature is
the bystander. For other acute medical events, such as cardiac

www.aurora.org/jpcrr

89

arrest and stroke, research supports that bystander presence
is associated with better outcomes. Despite the similarities,
this well-established conceptual framework has yet to be
applied in the context of overdose. Our objective was to
assess whether the degree of bystander-patient relationship is
associated with repeated opioid overdose events.
Methods: A retrospective cohort study was conducted
among adults who received naloxone administration in the
prehospital setting for suspected opioid overdose. Patients
were identified using a preexisting longitudinal registry
documenting all prehospital administrations of naloxone
by first responders in a midsized community in New York.
Individuals who received at least 1 administration for a
suspected opioid overdose from June 1, 2016, to July 31,
2018, with available emergency medical services and
medical record data were eligible for study inclusion.
Bystander type was defined as Close (spouse/family),
Proximal (friends), and Distal (no relation to patient). The
association between bystander type and repeated overdose
event was estimated using logistic regression models.
Results: A total of 610 opioid overdose encounters, among
545 unique patients, were identified from the registry. The
sample makeup was predominately male (67.2%), white
(73.6%) and 25–34 years of age (34.9%). More than 11%
of patients experienced a repeated overdose event within the
study time frame, and 5.6% experienced at least 1 within 90
days of their initial overdose encounter. Having a Proximal
bystander present during their initial encounter was associated
with 36% lower risk of a repeated overdose event within 90
days, compared to those with Distal bystanders (odds ratio:
0.6, 95% CI: 0.2 to 1.9). Conversely, risk of repeating was
53% higher for individuals with Close bystanders, relative
to Distal, but again this difference did not reach statistical
significance (95% CI: 0.7 to 3.4).
Conclusion: Although we did not find a significant
association between bystander type and odds of repeated
overdose event, these results offer an opportunity to further
evaluate the role of the bystander in the context of one’s
prospective substance use disorder recovery.
P1.06
Exploring the Mechanisms of Substance Use
Disorders Among Veterans: A Team Science
Approach
Margaret Kucia, Heather Basehore
1

1
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Background: Veterans face significant health disparities
as compared to nonveteran counterparts, and the complex,
multifaceted medical and social determinants underlying
these health disparities present a growing public health
problem. Most notably, veterans suffer from traumatic brain
injury (TBI) at rates disproportionate with nonveterans,
and this study aims to better characterize the nature of TBI
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sequelae and identify a causal directionality between TBI
and subsequent development of substance use disorders
through an interdisciplinary research team.
Methods: Data was gathered through patient interviews
conducted with validated Structured Clinical Interview for
DSM-Research Version (SCID-RV), PTSD Checklist for
DSM-5 (PCL-5), Patient-Reported Outcomes Measurement
Information System (PROMIS-29), and Ohio State University
TBI questionnaires to assess psychological comorbidities,
history of lifetime TBI, posttraumatic stress disorder (PTSD),
activity limitations, demographics, social factors, and reported
medical and psychological history. Measures of impulsivity
were assessed through computer-based testing. Additional data
mining was conducted through electronic health records to
identify periods of service, disability categorizations, combat
exposure, and disability percentages. Principal component
analysis, visualizations, and statistical analyses were used to
identify clustering, risk stratification, and predictive capacity
among patient comorbidities and risk factors.
Results: This study represents one aim of a multifaceted
investigation centered on identifying mechanisms and
treatment strategies to counter addiction susceptibility after
TBI across all populations, with an eventual goal of developing
medical intervention to attenuate TBI pathology and effects
on addiction. Preliminary results aim to identify entry points
for intervention and development of risk assessment tools to
assist veteran and health care teams across the care continuum.
Conclusion: This broad-based exploration supports continued
research in mitigating the sequelae of TBI and reducing
health disparities in veterans and underscored the value of
interdisciplinary team problem-solving. Most notably, the
use of dimension reduction and comparison across clinical,
psychological, demographic, and social data elements
enabled identification of avenues for clinical and psychosocial
intervention, risk assessment, and preventive methods.
P12.01
The Development, Optimization, and Pilot Testing
of a Brief Psychological Intervention for Chronic
Pain in Primary Care
Lisa Miller-Matero,1 Mary Kate Miller,1 Leah Hecht,1
Bethany Pester,1 Kirsti Autio,1 Brian Ahmedani1
Henry Ford Health System, Detroit, MI
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Background: Approximately 25% of primary care patients
have a chronic pain condition, half of which also have a
psychiatric diagnosis. Although patients with chronic pain
can benefit from behavioral interventions, few patients
who are referred by their primary care provider (PCP) to
see a behavioral health specialist at an outside clinic follow
through with the referral. Thus, offering evidence-based
behavioral treatments in primary care may improve patient
engagement and outcomes. The purpose of this presentation
is to discuss the development, optimization, and pilot testing
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of a brief, psychological intervention for chronic pain in a
primary care clinic.
Methods: A treatment manual was developed by a clinical
psychologist to integrate a brief, psychological intervention
in a primary care clinic. The intervention was optimized after
conducting focus groups with 9 psychologists, 9 PCPs, and
9 patients. The manual was further refined after an open trial
with 5 participants with chronic pain. Currently, a randomized
controlled trial of the 5-session intervention is being conducted
in a primary care clinic (N=60). The intervention integrates
components from evidence-based interventions for chronic
pain, including psychoeducation, cognitive behavioral
therapy, mindfulness, and acceptance. Participants complete a
baseline assessment and a postintervention assessment.
Results: The changes made to the treatment manual and
protocol based on feedback from the focus groups and open
trial will be presented. To date, 34 participants have been
randomized. More than half of participants in the intervention
group completed all 5 sessions (64.3%). Most participants
completed the postintervention assessment (92.9%). On a
1–5 point scale, patients liked the intervention (mean: 4.45,
standard deviation [SD]: 0.52), found the content to be useful
(mean: 4.91, SD: 0.30), and thought it was helpful (mean:
4.64, SD: 0.67).
Conclusion: Overall, it appears feasible to offer a brief,
psychological intervention for chronic pain in primary care.
Barriers to attending treatment will be discussed as well
as protocol changes being implemented. The information
gathered in this pilot trial will be used to inform a fully
powered, multisite randomized controlled trial leveraging the
HCSRN to evaluate efficacy of the integrated intervention on
physical functioning, psychological distress, mindfulness,
and acceptance of pain.

and without ASD using two methods: 1) a standardized
clinical research questionnaire of autonomic symptoms in
pediatric patients (Pediatric Autonomic Symptoms Scale
[PASS]); and 2) a chart review of patients’ electronic health
records (EHR) that coded for the presence and/or absence
of the behaviors measured by the PASS. This procedure was
completed in 3 groups of patients, including those with ASD
diagnoses with no known genetic cause (n=159), patients
with a de novo copy number variation (CNV) that confers
risk for the development of ASD (n=244), and age- and sex
matched controls (n=213). Symptoms of ANS dysregulation
were assessed across 4 main categories: 1) mood, behavior,
and emotion; 2) secretomotor, sensory integration; 3)
urinary, gastrointestinal, and digestion; and 4) circulation,
thermoregulation, circadian function, and sleep/wake cycles.
Results: Results from the chart review indicate an increased
rate of ANS symptoms, specifically those related to atypical
secretomotor activity, gastrointestinal function, heart rate,
and sleep-related problems in patients with ASD and/or a
de novo copy number variation relative to controls. Data
collection of the parental report of the PASS is ongoing,
and future planned analyses will compare ANS symptoms
derived from EHR review to parental report of symptoms.
We will also investigate the degree to which indices of ANS
dysfunction predict clinical features of ASD.
Conclusion: These results indicate that EHR review is a
potentially useful method for quantifying variance in ANS
dysfunction. Further, we show that symptoms of ANS
dysfunction are more prevalent in children with ASD and
genetic disorders conferring risk for ASD.

P12.02
Measurement of Autonomic Dysregulation in
Pediatric Patients With Autism Using Health
Record Data

Hsueh-Han Yeh,1 Joslyn Westphal,1 Frances Lynch,2
Rebecca Rossom,3 Beth Waitzfelder,4 Gregory Simon,5
Christine Y. Lu,6 Arne Beck,7 Stephen Waring,8 Ashli
Owen-Smith,9 Jennifer M. Boggs,7 Brian Ahmedani1
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1

Background: Autism spectrum disorder (ASD) is
characterized by social communication impairments and
repetitive behaviors. Sleep disturbances, gastrointestinal
problems, and atypical heart rate also are commonly observed
in patients with ASD and may all relate to an underlying
dysfunction of the autonomic nervous system (ANS). ANS
dysfunction has not been well-characterized in patients with
ASD, as it is not part of the core diagnostic criteria. The
overall objective of the current study was to quantitatively
characterize individual differences in ANS function that may
scale with the presence and severity of ASD symptoms.
Methods: We assessed ANS dysfunction in children with
Supplement

P12.03
Antidepressant Use and Suicide Mortality

Henry Ford Health System, Detroit, MI; 2Kaiser
Permanente Northwest, Portland, OR; 3HealthPartners,
Bloomington, MN; 4Kaiser Permanente Hawaii,
Honolulu, HI; 5Kaiser Permanente Washington, Seattle,
WA; 6Harvard Pilgrim Health Care, Boston, MA; 7Kaiser
Permanente Colorado, Denver, CO; 8Essentia Health,
Duluth, MN; 9Kaiser Permanente Georgia, Atlanta, GA
Background: Depression is one of the most common
underlying mental health disorders related to suicide death.
The use of antidepressants has raised concerns of increased
suicidal thoughts or behavior. Previous studies have shown
mixed results regarding the association between antidepressant
use and suicide ideation or attempts, and there are a lack of
studies examining the relationship between antidepressant use
and suicide death. This study aims to fill this gap.
Methods: Data were obtained from 8 health care systems in
www.aurora.org/jpcrr
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the Mental Health Research Network. This study used a casecontrol design. Cases were identified as those who died by
suicide between 2000 and 2015 and had a clinical diagnosis
of depression in the year before the index date. To minimize
potential bias introduced by poor access to antidepressants
and depression severity while comparing medication
adherence, a total of 652 cases were included in the analysis
who had at least 1 prescription 0–6 months and at least 1
prescription 7–12 months prior to the index date. Eligible
controls were those who had depression diagnoses and met
the same criteria of antidepressant exposure. Each case was
matched with 5 controls by age, sex, and enrollment period.
A cumulative medication adherence (CMA) metric was
inclusive of medication switches to different antidepressants
and calculated as the proportion of days that the medication
was covered. T-tests were used to test the mean difference
of CMA between cases and controls. Conditional logistic
regression was used to investigate the relationship between
CMA and suicide mortality.
Results: Patients who died by suicide had an average of 75.4%
of days covered by antidepressants compared to 78.7% of
days covered for the patients in the control group (P<0.001).
Moreover, for every 10% increase in CMA, there was a
5.4% decrease in the odds of suicide death after adjusting for
demographic characteristics and substance use disorders.
Conclusion: Patients who died by suicide were less likely
to be adherent to antidepressants than controls. In addition,
increased antidepressant adherence was associated with
decreased risk of suicide death. These findings suggest that
adherence to antidepressants may reduce risk of suicide
death among patients with depression.
P12.04
Rise and Regional Variance of Schedule II
Stimulant Use in the United States
Sneha Vaddadi,1 Nicholas Czelatka,1 Belsy Gutierrez,2
Carlos Torres-Teran,3 Daniel Tron,2 Holly Funk,1
Susannah Pitt,1 Alison Varano,1 John Boyle,1 Bhumika
Maddineni,4 Daniel Kaufman,1 Christen Ogden,1
Kenneth McCall,5 Brian Piper1
Geisinger Commonwealth School of Medicine,
Scranton, PA; 2University of Scranton, Scranton, PA;
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Danville, PA; 5University of New England, Biddeford, ME
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Background: Attention deficit hyperactivity disorder
(ADHD) is a common neuropsychiatric disorder afflicting
millions of children and adults, increasing in prevalence. As
stimulants are a common treatment modality for children
and adults with this condition, there is a great need to better
understand trends of stimulant usage in the past several
years. This report examines the pharmacoepidemiology of
3 Schedule II stimulants in the United States and evaluates
national patterns of use from 2017 to prior years.
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Methods: Data was extracted from the Automated Reports
and Consolidated Ordering Systems (ARCOS) database for
transactions involving amphetamine, methylphenidate, and
lisdexamfetamine. Data concerning total grams per drug
were averaged across all states and compared from 2010 to
2017. Based on 2018 stimulant orders from Geisinger Health
records, median values for daily dosage (mg/person/day)
per drug were determined and used to compare stimulant
usage trends across several years. For all data, outliers were
determined through a Grubbs analysis and excluded. Data
was averaged and compared with an unpaired t-test.
Results: Initial analysis of total grams averaged across
all states indicates a 67.5% increase in amphetamine and a
76.7% increase in lisdexamfetamine use from 2010 to 2017.
A change in methylphenidate was not significant. The rise in
lisdexamfetamine and amphetamine use was supported with
a daily-dose and population-considered analysis per state.
Further analysis indicated that persons/day usage of stimulants
in the West was lower than that of other U.S. regions from
2014 to 2017. A social variable analysis indicated a negative
correlation between the percentage of Hispanic population per
state and the daily dose/population per stimulant. Additional
analyses of the 2018 data are ongoing.
Conclusion: The increasing trend of amphetamine and
lisdexamfetamine use that is not seen in methylphenidate use
may be explained by a rise in adult ADHD diagnoses and
treatment. Regional analysis with daily dose indicates that the
use of stimulants in the West may be distinct from that in other
regions. A social variable analysis indicated lower stimulant
use in areas with greater Hispanic population, possibly due
to socioeconomic factors. Further research is being done with
2018 ARCOS data to investigate ongoing trends as well as
social factors driving stimulant use and regional variance.
P12.05
The Association Between Suicide Mortality and
Weight Change
Leah Hecht,1 Hseuh-Han Yeh,1 Lisa Miller-Matero,1
Anjali Thakrar,1 Shivali Patel,1 Gregory Simon,2 Frances
Lynch,3 Arne Beck,4 Ashli Owen-Smith,5 Rebecca
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M. Boggs,4 Brian Ahmedani1
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Background: There is an inverse association between body
mass index (BMI) and death by suicide. Weight fluctuation
has been associated with disease-related mortality, and some
evidence suggests self-reported unexplained weight loss is
Supplement

linked with suicide mortality among men. However, existing
research has not examined associations between objective
weight change and suicide mortality among men and
women, and existing research suffers from low power due
to small sample size. Examining this physiological marker
in a larger sample may provide a more robust base from
which providers can confidently detect individuals at risk
for suicide.
Methods: A case-control study was conducted to examine
the relation between change in BMI during the previous year
and suicide mortality. Cases (n=373 who died by suicide)
and controls (n=1865) with 2 or more recorded weights in
the previous year were derived from data from 7 Mental
Health Research Network-affiliated health care systems.
Results: Cases were predominantly male (71%) and
Caucasian (69%), with a mean age of 57 years, as compared
to controls (42% male; 60% Caucasian; mean age: 42 years).
Most cases (79%) had a mental/substance use disorder
diagnosis and a Charlson score of >0 (57%). Change in
BMI measured 7–12 months prior to index date (the date of
suicide death) to that measured 0–6 months prior differed
significantly between cases (mean: 0.52 kg/m2 decrease,
standard deviation [SD]: 1.86) and controls (mean 0.16
kg/m2 increase, SD: 4.52; P<0.0001). One unit decrease
in BMI was associated with increased risk of suicide
mortality (odds ratio: 0.87, 95% CI: 0.83–0.92; P<0.0001).
This association remained significant after adjusting for
demographic characteristics, diagnoses of mental disorders,
and Charlson comorbidity index (adjusted odds ratio: 0.93,
95% CI: 0.88–0.98; P=0.0097).
Conclusion: In the year prior to suicide, weight loss was
associated with suicide mortality even after accounting for
physical and mental health indicators. Health care providers
should evaluate weight change as a physiological marker and
recognize weight loss may indicate or confer elevated risk for
suicide mortality. Intervening when weight loss is observed
may help to prevent suicide among high-risk patients.
P12.06
Applying the Agile Implementation Method to a
Pilot Study Addressing Low-Risk Chest Pain and
Anxiety in the Emergency Department Setting
Jill Nault Connors,1 Kurt Kroenke,1 Patrick Monahan,1
Paul Musey,1 Yelena Chernyak,1 Emily Holmes,1
Marshall Conley,2 Steve Roumpf,3 Parveen Chand,3
Malaz Boustani1
Indiana University, Bloomington, IN; 2lead patient
partner; 3Indiana University Health, Indianapolis, IN
1

Background: Chest pain is one of the most common chief
complaints seen in emergency departments (ED); however,
only about 20% of these patients have a true cardiopulmonary
emergency. Undiagnosed or untreated anxiety is the likely
underlying cause of chest pain and related symptoms in up
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to half of the 80% of patients deemed low risk for a major
adverse cardiac event. However, current care in the ED is
focused on ruling out life-threatening cardiopulmonary
events and rarely is a discussion of anxiety initiated. This
represents a significant missed opportunity to initiate
treatment for anxiety among patients who present to the ED
with low-risk chest pain and anxiety (LRCP-A).
Methods: Agile implementation is a comprehensive
and cohesive model for identifying and implementing
evidence-based solutions to health care delivery problems.
These models draw on the theories and frameworks from
behavioral economics, complex adaptive systems, and social
networks. Agile implementation has been successfully
applied to multiple health care challenges related to
Alzheimer’s disease care, intensive care unit survivorship,
and central line-associated bloodstream infections. In
this study, the agile implementation model is applied
to implementation of screening, brief intervention, and
referral to treatment (SBIRT) for anxiety among LRCP-A
patients seeking care in the emergency department setting.
The agile implementation method entails an 8-step process
that includes: 1) Identify opportunities and confirm demand
for the solution; 2) Identify evidence-based (or innovative)
solutions; 3) Develop evaluation and termination plans; 4)
Assemble a team to develop the minimally viable service; 5)
Perform implementation sprints; 6) Monitor implementation;
7) Monitor whole system performance; and 8) Develop a
minimally standard operating procedure.
Results: Results will include presentation of multiple
agile implementation process tools (eg, rubric for
assessing demand) and their scoring, lessons learned
during implementation sprints, and outcome results of the
evaluation plan.
Conclusion: This study can demonstrate the feasibility for
successful implementation of SBIRT for LRCP-A in the
ED. Due to the pragmatism of the solution, findings from
the study have a high potential for real-world adoption. In
addition, SBIRT could potentially serve as a comparator for
future studies that incorporate referral directly to evidencebased psychological treatments.
P12.07
Variation in Diagnosis and Prescription Practices
in Pediatric Primary Care Within a Large Rural
Health System
Sean O'Dell,1 Anna Baker,1 Erin Van Enkevort,1
Amanda Young,1 Matthew Gass,1 Victoria Schlieder1
Geisinger Health, Danville, PA
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Background: Few studies have investigated system-level
practice characteristics of pediatricians, and no known
studies have included predominantly rural populations. This
project investigated variation in diagnosis and prescription
practices within a large rural health system.
www.aurora.org/jpcrr

93

Methods: A retrospective review of electronic health record
data was conducted in 28 rural practices for patients, 4–18
years of age, with 1 or more office visits from January
1, 2009, to December 31, 2017. To examine the roles
availability of child psychiatrists, colocation of mental
health professionals, and foster care prevalence have on
diagnoses and prescription practices, separate generalized
linear mixed models with a logit link were run. Practice
characteristics were included as fixed effects and practice
site was included as a random intercept to account for
the relatedness of patients within each clinic. All models
included sex, age, and the interactions between practice
characteristics and patient age and sex in the models.
Results: Among 78,762 youth, 13.68% received a mental
health diagnosis and 27.97% were prescribed psychotropic
medication. Attention deficit hyperactivity disorder was
the most common disorder diagnosed (7.8%), followed by
anxiety (5.3%) and depression (2.19%). Of note, 10.1%
had more than 1 medication prescribed, with selective
serotonin reuptake inhibitors (SSRI, 11.24%), anxiolytics
(13.74%), and stimulants (9.32%) being the most common.
Colocated behavioral health services were associated with
increased identification of mental health disorders and
reduced proportion of youth with multiple medications
prescribed. Stimulants were less common in colocated
clinics (odds ratio: 0.65), whereas SSRIs (odds ratio:
1.54) and alpha agonists were more commonly prescribed
(odds ratio: 1.32). Age and sex were frequently significant
interactions; however, patterns were not evident across
diagnoses and prescriptions. Community socioeconomic
deprivation was not a significant predictor of diagnosis or
prescription practices.
Conclusion: Compared with prior studies in mostly
urban and suburban youth, this rural health system
evidenced comparable identification of mental health
disorders. However, psychiatric medications overall,
multiple medications, and off-label prescriptions were
more prevalent. These results indicate possible targets for
de-implementation and warrant further investigation of
the role colocated behavioral health services may play in
practice variation.

MULTIPLE CHRONIC CONDITIONS AND
AGING POPULATIONS
OA5.01
Prescribing Cascades in Patients With Alzheimer’s
Disease: Engaging Patients, Caregivers, Payers,
and Providers
Sarah Bloomstone,1 Kathryn Anzuoni,1 Noelle Cocoros,2
Jerry Gurwitz,1 Kevin Haynes,3 Vinit Nair,4 Richard Platt,2
Paula Rochon,5 Sonal Singh,1 Kathleen M. Mazor1
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Background: Prescribing cascades occur when a health
care provider misinterprets a side effect as a new medical
condition and prescribes a second, potentially unnecessary
drug to address the side effect. Prescribing cascades can
increase symptom burden and adversely affect healthrelated quality of life. Patients with Alzheimer’s disease
and related dementia (ADRD) are at increased risk for
prescribing cascades due to high levels of multimorbidity,
polypharmacy, and complexity of care. Educating patients,
caregivers, and providers about prescribing cascades could
reduce cascades and improve medication safety. We engaged
patients, caregivers, providers, stakeholders, and experts to
help develop informational materials that would stimulate
patient/caregiver-provider conversations about prescribing
cascades.
Methods: We recruited patients with ADRD, their
caregivers, and providers from primary care and geriatric
practices at an academic medical center in Massachusetts
to provide feedback on draft materials. We also solicited
feedback from expert advisors and stakeholders. We used
an iterative approach — revising materials, soliciting
feedback, and revising again. We mailed a follow-up survey
to caregivers and providers to gather feedback on the revised
materials. We coded transcripts of interviews and meetings
using content analysis.
Results: Qualitative analysis of transcripts from interviews
(n=14 patient/caregiver; n=15 provider) and meetings
with stakeholders and advisors (n=5) highlighted several
challenges: 1) reaching caregivers, as materials would
be addressed to patients; 2) explaining the prescribing
cascade concept clearly; 3) capturing providers’ attention;
and 4) framing recommendations for providers to be both
actionable and respectful of clinical judgment. Caregivers
and providers expressed concern about the impact of the
materials on the encounter (eg, time) and relationship (eg,
trust), but also saw value in educating caregivers. Some
providers noted engaging caregivers to raise questions would
be an effective way to gain their attention. Providers found
the revised materials informative (11 of 11) and actionable
(10 of 11), and caregivers found them understandable (9 of
10) and useful (10 of 10).
Conclusion: Engaging patients, caregivers, providers,
stakeholders, and experts during the development of
informational materials on prescribing cascades identified
several challenges and ultimately resulted in materials
that providers considered informative and actionable and
that caregivers judged understandable and useful. The
effectiveness of these materials in reducing prescribing
cascades will be tested in a future trial.
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OA5.02
Medication Therapy Problems Identified Through
Comprehensive Medication Management by
Pharmacists in a Team-Based At-Home Care
Program

MTPs, however, often fail to be resolved. Future studies
should examine ways to improve intervention acceptance as
well as the clinical and economic impact of changes made as
a result of CMM and MTP identification.
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Geriatrics Research Instrument Library (GRIL):
A Comprehensive Online Resource for Guiding
Instrument Selection for Research in Older Adults
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Background: To control rising health care costs and
improve quality, health care systems have designed
approaches to care within the home for patients who have
high levels of health care utilization. Pharmacists, as part
of a multidisciplinary team within these programs, provide
a variety of services to patients including comprehensive
medication management (CMM), a collaborative patientcentered approach to medication optimization. Within
CMM, pharmacists identify and resolve medication
therapy problems (MTPs). The extent and impact on
MTP identification and resolution among pharmacists
functioning within multidisciplinary teams as part of an athome program has not previously been described.
Methods: Five pharmacists, practicing telephonically,
currently support 3 at-home multidisciplinary teams
across Geisinger, an integrated health delivery system in
Pennsylvania. All pharmacists completed didactic and
experiential training, along with fidelity and peer-review
quality assurance assessments for the performance of
CMM. Electronic health record notes were constructed
with Smart data elements to record MTPs and document
consultations, actions, follow-up, and resolutions of MTPs.
The categorization of MTPs was guided by a framework
developed by the Pharmacy Quality Alliance. We completed
a retrospective descriptive study of the MTPs identified from
within CMM electronic notes taken between December 12,
2018, and June 21, 2019. Descriptive statistics were run
using Microsoft Excel to determine the quantity of MTPs as
well as the acceptance rates of recommendations.
Results: We identified 232 patients who received CMM.
On average, pharmacists identified 4 MTPs per patient,
with a 35% acceptance rate (317 of 909). Of those accepted,
pharmacists were able to resolve 142 (45%) of these MTPs
on their own while providers resolved the remaining 175
(55%) MTPs. The most common MTP category was safety,
accounting for 44% of the total MTPs. The least common
MTP category was adherence, accounting for only 6% of the
total MTPs identified.
Conclusion: Pharmacists are valuable members of the health
care team and identified several MTPs when conducting
CMM within a team-based at-home care program. These
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Background: The Geriatrics Research Instrument Library
(GRIL), an online resource of data collection instruments
commonly used in gerontological research, has been revised
and updated by the Advancing Geriatrics Infrastructure
and Network Growth (AGING) Initiative in collaboration
with the Older Americans Independence Centers (OAIC)
Coordinating Center and the Yale OAIC. Clinical studies
of older adults need appropriate and validated instruments,
which often differ from those used in younger adults.
Methods: GRIL is systematically inventoried and updates
are made to instruments, domains, and features on an
ongoing basis. Instruments are included based on expert
feedback by domain using systematic instrument reviews
and instruments submitted by users. GRIL was programmed
into the newly developed National Institute on Aging OAIC
website with a platform utilizing Microsoft SQL 2017
database and an Adobe ColdFusion 2019 application server.
Results: Thus far, 116 instruments and 18 domains comprise
GRIL. Instrument characteristics such as time to completion,
mode of implementation, and validity in older adults are
incorporated. The new web-based platform includes userfriendly features and tracking statistics and can be accessed
by GRIL collaborators from the different networks to be
easily managed collaboratively.
Conclusion: GRIL provides a user-friendly public resource
to aid researchers in efficiently choosing appropriate
instruments to measure clinical outcomes in older adults
across different settings. By leveraging resources and
documenting a systematic, low-burden process to curate
GRIL, invested organizations can create a sustainable
resource over time. Evaluation measures will be developed
to demonstrate GRIL’s utility and to implement future
expansion of this important resource.

www.aurora.org/jpcrr

95

P4.02
Predictors of Glycemic Relapse in Adults With
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Background: Diabetes quality improvement stops when
the proportion of diabetes patients falling out of control in
a defined time period (relapse vector) equals or exceeds the
proportion of diabetes patients that are coming under control
(improvement vector). In high-performing care systems the
relapse vector is now acting as a brake on diabetes quality
improvement. Strategies to proactively identify and manage
diabetes patients at high risk for glycemic relapse are urgently
needed.
Methods: Purpose of this study was 1) to identify
characteristics of patients with type 2 diabetes (T2D) who
experience “glycemic relapse,” defined as transitioning from
being in A1c goal (<8%) to out of goal (≥8%) within the
subsequent year; and 2) to develop and compare 3 prediction
models that quantify a given patient’s risk of near-term
glycemic relapse. Eligible T2D patients had an index visit
between January 1, 2017, and May 31, 2018, with baseline
A1c of <8% within 3 months before the index visit, and at
least 1 more A1c reading within 12 months of index visit.
Glycemic relapse was defined as any post-index visit A1c
of ≥8% within 12 months. Prediction models for glycemic
relapse, using least absolute shrinkage and selection operator
(GL-LASS) logistic regression and random forest (GL-RF),
were compared to logistic regression with only index A1c
(GL-I). We evaluated the discriminatory performance using
area under the receiver operating characteristic curve (AUC),
net reclassification, and positive predictive value at a risk
threshold of 0.60, using a 10-fold cross-validation approach.
Results: Of 25,236 eligible T2D patients, 20.25%
experienced A1c relapse; median time to relapse was 9.2
months (interquartile range: 6.3–11.3 months). The GLLASSO model included age, gender, race, hypoglycemia,
microvascular comorbidities, glucose-lowering medications,
index A1c value, and pre-index A1c value. Cross-validated
AUCs were 0.80 for GL-I, 0.82 for GL-LASSO, and 0.81
for GL-RF. Net reclassification index was 0.04 for GLLASSO. Positive predictive value was 0.62 for GL-LASSO,
as compared to 0.59 for GL-I.
Conclusion: All 3 prediction models adequately identified
adults with T2D who have high risk of near-term glycemic
relapse, with GL-LASSO performing best. Proactive
approaches to preventing glycemic relapse should be
considered in high-performing care systems.
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P4.03
Health Care Utilization in the Year Following NonMuscle-Invasive Bladder Cancer Diagnosis Among
Older Adults With Multiple Chronic Conditions
Tullika Garg,1 Andrea Berger,1 H. Lester Kirchner1
Geisinger Health, Danville, PA
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Background: Two-thirds of older adults with cancer have 2
or more chronic conditions, ie, multiple chronic conditions
(MCC). Non-muscle-invasive bladder cancer (NMIBC)
affects older adults and is a burdensome chronic condition
in itself, requiring frequent outpatient visits and surgery.
Frequent visits may not align with the goals of medically
complex older patients with cancer, but little is known
about how NMIBC diagnosis impacts downstream health
care utilization. The objective was to describe health care
utilization following NMIBC diagnosis by MCC status.
Methods: We identified older adults (age of ≥60 years)
diagnosed with NMIBC (stage of <II) between 2003 and
2015. Health care utilization was defined as the number
of contact days in the form of outpatient visits, inpatient
days, and emergency department visits. Multiple visits
on the same day counted as one contact day. We applied
Agency of Healthcare Research and Quality’s Clinical
Classifications Software and Chronic Condition Indicator
tools to outpatient and inpatient diagnosis codes to identify
chronic conditions. MCC was defined as 2 or more chronic
conditions. A multivariable linear regression model adjusted
for age and prior cancer diagnosis was used to estimate the
difference in health care utilization in the year prior to and
following NMIBC diagnosis.
Results: Of 317 patients with NMIBC, 263 (83%) had
MCC. Patients with MCC were older (74 years vs 68.6
years), more often had prior cancers (29.7% vs 14.8%), and
had more prescribed medications (7 vs 2). Patients with
NMIBC and MCC had higher utilization prior to diagnosis
(14 days vs 2 days). Patients without MCC had a larger
change in utilization following NMIBC diagnosis, with an
average increase of 13.9 days compared to 7.5 days in the
MCC group. In the multivariable model, patients without
MCC had an increase of 6.23 days, more than those with
MCC (95% CI: 1.34–11.12, P=0.01).
Conclusion: Following NMIBC diagnosis, health care
utilization increased in older adults. Older adults without
MCC had larger increases in health care utilization than
those with MCC. Adding a new chronic condition such as
NMIBC increases the volume of health care work that older
adults perform. These data may serve as a baseline for future
studies to reduce burdens related to NMIBC diagnosis and
treatment in medically complex older adults.
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Non-Cardiac-Related Morbidity, Mobility Limitation,
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Background: To examine the individual and combined
associations of non-cardiac-related conditions and mobility
limitation with morbidity and mortality in adults with heart
failure.
Methods: We conducted a retrospective cohort study in a
large diverse group of adults with heart failure from 5 U.S.
integrated health care delivery systems. We characterized
patients with respect to the presence of noncardiac
conditions (<3 vs ≥3) and/or mobility impairment (defined
by the use/nonuse of a wheelchair, cane, or walker),
categorizing them into 4 subgroups. Outcomes included
all-cause death and hospitalizations for heart failure or any
cause.
Results: Study population comprised 114,553 adults
diagnosed with heart failure (mean age: 73 years; 46%
women). Compared to those with <3 noncardiac conditions
and no mobility limitation, adjusted hazard ratios for allcause death among those with <3 noncardiac conditions and
mobility limitation, those with ≥3 noncardiac conditions
and no mobility limitation, and those with ≥3 noncardiac
conditions and mobility limitation were 1.40 (95% CI: 1.31–
1.51), 1.72 (95% CI: 1.69–1.75), and 1.93 (95% CI: 1.85–
2.01), respectively. We did not observe an increased risk
of any-cause or heart failure-related hospitalization related
to the presence of mobility limitation among those with
a greater burden of noncardiac multimorbidity. Consistent
findings regarding mortality were observed within groups
defined according to age, gender, and heart failure type
(preserved, reduced, midrange ejection fraction), with the
most prominent impact of mobility limitation in those less
than 65 years of age.
Conclusion: There is an additive association of
mobility limitation — beyond the burden of noncardiac
multimorbidity — on mortality for patients with heart
failure, and this association is especially prominent in
younger patients.
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University of Pennsylvania, Philadelphia, PA; 2Drexel
University, Philadelphia, PA; 3Virginia Tech, Blacksburg, VA
Background: Effective care management is recognized
as essential to high-quality outcomes among diverse,
often complex patients whose needs are often addressed
by multiple health care and social service organizations.
Primary care plays a pivotal role in the provision of care
management services, yet little is known about patients’
experiences with these services. The purpose of this study
was to explore the experiences of older adult patients and
family caregivers accessing and engaging with primary
care services where care management is offered.
Methods: A purposive sample of patients and caregivers
who were members of patient and family advisory councils
(PFACs) at 6 Medicare-designated Comprehensive Primary
Care Plus practices affiliated with a large academic health
system in southeastern Pennsylvania and New Jersey were
invited to participate in a single telephone interview about
their experiences with their primary care practice and
services provided. All interviews were digitally recorded,
transcribed, reviewed for completeness, and then coded
using conventional content analysis techniques. Coded
data were organized in NVivo 12 based on the relevant
codes and then collapsed into common themes.
Results: A total of 30 PFAC members participated.
All participants were patients of the practices they
represented, with 1 also being a caregiver and 2 being a
married couple. Participants were mostly female and, on
average, 72 years old with 9 chronic conditions. Patients
and caregivers described their impressions of how
engaged they are in decisions about their care (themes:
adherence, goal-setting, self-triage, proactive); their
perceptions of their health care providers and quality of
health care services (themes: accessibility, competence,
caring, time spent); their experiences with their clinicians
and how they work with them to focus on goals and
preferences and preparation to manage health problems
(themes: communication quality, guidance); and their
perceptions about the primary care practice as the “go
to” place (compared to the emergency department) for
issues related to care (themes: care team, convenience,
electronic health record). Overall findings support patient
engagement and general satisfaction with care.
Conclusion: These patient and caregiver experiences
and perspectives on care management and primary care
illustrate that patient satisfaction can align closely with
existing quality metrics.
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Background: Most individuals with cognitive impairment
have multimorbidity and associated polypharmacy, placing
them at risk for adverse health outcomes. Optimizing
medications through deprescribing (reducing or stopping the
use of inappropriate medications or medications unlikely to
be beneficial) may improve outcomes for this population,
but optimal approaches to deprescribing remain unclear. Our
goal was to design and test a pragmatic, primary care-based,
patient-centered intervention to optimize prescribing for
older adults with cognitive impairment and multimorbidity.
Methods: The study consisted of qualitative stakeholder
engagement followed by a pilot test of the intervention. It
was conducted in a not-for-profit, integrated delivery system
targeting adults age 65 or older with cognitive impairment,
multimorbidity, and 5 or more chronic medications.
Intervention design was informed by interviews with patient/
family member dyads (n=4), primary care clinicians (n=6),
a patient/family advisory panel, and a clinician advisory
panel prior to the pilot. After the pilot, additional input was
obtained from 4 patient/family interviews and a clinician
focus group to inform intervention refinement. The 4-month
pilot intervention included two parts: an informational
brochure and short questionnaire mailed to patients prior to
primary care clinic visits to encourage patient engagement;
and a short initial presentation followed by periodic 1-page
“tip sheets” provided to clinicians to increase awareness about
deprescribing processes and communication. Primary pilot
outcomes were feasibility and acceptability.
Results: During intervention development, stakeholders
emphasized the importance of lay language, continuity
relationships, and a longitudinal approach to deprescribing.
During the pilot intervention, 58 patients received materials
and 15 clinicians received 6 tip sheets. In debriefing interviews,
patients/family members found the intervention to be
acceptable and were receptive to deprescribing conversations.
They recommended materials be sent twice over 12 months.
Clinicians found the tip sheets to be useful and requested
additional “pearls” for deprescribing. Of 20 random postpilot
chart reviews, 5 revealed medication discontinuation or
deintensification activities during the pilot period.
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Conclusion: A pragmatic, primary care-based deprescribing
intervention designed with stakeholder input is feasible and
acceptable. A cluster randomized pragmatic trial will assess
the effect of a refined intervention on optimal prescribing for
patients with cognitive impairment.
P4.07
Prediabetes Awareness, Clinical Risk Factors,
Lifestyle Behaviors, and Provider Experience in
Rural and Nonrural Patients in a Midwestern Health
Care System
Jay Desai,1 Daniel Saman,2 Jacob Haapala,1 A.
Lauren Crain,1 Clayton Allen,2 Kris Ohsorg,1 Patrick J.
O'Connor,1 JoAnn Sperl-Hillen,1 Steven Dehmer1
HealthPartners, Bloomington, MN; 2Essentia Health,
Duluth, MN
1

Background: Prediabetes impacts over 84 million
Americans, but few studies have examined the burden of
prediabetes within rural communities.
Methods: In 2016, as part of an intervention trial, we
conducted web-based surveys among patients 18–72 years of
age without diabetes and who had a hemoglobin A1c of 5.7%–
6.4%. Patients attended clinics in Rural (small town/rural)
or Nonrural (metropolitan/micropolitan) commuting areas.
Survey measures included sociodemographic and clinical
characteristics, health status and well-being, lifestyle behaviors,
and provider engagement. Key risk factors (body mass index,
blood pressure, tobacco use, aspirin use), laboratory data
(hemoglobin A1c, lipids), and comorbid diagnosis data will be
collected from the electronic medical record.
Results: Of the 1528 patients contacted, 122 did not meet
intervention trial eligibility criteria, 708 refused, 698 consented,
and 550 completed the survey. Participant demographics
were similar between the Rural and Nonrural participants.
Among participants, awareness of prediabetes was 40%;
78% reported a blood glucose test in the past year; and 57%
reported high blood pressure. About 10% of participants
reported 5+ daily servings of fruits and vegetables. Almost
24% of Nonrural participants reported daily consumption
of 1+ sugar-sweetened beverage compared to 15% of Rural
participants. Similarly, 40% of Nonrural participants reported
eating 2+ times/week at a fast food or sit-down restaurant
compared to 24% of Rural participants. Approximately 39%
reported 150+ minutes/week of leisure-time physical activity,
and 22% reported strength training 2+ days/week. Daily
sedentary time was 11.5 hours compared to 10.3 hours among
Nonrural and Rural participants, respectively. Satisfaction
with providers ranged from 71% for knowing about patient
history to 82% for demonstrating respect for what patients
had to say. Provider discussions about blood glucose, weight
control, healthy eating, and physical activity was around 60%
among participants but was lower for cardiovascular and
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diabetes risk at 37% and 49%, respectively. Collection of
electronic medical record data is in progress.
Conclusion: Rural participants had some more favorable
physical activity and nutrition practices, but there is a
substantial gap in prediabetes awareness and management in
both groups. Results suggest that increased clinician discussion
of prediabetes and its management, and greater integration of
patient-reported behaviors into primary care shared decisionmaking are areas of interest for future intervention studies.
P4.08
Prevalence of Medication Adherence Issues in
Patients Not Achieving Recommended Care Goals
JoAnn Sperl-Hillen, Jeffrey Anderson, Jacob Haapala,
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Background: As part of a pragmatic trial of a clinical
decision support (CDS) intervention to improve medication
adherence for diabetes, hypertension, and hyperlipidemia, we
first collected data on the prevalence of medication adherence
issues.
Methods: In two large care systems in Minnesota, 28 clinics
were randomized to an adherence CDS intervention or
control. The CDS intervention used web-based algorithms
to identify people 18–75 years old who met one of the
following clinical criteria and also had an objective adherence
issue using an Epic-based measurement of proportion of
days covered (ePDC): 1) A1c of ≥8% with a noninsulin
glycemic medication ePDC of <80%; 2) blood pressure
(BP) of ≥140/90 on 2 separate consecutive dates with a BP
medication ePDC of <80%; and 3) ACC/AHA criteria for
statin use and low-density lipoprotein of >70 mg/dl with
statin ePDC of <80%. The ePDC was calculated within Epic
using SureScripts dispense and claims data. For the first 6
weeks prior to beginning the adherence intervention, August
7, 2019–September 17, 2019, the CDS was run silently in
all clinics to quantify the number of patients who would
be eligible to receive the adherence CDS and pharmacist
outreach intervention.
Results: Of 55,377 patients, age 18–75, with 1 or more
encounters in the 6-week period, a BP medication was
identified in 20,181 (BP Cohort). Of these, 2363 met the
criteria for not being at clinical goal and 1452 also had
ePDC of <80% (61%). A noninsulin diabetes medication
was identified in 6573 (Diabetes Cohort). Of these, 1701
met the criteria for not being at clinical goal and 1095 also
had ePDC of <80% (64%). A statin was identified in 14,171
(Lipid Cohort). Of these, 8674 met the clinical criteria for
lipids and 4098 also had ePDC of <80% (47%). Of 2069
patients who met all the study inclusion and exclusion
criteria, 12% were eligible for more than 1 cohort.
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Conclusion: Rates of medication adherence issues are high
among patients who are not meeting recommended care
goals for blood pressure, diabetes, and lipids. No problems
are anticipated for accrual rates of study-eligible patients or
power to detect clinically significant changes in medication
adherence and clinical outcomes.
P4.09
User-Centered Decision Support: Formative
Provider-Usability Evaluation of Integrated Clinical
Decision Support for Chronic Kidney Disease Care
and Management in Primary Care
Pritika Kumar,1 Stephanie Freund,1 Deepika Appana,1
Lilian Chumba,1 Patrick J. O’Connor,1 JoAnn SperlHillen1
HealthPartners, Bloomington, MN
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Background: To prevent serious chronic kidney disease
(CKD) complications such as end-stage renal disease
and cardiovascular events, better strategies are needed to
identify, treat, and refer patients with CKD who are seen in
primary care clinics. The CKD-Wizard (CW) is an addition
to an existing and successful nonproprietary web-based
clinical decision support system, called Priorities Wizard,
and includes key elements of CKD care for patients
seen in primary care settings, including recognition of
CKD, management of blood pressure and glucose, and
timely referral to nephrologists when appropriate. Our
objective is to formatively evaluate CW that not only helps
clinicians plan treatment protocols with a comprehensive
understanding of the patients’ comorbid diagnoses but also
promotes evidence-based conversations between patients
and clinicians regarding patient-specific risk and patients’
specific concerns.
Methods: User-centered design with practice-based and
participatory decision aid development will be used to
design, develop, and evaluate patient-centered decision
support regarding CKD care in primary care clinics
within the HealthPartners (HP) Medical Group. User
experience and user interface (UX/UI) development will
involve successive iterations with incremental refinement
in 4 phases: 1) initial prototype development; 2) usability
assessment; 3) field testing; and 4) beta testing. This
qualitative approach will involve input from the HP
patient advisory board members, primary care clinicians,
health services researchers, designers, and programmers
at every stage.
Results: The CW will be a product of successive iterative
revisions in accordance with UX/UI industry design
standards. This will result in a useful and usable final
product that integrates clinical decision support with a
patient decision aid to promote shared decision-making
between the primary care physician and patients. This
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electronic health record-integrated tool will facilitate
evidence-based conversations regarding CKD in patients
living with other comorbid conditions.
Conclusion: The CW is designed to align evidence-based
practices about CKD in primary care patients. It aims to
build trust, empower active participation by the patients
about their condition, and promote shared decision-making
between the primary care physicians and patients. We
hypothesize that, when implemented, the CW will support
the clinician-patient relationship, effectively manage CKD
(especially so for patients with other comorbid conditions),
and improve the patient experience of care.
P4.10
Efficacy of a Nitric Oxide Dressing in Decreasing
Bacterial Counts on Human Skin
Rachel Nye,1 Kristi Robinia,1 Josh Sharp,1 Paul
Peterson1
Northern Michigan University, Marquette, MI
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Background: The presence of infection contributes to
prolonged and costlier hospitalizations and may even cause
death. Surgical site infections, blood stream infections, and
antimicrobial resistance are global health problems. 1,2,3,4
nitric oxide (NO) use is a potential strategy for preventing
skin infections, which may be implicated in blood stream
infections and antibiotic use.
Methods: Three dressings containing the experimental
compound (NO) as well as 3 control dressings were applied
without antiseptic preparation to intact skin on the backs
of 66 healthy volunteers. Baseline microflora bacterial
counts were obtained on day 3 of the study. Subsequent
skin cultures were obtained underneath dressing pairs
(1 experimental and 1 control) on days 3, 5, and 7 after
application. A within-subjects design using a sample of
convenience was completed to compare the efficacy of
bacterial reduction under the experimental and control
dressings.
Results: On each removal day the experimental NO
dressing demonstrated a statistically significant reduction
(P-values ranged from <0.001 to <0.007) in bacterial count
when compared to the control dressing. In summary, the NO
compound film dressings had significantly lower bacterial
colony counts as compared to the control Tegaderm® on
days 3, 5, and 7.
Conclusion: Incorporating a nitric oxide compound into
a dressing has an antibacterial effect lasting a minimum
of 7 days. This dressing has the potential to prevent skin
infection, thereby potentially reducing cost and length of
stay.
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Background: In partnership with the National Cancer
Institute, we are developing a prospective cohort of adults,
40–65 years old, to study cancer etiology and prevention
(https://dceg.cancer.gov/research/who-we-study/cohorts/
connect). For this cohort, it is imperative to enroll a cancerfree population. While tumor registries are the “gold standard”
to identify incident cancers, tumor registries may not include
recent diagnoses (within the past 12–18 months) or a history
of cancer prior to health plan enrollment. An algorithm
developed in 2013 from Kaiser Permanente (KP) Colorado’s
electronic medical record combined tumor registry data and
diagnosis codes to achieve a 100% sensitivity and 84.6%
specificity for identifying prior cancers, although it has not
been validated in other health care settings. Our goal is to
update this “history of cancer” algorithm and validate it across
6 geographically diverse health plans (HP).
Methods: We included all 2016 members between the ages
of 40 and 65 years from the participating sites to ensure the
tumor registry was complete at each participating health plan.
Patients who ever had an inpatient or outpatient diagnosis
code or ever had an observation in the tumor registry were
flagged as having a history of cancer. In situ cancer diagnosis
codes, previously excluded from the 2013 algorithm, were
included. Each health plan will validate the algorithm through
chart review (n=200) and calculate the sensitivity, specificity,
positive predictive value, and negative predictive value.
Results: A total of 529,254 members from 4 health plans
are included in our preliminary findings: KP Colorado
(n=177,515), KP Georgia (n=104,638), KP Hawaii (n=76,910),
and KP Northwest (n=170,191). The algorithm identified an
average of 91.5% cancer-free adults. Averages per site were
90.3% for KP Colorado, 93.0% for KP Georgia, 93.0% for
KP Hawaii, and 90.1% for KP Northwest. Across sites, there
were more cancer-free individuals who were younger and
male. Marshfield Clinic and University of Chicago also will
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be participating in the algorithm validation. Results from
validation of the algorithm at all health plans is underway.
Conclusion: A validated algorithm to identify cancer cases
that may fall outside of tumor registries may be a useful
tool in a variety of analytic settings. Understanding how the
algorithm performs in different health plans will help optimize
the process for broad dissemination.

visited a provider with more patients referred to LCS-LDCT
are more likely to complete the screening test.
Conclusion: This abstract is considered “work in progress"
to be completed by April 2020. Our findings on the barriers
and facilitators to LCS-LDCT screening recommendations
are likely to influence clinical practice at patient, provider,
and systems levels to inform targeted interventions.

OA6.02
Adherence to Provider Referrals for Lung Cancer
Screening With Low-Dose Computed Tomography

OA6.03
Implementing
Universal
Lynch
Syndrome
Screening Programs Across Three Health Care
Systems: A Qualitative Cross-Case Comparison

Jiang Li,1 Meghan Martinez,1 Harold S. Luft1
Sutter Health, Walnut Creek, CA

1

Background: In 2013, guidelines for lung cancer screening
(LCS) with low-dose computer tomography (LDCT) were
released and LCS-LDCT became a Medicare-covered benefit
in 2015. Despite this, LCS-LDCT uptake remains low, in
part because LCS-LDCT is a complex multistep process that
requires considerable effort on the part of the patient, provider,
and health system. Older heavy smokers who are eligible
for LCS-LDCT may face barriers such as inconvenience,
perceived smoking-related stigma, and distrust of the health
care system, which may lead to decreased LCS-LDCT
participation. At the system level, there is no unified way to
schedule, track, or ensure patients complete screenings or
follow-ups. Instead, each department has their own processes,
systems, and workflows, which may influence uptake of
LCS-LDCT in clinical settings. This study aims to examine
trends in adherence to provider referrals for LCS-LDCT and
the multilevel factors influencing completion rate of LCSLDCT orders in one health care system following a series of
guideline/policy changes.
Methods: We analyzed electronic health record data from
a large health care system in Northern California between
January 2010 and May 2019. A total of 46,100 LCS-LDCT
orders were included in the analysis. For any patient with
an LCS-LDCT order, trends in the proportion of eligible vs
ineligible patients (per screening guidelines) and screening
completion rates were assessed and compared. Multilevel
factors associated with completion of the LCS-LDCT order
were explored using hierarchical generalized linear models.
Results: About 40% of patients referred for LCS-LDCT did
not meet all eligibility criteria for screening. Completion rate
varies from the lowest (2% in 2014) before Medicare coverage
to the highest (63% in 2018) after Medicare coverage.
Completion rates vary significantly across providers (𝜏𝜏00:
1.4261, standard error: 0.06141). Approximately 25.4% of
variability in the LCS-LDCT completion rate is accounted
for by the providers, leaving 74.6% of the variability to
be accounted for by the patients or other unknown factors.
Older age and being ineligible for LCS-LDCT are factors
that negatively impact LCS-LDCT completion. Those who
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Background: Despite multiple guidelines, implementation of
universal tumor screening (UTS) for Lynch syndrome (LS) in
health care systems remains variable. The IMPULSS study
was created to better understand and use this variability to
guide implementation in a variety of health care settings.
Methods: Nine health care systems (7 HCSRN, 1 academic,
1 national system) were purposively selected for variability
in implementing UTS for the IMPULSS study (2 with
UTS, 1 without UTS). To date, stakeholder interviews
have been completed across 3 organizations (2 HCSRN, 1
non-HCSRN). Multiple stakeholders at each organization,
including leaders, oncologists, genetic counselors, and
gastroenterologists, participated in semi-structured interviews
guided by the Consolidated Framework for Implementation
Research (CFIR). Interviews were audio-recorded and
transcribed for coding and analysis. Within each organization,
we coded organization data relevant to the CFIR domains
of inner setting, process, characteristics of individuals, and
intervention characteristics.
Results: We completed 16 stakeholder interviews across 3
organizations. Respondents included 7 genetic counselors/
genetics nurses, 3 administrators/clinician leaders, 2
oncologists, 1 pathologist, and 3 other clinicians (family
practice, pharmacy). Using a qualitative cross-case comparison
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approach, similar implementation challenges were identified
across all 3 organizations related to structural characteristics,
resources, communication, and champions. Factors reported
as important to initial program implementation were internal
pathology and leadership support, while availability of
systematic processes and tracking were reported as important
to program optimization. Intraorganizational variability
in UTS implementation also was uncovered. Within one
organization reporting UTS implementation, interviews
revealed UTS was implemented only at locations with
internal pathology. Within the organization without UTS,
stakeholders reported implementing tumor screening in one
location via a clinical trial (not specific to LS identification).
Conclusion: Findings of intra-organizational variability in
UTS implementation illuminates additional complexities in
health care systems due to heterogeneity in organizational
structures and availability of resources within organizations.
These preliminary data demonstrate that implementation
may need to be characterized differently within organizations
to understand barriers and facilitators accurately, and that
additional facilitating factors may be found in unrelated
programs indirectly achieving the desired practice.
These findings also confirm the importance of viewing
implementation as an ongoing process that is best facilitated
through the lens of opportunities within local contexts.
OA6.04
Associations Between Patient and Tumor
Characteristics and Screen-Detected Versus
Symptomatic Colon Cancers in Two Integrated
Health Care Systems
Elizabeth Sarma,1 Matthew Thompson,2 Erin Bowles,3
Andrea Burnett-Hartman,4 Lu Chen,3 Rebecca
Hubbard,5 Onchee Yu,3 Jessica Chubak3
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Background: Colon cancer screening is credited with
reducing colon cancer mortality, but little is known about
the characteristics of patients and tumors of screendetected colon cancers compared to colon cancers that are
detected symptomatically. Our objective was to describe the
proportions of colon cancer diagnoses detected by screening
or symptomatic presentation and to assess patient and tumor
characteristics associated with these diagnosis routes in two
integrated health care delivery systems.
Methods: We conducted a study among adults, age 50 to
85 years, with stage I–IIIA colon cancer diagnosed during
1995–2014 at Kaiser Permanente Colorado or Kaiser
Permanente Washington. Mode of detection (screen-detected/
asymptomatic or symptomatic) was ascertained from
102 JPCRR • Volume 7, Issue 1 • Winter 2020

medical records. Multivariable logistic regression models
were used to estimate odds ratios (OR) and 95% confidence
intervals (CI) comparing the odds of screen-detected colon
cancer by patient factors — demographics at diagnosis (year,
age, sex, race, smoking status, body mass index [BMI],
Charlson score), prediagnosis primary care utilization, and
disease factors (stage, location) — adjusted for included
factors and study site.
Results: Of 1675 colon cancer patients, 38.4% had
screen-detected colon cancer and 61.6% were detected
symptomatically. Patients more likely to have a screen-detected
diagnosis were diagnosed during 2010–2014 vs 1995–1999
(OR: 1.57, 95% CI: 1.07–2.30), were male (OR: 1.30, 95%
CI: 1.04–1.63), had a BMI of 25–<30 kg/m2 (OR: 1.36, 95%
CI: 1.04–1.80) or 30+ kg/m2 (OR: 1.39, 95% CI: 1.05–1.85)
vs <25 kg/m2, and had transverse vs left-side cancer (OR:
1.66, 95% CI: 1.10–2.50). Relative to patients with no
comorbidities, patients with 1 (OR: 0.72, 95% CI: 0.55–0.95)
or 2+ comorbidities (OR: 0.35, 95% CI: 0.25–0.49) at the
time of diagnosis were less likely to have a screen-detected
cancer, as were patients diagnosed with stage IIA (OR: 0.34,
95% CI: 0.27–0.43) or IIB (OR: 0.12, 95% CI: 0.06–0.24)
relative to stage I.
Conclusion: The majority of colon cancers were diagnosed
following symptomatic presentation, but the proportion
that were screen-detected increased over time. Certain
patients, particularly those with more comorbidities and
higher-stage cancers, are less likely to have a screendetected diagnosis, even after adjusting for health care
utilization. Additional research is needed to increase
colon cancer screening in patients likely to benefit from it.
OA11.01
Development of an Electronic Intervention Tool
in Epic for the Ambulatory Stem Cell Transplant
Pharmacist
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Background: National guidelines recommend pharmacists be
included as part of the multidisciplinary care team for patients
undergoing stem cell transplant. While previous efforts have
sought to justify their role through metrics such as inpatient
services and outpatient prescription retention, evaluations
of the ambulatory stem cell transplant pharmacists’ direct
impact remain uncertain. We describe the development and
implementation of an electronic pharmacist intervention tool
smart phrase in Epic to capture and quantify ambulatory
interventions by the stem cell transplant pharmacist.
Methods: The pharmacist intervention tool was designed
based on the Pharmacy Quality Alliance’s Medication
Therapy Problem Categories Framework. The intent of this
framework was to utilize nationally recognized standard
Supplement

definitions for benchmarking. The intervention tool documents
the medication or disease status on which the pharmacist
intervened as well as classification of the intervention and
magnitude of the encounter. The pharmacist intervention tool
was built into Epic using standard data elements incorporated
through a smart phrase. Stem cell transplant pharmacists were
then educated to incorporate the smart phrase as a part of their
routine documentation of direct patient care.
Results: The pharmacist intervention tool was implemented
in May 2019, and interim evaluation of the tool was conducted
in October 2019. The pharmacist intervention tool was used
in 662 unique encounters across 47 stem cell transplant
patients, the majority of whom underwent allogeneic stem
cell transplant (97%). An average of 1.56 medications was
managed per encounter, and the pharmacist addressed an
average of 1.44 medication-related problems per encounter.
The most frequently managed issues included cyclosporine
(328), tacrolimus (17), and disease (14). Pharmacists most
often made 2.25 interventions per encounter. The most
frequently documented inventions were monitoring (354),
graft-vs-host-disease surveillance (185), infection surveillance
(152), and immunosuppression management (69).
Conclusion: A standard data element-based smart phrase can
be utilized to document interventions of the ambulatory stem
cell transplant pharmacist. This pharmacist intervention tool
allows for quantification of the pharmacist’s direct impact on
patient care versus other surrogate outcomes. Future analysis
should incorporate such pharmacist intervention data to
elucidate the value to the stem cell transplant patient in the
ambulatory setting.
OA11.02
Implementation of Objective Assessment of
Swallow Function Before and After Treatment of
Head and Neck Cancers
Samantha Tam

1
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Background: Management of head and neck cancer is
complicated due to the debilitating functional impairments
often accompanying the primary disease and/or related
therapeutic interventions. Unfortunately, there are limited data
objectively describing change in functional swallowing after
the treatment of head and neck cancer. To this end, we utilized
an objective measure of swallow function, the Functional
Oral Intake Scale (FOIS), to investigate the impact and further
define the prognosis for head and neck cancer treatment.
Methods: Retrospective chart review was performed
analyzing data from 219 patients with diagnosed head and neck
cancer. Patients underwent pretreatment and posttreatment
swallow studies, in which swallow function was assessed and
categorized using the FOIS. The FOIS classifies swallowing
capabilities by examining oral and pharyngeal phases of
swallowing on a scale from 1 to 7. A score of 7 indicates no
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functional swallowing deficit, whereas a 1 indicates no oral
intake ability. Scores of 1–3 are feeding tube-dependent,
whereas scores of 4–7 can receive oral preparations to various
degrees. Paired t-tests were used to detect changes in swallow
function from pretreatment to posttreatment.
Results: Overall, head and neck cancer treatment resulted
in a statistically significant decrease in FOIS score from 6.3
to 4.6 (P<0.0001). For stage IV squamous cell carcinoma
(n=126), FOIS decreased from 6.2 to 4.3 (P<0.0001); 19%
(n=24) required a feeding tube 1-year posttreatment. For stage
III squamous cell carcinoma (n=33), FOIS scores trended
downward from 5.8 to 5.1 (P=0.26); 6% (n=2) required a
feeding tube 1-year posttreatment. For stage II squamous cell
carcinoma (n=35), FOIS decreased from 6.4 to 4.8 (P<0.001);
9% (n=3) required a feeding tube 1-year posttreatment. For
stage I squamous cell carcinoma (n=25), FOIS scores trended
downward from 6.8 to 5.5 (P=0.09); 8% (n=2) required a
feeding tube 1-year posttreatment.
Conclusion: The treatment of head and neck cancer resulted
in significant decreases in FOIS. Additionally, patients
with stage IV squamous cell carcinoma experience the
most substantial decline in swallow function, with a higher
need for a feeding tube 1-year posttreatment. This study
demonstrates the first pre- and posttreatment objective
assessment of swallow studies for patient undergoing head
and neck cancer treatment.
OA11.03
Cost-Effectiveness
of
Upfront
Maintenance
Therapies in Advanced Ovarian Cancer: Does It
Work for Everyone or Targeted Patients Only?
Su-Ying Liang,1 Michael Richardson,2 Daniel S. Kapp,2
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Background: Several new maintenance therapies with
antivascular and poly (ADP-ribose) polymerase (PARP)
inhibitors (bevacizumab, niraparib, and olaparib) for ovarian
cancer have been approved by the U.S. Food and Drug
Administration in recent years. While economic analysis of
bevacizumab has been conducted, relatively little is known
about niraparib and olaparib due to insufficient effectiveness
data. Taking advantage of effectiveness data from clinical
trials that recently became available in September 2019, this
study evaluates cost-effectiveness of maintenance therapies in
advanced ovarian cancer, with a specific focus on niraparib
and olaparib.
Methods: Data on clinical outcomes, including progressionfree survival (PFS), were obtained from clinical trials
(PRIMA and PAOLA-1). Cost data were obtained from our
previous work and the Centers for Medicare & Medicaid drug
payment and physician fee schedule. We developed a Markov
model and computed the incremental cost-effectiveness ratios
www.aurora.org/jpcrr
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(ICERs) of maintenance therapies relative to placebo. We
conducted stratified analyses to assess variations in ICERs
across subpopulations (eg, homologous recombination [HR]
status: deficient, proficient, or undetermined; biomarker status:
BRCA-muted [BRCAm] or wild-type). Sensitivity analyses
were performed to evaluate impacts of key parameters,
particularly drug costs, on ICERs.
Results: Based on estimated costs of niraparib (200 mg at
$9883 per month over 3 years of maintenance) and 5.6
months PFS gained for the overall stage III–IV ovarian cancer
patients, 12 months PFS gained for BRCAm patients, and
11.5 months PFS gained for patients who were HR-deficient,
the incremental costs per progression-free life-year gained
were $758,546, $353,988, and $369,379, respectively. Based
on estimated costs of olaparib ($16,178 per month for 2 years
of maintenance, with bevacizumab $9775 per month for 21
months) and 5.5 months PFS gained for the overall sample,
20 months PFS gained for BRCAm patients, and 11 months
PFS gained for HR-deficient patients, the incremental
costs per progression-free life-year gained were $837,818,
$236,308, and $418,909, respectively. In comparison, the
ICER of bevacizumab was $416,051 with 6 months PFS.
A Markov model incorporating quality of life is under
development, and estimates of ICERs will be updated.
Conclusion: Our preliminary findings suggest that benefits
of the maintenance therapies vary across the overall sample
and subgroups. Maintenance with targeted therapies in
advanced ovarian cancer can be cost-effective, particularly
with companion biomarker guidance.

social workers, etc) completed interviews. Goals-of-care
conversations arose at 2 time points: 1) at diagnosis of stage
IV cancer or metastasis (“establishing goals of care”); and
2) when disease progressed or pain and symptoms became
too difficult (“changing goals-of-care conversations”).
Establishing goals-of-care conversations with oncology teams
were about understanding the goal of treatment (to cure cancer,
extend life, etc), and prognosis (“How much time do I have?”).
Patients and oncologists varied in their desire to hear or give
specific prognostic timelines, with some patients expressing
ambivalence. Both patients and providers expressed beliefs
about the fluidity of prognosis, particularly due to new cancer
treatments. Changing goals-of-care conversations concerned
stopping treatment, hospice care, prognostic awareness,
quality of life, advance care planning, and end-of-life planning.
Palliative care teams often facilitated these conversations, and
patients appreciated discussing their options and preferences.
Both patients and care teams acknowledged challenges, such
as when to have these conversations. Some patients desired
earlier conversations and palliative care involvement; others
wanted to get through their first round of treatment or wait
until things were “going downhill.”
Conclusion: Both patients and care teams acknowledged the
complexity around having goals-of-care conversations but
desired improved communication to enhance goal-aligned
care and improve patient and family end-of-life experiences.
Patients reported that palliative care teams played an important
role in enhancing changing goals-of-care conversations and
decisions.

OA11.04
Conversations About Goals of Care: Insights From
Interviews With Patients With Advanced Cancer
and Oncology and Palliative Care Teams
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Economic Evaluation of Universal Lynch Syndrome
Screening Strategies Among Newly Diagnosed
Patients With Colorectal Cancer
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Background: There is widespread agreement that patientcentered care begins with understanding patients’ goals and
values. There are concerns that individuals with advanced
cancer receive serious illness and end-of-life care that is not
aligned with their values and preferences. However, we lack
in-depth information on how these goals are discussed in
conversations between patients and clinicians.
Methods: In-depth interviews were conducted with a
convenience sample of patients with advanced cancer and
members of medical oncology, gynecological oncology,
and palliative care teams in a large multispecialty group in
Northern California. The research team conducted qualitative
data analysis using open coding to identify emergent themes.
Results: Of those contacted, 25 of 29 (86%) patients and
25 of 38 (66%) care team members (physicians, nurses,
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Background: Lynch syndrome (LS) is the most common
form of inherited colorectal cancer (CRC). Tumor screening
for LS in all newly diagnosed CRC patients has the highest
(tier 1) Centers for Disease Control and Prevention evidence
rating and support for broad implementation in health
care systems; however, implementation of universal LS
screening remains suboptimal. The objective of this study
is to compare the relative effectiveness and efficiency of
different LS screening strategies among newly diagnosed
CRC populations from the health care system perspective.
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Methods: Decision analytic models were created from
previous work and updated to reflect new LS screening
developments, including reduced genetic testing costs, new
evidence on the value of double somatic tumor sequencing,
and consideration of tumor sequencing as an upfront test.
We developed decision analytic models representing 8 viable
LS screening protocols for a hypothetical cohort of 1000
patients with newly diagnosed CRC. Model assumptions and
parameter values were extracted from a literature review and
augmented by input from clinical experts. Costs were mainly
obtained from the Medicare fee schedule and are in 2018 U.S.
dollars.
Results: Preliminary results based on the models of the
first 7 protocols indicated the direct germline sequencing
protocol provided the best sensitivity (99.90%, 95% CI:
99.57%–99.93%) and equal specificity (99.50%, 95% CI:
97.28%–99.85%) in terms of identifying LS cases, compared
to immunohistochemistry (IHC) (sensitivity: 79.33%, 95%
CI: 72.17%–80.99%; specificity: 99.98%, 95% CI: 99.88%–
99.99%) and microsatellite instability (MSI) (sensitivity:
81.13%, 95% CI: 73.60%–82.91%; specificity: 99.99%,
95% CI: 99.93%–100%) protocols. The total program costs
were $0.9M (95% CI: $0.5M–$1.7M) for direct germline
sequencing, compared to $0.5M (95% CI: $0.4M–$0.6M) for
IHC and $0.6M (95% CI: $0.4M–$0.7M) for MSI. Threshold
analysis showed that the cost of the genetic sequencing panel
to the health care system would need to be $376 for direct
germline sequencing to be as efficient as the IHC protocol, ie,
have the same cost per LS case identified.
Conclusion: Direct germline sequencing was the most
effective protocol for identifying LS cases but was more
expensive than the IHC protocol, which had the lowest cost
per LS case identified but misses more LS cases. Direct
germline sequencing would be as efficient as the IHC protocol
if the costs of the tests decline.

receiving ibrutinib therapy, and the age at AF was categorized
into <60, 60–80, and >80 years. Stepwise Cox regressions
were employed to select vital predictors.
Results: 192 patients on ibrutinib therapy were recruited for
the study; 65.6% were male, median age was 72 years (71.9
± 11.2), with 79% between 60 and 80 years, and 91% were of
non-Hispanic white ethnicity. Of the 192 patients, 56 (29.2%)
developed AF, with 2 months as median time to AF. The first
Cox model indicated age, prior AF history, and congenital
heart disease as crucial predictors for AF outcome while
on ibrutinib therapy. Patients who were >80 years old, with
previous history of AF/coronary heart disease, were at the
highest risk of developing AF at 12-month follow-up (hazard
ratio [HR]: 11.7, 95% CI: 6.5–21.2). In the second Cox model,
a history of congestive cardiac failure (HR: 5.5, 95% CI: 2.9–
10.4), congenital heart disease (HR: 5.9, 95% CI: 1.4–25.4),
and hypertension (HR: 2.9, 95% CI: 1.5–5.6) significantly
predicted AF event, when age was not considered.
Conclusion: Our study illustrates the relationship of an
increased risk in atrial fibrillation in elderly patients with
cardiovascular comorbidities who receive ibrutinib therapy,
indicating the significance of timely screening and intervention
in populations at risk to improve patient outcomes. Our study
is one of the first to identify congenital heart disease as a risk
factor for the development of ibrutinib therapy-related AF.

P2.02
Determinants of Atrial Fibrillation Development
Among Patients Undergoing Ibrutinib Therapy

Background: Due to human papillomavirus (HPV)related oropharyngeal carcinoma, its incidence is increasing
significantly, despite the decrease of incidence of head and neck
cancer at other subsites. While HPV status in oropharyngeal
cancer is a known predictor of survival, the effect of race and
socioeconomic status has not been investigated. This study
aims to investigate the effect of race and socioeconomic status
on survival in patients with oropharyngeal carcinoma.
Methods: This was a retrospective cohort study of African
American and Caucasian American patients treated for
squamous cell carcinoma of the oropharynx from 1991 to
2012. Univariate and multivariate Cox proportional hazards
models were created to understand the relationship between
race, socioeconomic status, and overall survival.
Results: A total of 192 patients were included in the study
cohort; 104 patients (54.2%) had tumors that were positive for
HPV. Of the 192 patients, 68 (35.4%) were African American
compared to 124 (64.6%) Caucasian Americans. After
adjusting for HPV status, stage at diagnosis, median household
income in patient zip code, and proportion of residents in
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Background: Within the last decade, the use of ibrutinib, a
first-generation, nonselective, irreversible Burton’s tyrosine
kinase inhibitor for the treatment of hematologic malignancies
has proved to be highly effective in improving patient
outcomes. Although ibrutinib has been associated with an
increase in atrial fibrillation (AF), yet the predisposing factors
have not been well defined.
Methods: A retrospective approach was taken to identify
patients diagnosed with hematologic (B-cell) malignancies
and receiving ibrutinib therapy at Marshfield Clinic to
evaluate the risk factors associated with the development of
AF. The outcome of interest was the time to AF diagnosis after
Supplement
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patient zip code who did not complete high school, African
American race continued to be an independent predictor
of overall survival (adjusted hazard ratio: 2.58, 95% CI:
1.26–5.26). Other markers of socioeconomic status (median
household income and education) were no longer predictors
of overall survival following multivariate adjustment.
Conclusion: Even after adjusting for HPV status, race
continued to be an important predictor for overall survival
in patients with oropharyngeal cancer. Understanding the
drivers for this racial disparity may allow for improved
treatment decision-making in African American patients with
oropharyngeal carcinoma.
P2.04
Neoadjuvant Modified Docetaxel, Cisplatin, and
Fluorouracil Integrated Into a Multimodal Treatment
Approach in Nonmetastatic Esophageal Cancer: A
Community Experience
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Background: A modified docetaxel, cisplatin, and
fluorouracil (mDCF) regimen as the first-line treatment for
metastatic adenocarcinoma has been associated with higher
rates of disease-free survival (DFS) and overall survival
and lower rates of toxicities compared to DCF in the
clinical trial setting. Yet, whether mDCF incorporated into
a multimodal treatment approach will benefit patients with
gastroesophageal cancer remains unknown.
Methods: A retrospective approach was taken to study
the benefit and risk of adapting mDCF neoadjuvant into
multimodal treatment for patients with nonmetastatic
esophagus/gastroesophageal junction cancer (NMEGJC) in
the community setting. Patients diagnosed with NMEGJC
between August 2008 and November 2017 and prescribed
mDCF as adjuvant along with other chemotherapies, surgeries,
and/or radiotherapy were identified for retrospective review.
mDCF consists of docetaxel 40 mg/m2 intravenous (IV)
infusion (day 1), cisplatin 40 mg/m2 IV (day 3), fluorouracil
400 mg/m2 IV (day 1), fluorouracil 1000 mg/m2 continuous
IV infusion over 48 hours (days 1 and 2), and leucovorin
400 mg/m2 (day 1). Outcomes of interest included diseasefree survival, overall survival, and hematologic toxicities.
Descriptive statistics and Kaplan-Meier curves were
performed using SAS 9.4.
Results: Thirty patients met inclusion criteria (median age:
64.9 years); 90% of the population was male. Of the 30, 77%
of NMEGJC had adenocarcinoma; 23% had squamous cell
carcinoma. The majority had stage II or higher NMEGJC
(90%); 63.3% underwent esophagectomy. The 2-year
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and 5-year disease-free survival was 60.8% and 41.7%,
respectively, for adenocarcinoma and 71.4% and 71.4%
for squamous cell carcinoma, respectively. The 2-year and
5-year overall survival was 64.9% and 44.5%, respectively,
for adenocarcinoma and 71.4% and 71.4% for squamous
cell carcinoma, respectively. Both disease-free and overall
survival decreased with increasing disease stage, histology
(adenocarcinoma vs squamous), esophageal compared
to gastroesophageal junction involvement, and without
surgical intervention. The most frequent toxicity (Common
Terminology Criteria for Adverse Events Version 5.0) for
leukopenia (56.7%) and thrombocytopenia (84.2%) were
grades I and II.
Conclusion: The mDCF neoadjuvant can be integrated into
the multimodal treatment approach for stage II or higher
NMEGJC as the first-line treatment because of noninferior
survival rates and lower grade of toxicity compared to
conventional perioperative regimens. Further studies with
higher numbers of patients in different subtypes of carcinoma
are urgently needed to confirm the preliminary findings.
P2.05
Local Implementation of Cancer Care Delivery
Research Within a Community NCORP
Pamala A. Pawloski,1 Heather Kehn,1 Alice Shapiro,2
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Background: Metro-Minnesota Community Oncology
Research Consortium (MMCORC) is part of the National
Cancer Institute Community Oncology Research Program
(NCORP), a national network of cancer care investigators,
providers, academia, and other organizations that care for
diverse populations in health systems. MMCORC represents
28 hospitals and clinics in the Minneapolis, Minnesota,
metropolitan area, suburbs, and rural locations, with more
than 160 participating physician investigators. More than
600 patients are enrolled into clinical studies annually. The
portfolio of clinical trials includes cancer care delivery
research (CCDR). Our affiliate membership is the cornerstone
of our CCDR program within MMCORC. The majority of
affiliate member locations reside in rural locations within
Minnesota and Wisconsin. Research coordinators at affiliate
sites are employees of the health system and often have
embedded roles within the cancer center. Affiliate sites are
smaller due to lower patient volumes. Specialty departments
already work closely together with established working
relationships and single service line leadership.
Methods: Facilitators: Supportive providers introduce study
to patient during clinic visit, followed by discussion with
research coordinator. Use of the central screening innovation
will alleviate burden on site research staff and target priority
protocol needs. Collaboration will include patient advocates
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and community-based programs. Barriers include challenging
clinic flow and timing of enrolling multiple patients with
complex clinic visits within the protocol eligibility window.
With nontraditional research partners, it takes an extra amount
of time and effort to bring partners on board who were not
previously part of Community NCORP research, such as
pathology leaders, pharmacists, nurse navigators, lung
screening departments, and surgical practices.
Results: Current number of open and enrolling care delivery
protocols is 7, number of enrolled patient participants to
date is 100, number of enrolled providers to date is 88, and
number of enrolled practices to date is 19. MMCORC has 25
component sites, part of the 1000 study locations nationally.
Conclusion: Successful local implementation includes
multidisciplinary leadership and a framework that provides
resources to site staff who have engaged providers and
working relationships with nontraditional research partners
throughout the health system. Opportunities for growth include
closely examining local cancer disparities and identifying
care delivery research questions to address the issues.

HEALTH EQUITY AND SOCIAL NEEDS
OA8.01
Barriers to Implementing Social Needs Screening in
Medical Care Settings: Findings From the National
Academies of Sciences, Engineering, and Medicine

perspectives. The committee met 6 times over an 18-month
period to gather, review, and discuss the collected evidence
before developing the conclusions and recommendations
presented in the report.
Results: The identified implementation barriers associated
with social needs care integration were grouped into 4
categories: barriers to initiating social care integration
(eg, obtaining leadership support and staff buy-in, setting
operational goals); documenting social needs (eg, identifying
a target population, designing workflows, providing training,
identifying appropriate screening methods); reviewing social
needs (eg, identifying referral resources, creating/maintaining
partnerships with social service providers); and responding to
social needs (eg, developing workflows for internal referrals,
identifying local resources for external referrals). The report
proposes several strategies to address these identified barriers.
Conclusion: National momentum for strengthening the
intersection of social and medical care delivery is growing
rapidly. However, efforts to implement social-medical care
integration are likely to encounter implementation barriers.
Findings from this NASEM report summarize the existing
evidence and evidence gaps on potential barriers to social
care integration as well as strategies that may support the
implementation and sustainability of integrated medical
and social care programming. Further research is needed
to identify which implementation strategies will be most
effective in different care settings.
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Community Health Centers

Kaiser Permanente Center for Health Research,
Portland, OR; 2University of North Carolina at Chapel
Hill, Chapel Hill, NC; 3Johns Hopkins University,
Baltimore, MD; 4University of California, San Francisco,
San Francisco, CA

Erika Cottrell,1 Miguel Marino,2 Stuart Cowburn,1 Jorge
Kaufmann,2 David Ezekiel-Herrera,2 Katie Dambrun,1
Arwen Bunce,1 Ned Mossman,1 Megan Hoopes,1 Molly
Krancari,1 Rachel Gold3

1

Background: A National Academies of Sciences,
Engineering, and Medicine (NASEM) committee convened
to examine the potential for integrating social needs care into
the delivery of medical care. The committee was charged
with assessing 1) current and emerging approaches to social
needs care integration in diverse health care systems, 2) the
roles of different disciplines, care organizations, and types
of providers in the integration process, and 3) current and
emerging efforts to inform the delivery of effective, efficient
care that addresses social needs, improves health, and
reduces health inequities. The committee’s final report was
released in September 2019. This presentation will provide
an in-depth review of the report’s findings on barriers to
implementing social needs care integration and possible
solutions to address these barriers.
Methods: The committee was comprised of 18 subject
matter experts. A broad literature search was conducted, and
3 public sessions were held to obtain further information and
Supplement

OCHIN, Inc., Portland, OR; 2Oregon Health & Science
University, Portland, OR; 3Kaiser Permanente Center
for Health Research, Portland, OR
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Background: Preliminary research suggests that electronic
health record (EHR)-documented data on patients’ social
determinants of health (SDH) can inform care teams about
patient needs and facilitate referrals to social services. The
need for standardized SDH data collection and response
is arguably greatest in community health centers (CHCs),
but little has been reported in implementation of SDH
documentation in this important care setting.
Methods: We developed a suite of EHR tools for documenting
patient-reported SDH data and implemented these tools
in OCHIN’s national network of CHCs in June 2016. In
descriptive analyses on tool adoption, we used EHR data on
the 581 clinics that had access to the tools at any time during
the study period. We then conducted logistic regressions to
www.aurora.org/jpcrr
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model associations between SDH documentation and clinic
characteristics among the 345 clinics that had access to the
tools for the entire study period.
Results: In our descriptive analyses, 31,549 patients had
a documented SDH screening from June 2016 to May
2018. The total number of screenings increased over time.
Although 31% of eligible CHC clinics (n=179) used the tool
to document at least 1 SDH screening, more than 50% of
documented screenings occurred in just 4 of the 106 CHC
organizations, and more than half (55%) of documented
screenings only included responses for 1 SDH domain. In our
regression analyses, clinic-level analyses found no differences
in SDH documentation by clinic rurality, percentage female,
or racial/ethnic distribution of clinic patients. Clinics with
a higher percentage of older patients had increased odds of
SDH screening compared to those with younger populations.
Clinics with higher rates of missing data on patients’ federal
poverty levels had decreased odds of SDH screening. Last,
clinics with higher percentages of Medicaid or uninsured
visits had lower odds of SDH screening.
Conclusion: With many national calls to document patients’
SDH in the EHR, it is important to consider whether and how
such screening varies across different kinds of clinics. These
results suggest that national initiatives seeking to encourage
EHR-based SDH documentation may need to account for
clinic characteristics that may serve as barriers or facilitators
to adopting this practice change.
OA8.03
The Potential for Electronic Health Record Digitized
Text to Identify Indications of Social Needs That Can
Influence Patient Health and Health Care Delivery
Douglas Roblin,1 Haihong Hu,1 Claudia Nau2

or co-occurrence of “medication” and “assistance”) and
classified each patient over the 3-year period into having
or not having each type of social need. Data were linked
with ICD-10-CM codes for social needs associated with
health care encounters and with an area deprivation index
describing the patients’ residential Census block group.
Results: ICD-10-CM codes identified social needs for very
few patients (eg, 1.3% for “Z59.xx Housing and economic
circumstances"). By comparison, the SAS algorithm identified
many more patients with indications of need for assistance
in housing (11.7%), utilities payment (22.8%), meals/food
preparation (56.9%), medication (58.0%), and transportation
(75.3%). Patients with one social need were likely to have
another social need (P<0.05). Social needs clustered within
Census block groups (intraclass correlation coefficients of
approximately 0.1 (P<0.05); higher percentages of patients
with indications of social needs lived in areas of greater
deprivation (P<0.05).
Conclusion: We found face and concurrent validity of a
straightforward SAS algorithm for identifying indications of
social needs in EHR notes. Our work establishes a framework
for development of a natural language processing algorithm
that can account for negation (eg, need assessed and ruled
out) and context (eg, transportation assistance needed due to
immobility vs lack of social support).
OA8.04
What Does the Unstructured Narrative Text in the
Electronic Health Record Reveal About Social
Influencers of Health?
David Chin,1 Terrence Habiyaremye,2 Vishal Shetty,1
Melissa Kern,2 Eric Wright2

1

Kaiser Permanente Mid-Atlantic States, Rockville, MD;
2
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School of Public Health and Health Sciences,
University of Massachusetts Amherst, Amherst, MA;
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Background: Social determinants of health are increasingly
relevant to the study of health care delivery and design of
interventions to improve population health (eg, KP Thrive
Local). There is little evidence or consensus on how best to
measure social needs from the electronic health record (EHR).
The objectives of our preliminary study were to 1) develop
a straightforward SAS text-mining algorithm to identify
indications of social risks and needs from free-text provider
notes in a test population, and 2) assess the validity of this
algorithm in identifying indications of social risks and needs.
Methods: We reviewed more than 60,000 lines from EHR
notes associated with the care of 6337 adults who were eligible
for the Kaiser Permanente Mid-Atlantic States Complex Care
Program during 2016–2018. We developed lists of keywords
and phrases to indicate possible need for assistance in
transportation, medication, housing, food/meal preparation,
and utilities payment. The SAS algorithm scanned EHR
notes for occurrences of text strings (eg, “cost of medication”

Background: Social influencers of health (SIoH) — the
economic, educational, social, cultural, and physical
environments in which patients live — are widely
recognized to have a potent effect on a patient’s health
outcomes. Although validated instruments to collect SIoH
exist, adoption of regular capture is challenging and limited.
Clinical notes, the unstructured textual fields written
by providers, provide another potential source of SIoH
information, but these fields remain underexplored for SIoH
information. We examined the prevalence and characteristics
of markers for SIoH recorded in text narrative.
Methods: Patients, age 18 to 89 years, who had at least 5
encounters between June 1, 2018, and June 1, 2019, with at
least 1 encounter with a primary diagnosis of major depression,
within Geisinger Health, an integrated health care delivery
system in Pennsylvania, were eligible. Among 2415 patients
who met the inclusion criteria, 2000 were randomly selected
for manual chart review by an abstractor. Unstructured text
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was abstracted from any clinical setting using a modified
PRAPARE tool. We refined our abstraction tool using the
first 15 records, excluded patients with more than 150 notes
during the study period, and focused on 3 domains: 1)
social interaction/connectivity; 2) social class; and 3) health
behavior. Unstructured text was collected for these domains
and independently annotated by a blinded abstractor.
Results: Among 100 patient records, we found 1693 unique
textual strings relating to a SIoH domain. All charts (100
of 100) had at least 1 SIoH domain identified. SIoH textual
strings were most prevalent among psychiatry (27.8%),
family medicine (19.0%), and emergency medicine (7.7%).
Among 20 subdomains, 16 were identified in ≥30% of charts,
with food insecurity, language, ethnicity, and poverty least
reported.
Conclusion: SIoH are documented in unstructured textual
narratives of patients with depression. We have built a
conceptual model that represents some of the social and
behavioral complexity of patients’ lives that will serve as a
roadmap for our long-term goal: the development of a natural
language processing engine that retrospectively processes
text, consolidating and presenting this knowledge to clinicians
at the point-of-care. These findings provide some evidence of
the potential for natural language processing implementation
to understand SIoH in an integrated health care system.
P9.01
Examining the Association Between Social Isolation
and Future Utilization Among the Elderly Population
David Mosen,1 Matthew Banegas,1 Erin Keast,1 Briar
Ertz-Berger1
Kaiser Permanente Northwest, Portland, OR
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Background: Previous research has found that social isolation
among individuals 65+ years old may be associated with
health outcomes. However, there is limited research examining
health care utilization patterns among patients identified with
high social isolation. We evaluated the associations between
social isolation and hospital and emergency department (ED)
utilization among Medicare patients 65+ years of age.
Methods: We analyzed a retrospective cohort of 18,557
Medicare patients age 65+ who completed a Medicare Total
Health Assessment survey during January 1, 2016–June 30,
2018. The Total Health Assessment is an operations-based
survey of quality of care among Medicare members at Kaiser
Permanente Northwest, an integrated health care system
in Oregon and southwest Washington. Social isolation was
assessed by asking patients how often (5-point Likert scale:
always, often, sometimes, rarely, never) they felt lonely or
social isolated from those around them. Hospital and ED
utilization, demographic, and clinical data were obtained
via electronic health record. The primary outcomes included
any hospital admission (binary) and any ED visit (binary) in
the 12 months following index survey date. Multivariable
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logistic regression models were used to assess the association
of social isolation (often/always, sometimes vs rarely/never
[reference group]) with hospital and ED utilization, adjusting
for age, sex, area deprivation index, Charlson comorbidity
index (CCI), any hospital admissions, or ED utilization prior
to the index survey date.
Results: Patients’ average age was 73.4 years; 56.5% were
female, and 25.2% had a CCI score of ≥2. Those who
reported social isolation “sometimes” were more likely to
have any hospital admissions (odds ratio [OR]: 1.17, 95%
CI: 1.01–1.35, P=0.04), compared to those who “rarely/
never” experienced social isolation. In adjusted models,
those that experienced social isolation “sometimes” or
“always/often” were more likely to have any ED visits (OR:
1.28, 95% CI: 1.15–1.41, P<0.0001, and OR: 1.51, 95% CI:
1.25–1.84, P<0.0001, respectively) compared to those who
“rarely/never” experienced social isolation.
Conclusion: These findings suggest that self-reported social
isolation may be predictive of future hospital admissions and
ED utilization, reflecting the importance of assessing and
documenting social isolation among patients. It is imperative
to better understand how addressing social isolation needs
within the health care system may reduce hospital admission
and ED utilization, and ultimately improve health outcomes.
P9.02
Variation in Quality Metrics Across Adult Asian
Ethnic Groups: The Kaiser Permanente Northern
California DECKA2016 Cohort Study
Nancy P. Gordon,1 Joan C. Lo1
Kaiser Permanente Northern California, Oakland, CA
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Background: A recently published study based on
electronic health record data for a Kaiser Permanente
Northern California adult cohort (DECKA2016) showed
significant variation in prevalence of chronic conditions
and risk factors across Asian ethnic groups and between
Asian ethnic groups and an aggregated Asian race group.
This study used the same cohort to examine whether similar
ethnic variation would be seen in Healthcare Effectiveness
Data and Information Set (HEDIS®) quality metrics.
Methods: Algorithms used to identify HEDIS-eligible cohorts
for cervical, breast, and colorectal cancer screening, blood
pressure management (BPM), and diabetes management (A1c
test, A1c of <8, A1c of >9, DiabBPM) were applied to the
DECKA2016 cohort. Age-sex and age-standardized (to 2016
U.S. Census) quality metrics were produced for All Asians,
Filipinos, Chinese, Japanese, Vietnamese, South Asians, and
Native Hawaiian/Pacific Islanders (PIs).
Results: Metrics for Asians were 90% for cervical cancer
screening, 89.3% for breast cancer screening, 85.3% for
colorectal cancer screening, 67.7% for A1c of <8, 21.3% for
A1c of >9, and 89.3% for DiabBPM. Compared to Asian
race statistics, Asian ethnic groups did not significantly differ
www.aurora.org/jpcrr
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on cervical or breast cancer screening, but Filipinos, South
Asians, and PIs were lower and Chinese and Vietnamese
higher on colorectal cancer screening. Among hypertensives,
Chinese were higher and PIs lower on BPM, but other ethnic
groups were similar to the Asian metric. Among diabetics,
ethnic groups were similar for A1c testing, but Filipinos and
PIs were lower on A1c of <8 and higher on A1c of >9, while
the opposite was true for Chinese and South Asians. Filipino
and PI diabetics also were lower on the BPM metric. PIs were
very similar to Blacks on the BPM and diabetes management
metrics, while Filipinos did better than Blacks on BPM, A1c
of <8, and A1c of >9.
Conclusion: In our earlier study, we found wide variation
across Asian ethnic groups in prevalence of cardiovascular
risks, with Filipinos and PIs having similar prevalence profiles
to Blacks and Latinos. In this study, we found much narrower
variation in quality metrics across Asian ethnic groups,
although quality metrics for Filipinos and PIs tended to be
worse than for Chinese and South Asians. Further research is
needed to identify reasons why Filipinos and PIs are at higher
risk of chronic cardiovascular conditions and are having more
difficulty managing these conditions.
P9.03
People in Communities: Can We Use Community
Social Need Indicators as Predictors for Individual
Social Need?
Morgan J. Fuoco, Michael Leo, Lindsay Jenkins,
Mary Ann McBurnie,1 Stephanie L. Fitzpatrick1
1

1

1

Kaiser Permanente Northwest, Portland, OR
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Background: Social determinants of health, including
the economic, social, and environmental characteristics of
communities where people live, affect a wide range of health
outcomes and risks. Research suggests that social needs
contribute more to health outcomes than clinical factors.
Currently, community-level data can be collected more
efficiently and cost-effectively, while collection of patientlevel data requires additional resources.
Methods: We sought to understand the relationship between
tract-level social need measures and individual-level social
need screener responses. For the individual-level measures,
we used data from the Your Current Life Situation (YCLS)
survey, a social needs screener administered at Kaiser
Permanente. For the community measures, we used data from
the American Community Survey and indices from the Robert
Graham Center. Our sample (N=6457) consisted of adults,
18 years of age or older, who were administered the YCLS
during 2017. First, we assessed the degree to which individual
responses to the YCLS and community-level variables were
correlated. Next, we analyzed odds ratios from a mixedeffects logistic regression model using the community-level
variables as predictors of individual responses to the YCLS.
Results: The largest standardized effect size was 0.20
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between social need (yes or no) and the Social Deprivation
Index (SDI). Most correlations, however, were between -0.03
and 0.05, suggesting that there is a low level of correlation
between the two levels of measurement for a given set of
items. In the multivariable model, many of the associations
were significant, with odds ratios ranging from 1.14 to 1.25,
particularly among specific needs and living below 100% of
the federal poverty level. For every 1-point increase in the
Gini Index, there was a 2% (95% CI: 1.01–1.02) increase in
the odds of reporting at least 1 financial insecurity. For every
1-point increase in SDI score, the odds of reporting any social
need increased by 2% (95% CI: 1.01–1.02).
Conclusion: The bivariate results suggest that most tractlevel community variables are poor proxies of individuallevel social needs. However, there is some ability of federal
poverty indicators at the community level to predict individual
financial needs, suggesting some community metrics may be
useful in characterizing patient individual financial insecurity.
P9.04
Role of External Incentives in Initiating Electronic
Health Record-Based Social Determinants of Health
Data Collection in Community Health Centers
Inga Gruß,1 Arwen Bunce,2 James Davis,1 Katie
Dambrun,2 Erika Cottrell,2 Rachel Gold1
Kaiser Permanente Center for Health Research,
Portland, OR; 2OCHIN, Inc., Portland, OR
1

Background: Successfully incorporating social determinants
of health (SDH) screening into clinic workflows can help
care teams provide targeted care and appropriate referrals
or other interventions for patients reporting SDH needs.
However, integrating SDH screening into clinical routines is
notoriously challenging. To achieve broad implementation of
SDH screening, an improved understanding of the factors that
can facilitate effective implementation is necessary.
Methods: We interviewed 43 health care professionals at 8
safety-net community health center (CHC) organizations
across the United States that had adopted an electronic health
record (EHR)-based SDH documentation tool with no outside
implementation support. Interviewees included staff in
administration, quality improvement, informatics, front desk,
clinical (providers, nurses, behavioral health), and community
health worker roles. Interviews focused on why and how each
organization integrated these tools into clinic workflows and
on factors that affected the adoption of this practice change.
Results: External motivators were one important factor that
facilitated effective introduction and integration of EHRbased SDH screening. External motivators that supported the
introduction of SDH screening included grant requirements
and participation in accountable care organizations or
certification processes. For example, through participation in
accountable care organizations, integration was facilitated as
CHCs were reimbursed for the needed additional care steps
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or were able to make additional hires to support SDH data
collection.
Conclusion: Identifying and addressing factors that can
support the successful integration of SDH screening into
clinic workflows is necessary to support widespread SDH
screening implementation. Creating and maintaining a variety
of external motivators may be an effective tool to help CHCs
and others initiate and sustain SDH screening.
P9.05
Advantages, Limitations, and Key Themes for
Integrating Community Health Workers in a
Large Health Care Delivery System for Diabetes
Management Among Vulnerable Populations:
Qualitative Findings
Dea Papajorgji-Taylor,1
Stephanie L. Fitzpatrick1

Jennifer

L.

Schneider,1
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Background: There is increasing evidence that traditional
health workers can play an essential role in chronic disease
management and helping individuals address unmet basic
needs. The Bridge to Health study, an ongoing 2-year clinical
trial, is exploring whether utilizing community health
workers (CHWs) to navigate patients from underserved
populations (racial/ethnic minorities and patients on
Medicaid) to resources and provide evidence-based
diabetes self-management training may be more effective
than navigation alone in an integrated health care delivery
system. To begin to assess determinants of implementation
of a CHW-led intervention in an integrated health system,
we conducted qualitative interviews with senior health
system leaders, health system navigators, and CHWs.
Methods: In-depth semi-structured guides were developed,
and interviews were conducted by phone and in person.
Interviews were audio-recorded, transcribed, and coded using
NVIVO software. Thematic analysis identified key themes
related to advantages, limitations, and recommendations for
integrating CHWs in the health care system to support patients
with unmanaged diabetes. Seven interviews were completed
with senior health system leaders, and a group interview
was conducted with 6 CHWs. (The group interview with the
health system navigators is being scheduled and results will
be available to incorporate in the final presentation).
Results: Initial interview findings demonstrate the value and
importance seen by health system leaders in collaborating with
community partners to extend reach in providing culturally
sensitive care and navigation services to diverse patient
populations. Clearly defined roles and expectations for the
partnership to be effective between a CHW and the clinical
care team was a reoccurring theme that came up for both
health system leaders and the CHWs. The advantages that
CHWs can bring to the patient’s overall clinical care, based
on their positioning in the community and associations with
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various community-based organizations, were recognized as
valuable.
Conclusion: The qualitative findings for this study will offer
guidance to and serve as a critical step in understanding how
to best integrate CHWs in a health care delivery system
for providing comprehensive care and resource navigation
toward eliminating health disparities in diabetes management.
P9.06
Financial Difficulties in Families With Children
With a Chronic Health Condition
Alexandra Varga,1 Joanna Bulkley,1 John Dickerson,1
Beth Waitzfelder,1 Lisa Croen,2 Eric Fombonne,3
Phillip Crawford,1 Frances Lynch1
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Health & Science University, Portland, OR
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Background: It has been well documented that children
with chronic health conditions may incur higher costs than
children without these conditions. Some of these costs
may not be covered by insurance and may lead to financial
difficulties. More than 15% of children suffer from a chronic
health condition, yet little is known about the prevalence
of financial strain in these families and whether it varies by
chronic condition.
Methods: Using electronic health records from 3 Kaiser
Permanente sites and several safety-net clinics, we identified
3 groups of children (3–16.5 years of age): 1) those with
autism spectrum disorders (ASD); 2) those with asthma
(Asthma); and 3) those without these conditions (GenPop).
Groups were matched on age and gender. Eligible families
that consented to participate completed an online survey about
costs, insurance, income, financial difficulties, education, and
employment. Among those participants who answered at least
1 financial question, we report demographic characteristics
of the children and caregivers (the respondent), summarize
responses about financial difficulties, and compare the groups
using chi-squared and ANOVA tests.
Results: Of 1461 families in the study, 1320 responded to
1 or more financial question. Age and gender were balanced
between groups; overall, 79.1% were male and average age
was 9.15. About 44.6% of GenPop, 37.0% of ASD, and
37.5% of Asthma families reported a monthly income of more
than $6000. Employment status was significantly different
between groups (P<0.001); 26.6% of the ASD respondents
were not employed compared to 19.9% for Asthma and
19.7% for GenPop. Also, 54.1% of families of children
with ASD reported financial difficulty related to the child’s
health compared to 28.8% for Asthma and 16.7% for GenPop
(P<0.001). Similarly, 5.9% of families of children with ASD
borrowed money to pay for medical services compared to
2.6% for Asthma and 1.7% for GenPop (P=0.002). In the ASD
group, 60% of respondents reported distress due to the cost of
www.aurora.org/jpcrr
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their child’s medical care compared to 32.5% of Asthma and
20.9% of GenPop.
Conclusion: Findings provide evidence of higher financial
burden for families with children with chronic health
conditions compared to those with no significant health
conditions. This is particularly pronounced in families of
children with ASD.
P9.07
Homelessness Within and Beyond the Hospital
Walls: Exploring the Documentation and Use of
Diagnosis Codes to Identify Homelessness
Navin Vij,1 Keshab Subedi,1 Adebayo Gbadebo1
ChristianaCare, Wilmington, DE
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Background: It is widely acknowledged that health
outcomes are determined not only by access to care but
also by the social and economic conditions that shape an
individual’s daily life — the social determinants of health,
including homelessness. Individuals who experience
homelessness have higher rates of untreated chronic physical
and behavioral health conditions, which contribute to higher
rates of health care utilization and increased mortality
compared to the general population. In recent years, health
systems have begun investing resources in identifying such
patients. One emerging method to help quantify the impact
of homelessness is the use of electronic medical record data,
including International Classification of Diseases (ICD)
codes to identify clinical encounters. With the shift to ICD10, systems have an opportunity to understand how the
expanded use of Z codes can help identify and intervene on
the social factors influencing the health of patients.
Methods: We conducted a retrospective, time- and propensity
score-matched cohort design to identify individuals with
homelessness using ICD-10 code for Z59, a residential address
listed as a shelter or none, or a social work consultation for
homelessness with an emergency room visit or hospitalization
from October 2015 to September 2019 at ChristianaCare.
Results: More than 2600 unique patients were identified as
homeless through encounters with the emergency room and
hospitalizations as inpatients. A summative evaluation of this
population’s visits will assess outcomes, including hospital
readmissions, length of stay, discharge disposition, primary
and secondary reasons for presentation, and health-related
medical comorbidity including associated behavioral and
medical conditions. These will be compared to a matched
cohort balanced with respect to age, gender, race, insurance
status, comorbidities, and rate of hospitalization prior to the
index visit, with a particular focus on disparities in care and
outcomes. Furthermore, we will compare the use of ICD10 diagnosis codes to the other two methods of identifying
homelessness, including rates of overlap.
Conclusion: Three methods of identifying homelessness
yielded different estimates, suggesting that further research
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into the validity of diagnosis codes to assess homelessness
is needed. Increasing awareness of their application could
provide timely information for health systems to improve
interventions for patients experiencing homelessness.
P9.08
Disparities in Opioid Prescribing Rates by Dentists
Based on Patient Gender, Race/Ethnicity, and
Sociodemographic Status
D. Brad Rindal,1 Steve E. Asche,1 Sheryl Kane,1 Anjali
R. Truitt,1 Lauryn Davin,1 Tracy Shea,1 Donald Worley,1
Jan Gryczynski,2 Shannon G. Mitchell2
HealthPartners, Bloomington, MN; 2Friends Research
Institute, Inc., Baltimore, MD
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Background: Data examining disparities in opioid prescribing
patterns related to oral pain management come largely
from emergency rooms, where patients present with dental
emergencies. Reports examining disparities in prescribing
patterns in ambulatory dental settings are lacking.
Methods: This cross-sectional study examined disparities
in opioid prescribing among patients undergoing dental
procedures from September 1, 2018, to August 31, 2019,
representing a 12-month baseline period for a clinical trial
focused on de-implementing opioid prescribing for dental
extraction procedures. The sample consists of 175,091
encounters (165,316 nonextraction + 9775 extraction) from
90,215 patients of all ages undergoing any dental procedure
(except exclusively preventive or orthodontic procedures)
conducted at 22 dental clinics by 66 dental providers. All data
come from the electronic health record. The encounter-level
endpoint is a binary variable indicating that the patient was
prescribed an opioid analgesic within 7 days of their dental
procedure.
Results: More than half of patients at encounters were female
(57%); 22% were under age 18 years, 32% were 18–45, 27%
were 46–65, and 19% were 66 or older; 60% were white; and
34% had public-pay insurance. Opioid prescribing within 7
days occurred at 1.9% of encounters and varied by procedure:
25.8% at extraction encounters, and 0.5% at nonextraction
encounters. Among nonextraction encounters, opioid
prescribing was most likely for nonextraction oral surgery
(17.3%) and prosthodontic fixed (8.0%) procedures. Opioid
prescribing rates were highest for encounters with patients
18–25 years of age (6.7%); Pacific Islander (4.2%), Native
American (2.9%), or Black (2.7%) race; and those with
public-pay insurance (2.8%). Opioid prescribing was highest
for encounters with an oral surgeon (33.2%), followed by
periodontist (0.7%), general dentist (0.7%), and endodontist
(0.6%).
Conclusion: Opioid prescriptions are most common for
extractions and other nonextraction oral surgery procedures.
Higher rates of prescribing occur in younger age groups,
minority populations, and lower socioeconomic groups. This
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inequity could be partially explained by more oral disease and
subsequent need for extractions in these groups.
P9.09
Using Patient Activation Measure and Decisional
Conflict Scale to Assess the Relationship Between
Levels of Self-Management and Decisional Conflict
in Southeastern Patients With Chronic Kidney
Disease
Serena Kongara,1 Musu Sesay,2 Doraina WalkerWilliams,2 Lee Cromwell,2 Nirvan Mukerji,2 Jennifer
Gander2
Tulane University, New Orleans,
Permanente Georgia, Atlanta, GA
1
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Background: Self-management has been shown to be
beneficial in reducing the progression of kidney loss in
patients with chronic kidney disease (CKD). High levels
of patient activation are correlated with high levels of selfcare among patients with CKD. We aimed to use the patient
activation measure and decisional conflict scale to discover
barriers to care.
Methods: Focus group participants diagnosed with CKD
(n=28) completed 2 surveys following the focus group
discussion. Each patient answered a 13-item patient activation
measure survey to measure their level of activation and a 16item decisional conflict survey measured on a scale from 0
(no decisional conflict) to 100 (extremely high decisional
conflict). Patient activation was categorized into 4 levels:
disengaged and overwhelmed; becoming aware but still
struggling; taking action and gaining control; and maintaining
behaviors and pushing further. Kruskal-Wallis and chi-squared
tests compared decisional conflict and patient activation
across demographics, respectively, and Pearson correlation
determined the correlation between decisional conflict and
patient activation.
Results: Patients with CKD who completed the surveys
(n=28) were 67% male, 82% black, and had a mean age of 54.8
years (standard deviation: 8.3). Median decisional conflict
score was 17.2 (interquartile range [IQR]: 0–27.3). Females
had higher decisional conflict (median: 23.4, IQR: 17.2–34.4)
compared to males (median: 11.7, IQR: 0–23.4; P=0.1094).
Based on the Patient Activation Measure, 4 patients (15.4%)
were categorized as disengaged and overwhelmed or
becoming aware but still struggling. No significant difference
in patient activation was found for gender (P=0.491) or race
(P=0.798). Decisional conflict and patient activation were
significantly inversely correlated (R=-0.789, P<0.0001).
Conclusion: Patients with CKD experience various barriers to
managing their disease. High patient activation was inversely
correlated with low decisional conflict. Patients with CKD
may be conflicted or feel overwhelmed when determining the
best course of action for their treatment or be struggling with
their CKD diagnosis. Female patients may have a harder time
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making a decision. Health care professionals should consider
the gender differences in decisional challenges and counsel
all their patients to help them make decisions and become
activated in their disease management.
P9.10
Systematic Availability of Education Data in
Electronic Health Records Could Be Valuable for
Clinical Care, Population Health Management, and
Research
Nancy P. Gordon,1 Joan C. Lo1
Kaiser Permanente Northern California, Oakland, CA
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Background: Educational attainment is recognized as an
important social determinant of health. Research indicates
that better-educated adults have a healthier lifestyle, have
higher health literacy, are at lower risk for developing chronic
conditions, and are more likely to use online health resources.
While paper medical charts usually contained patient
education information, education is often not available in
electronic health records (EHR), thus making it unavailable
for clinical care, population health management, and research.
This study examined the relationship of education with EHRderived health-related characteristics in a Medicare-age
cohort.
Methods: Using survey, clinical questionnaire, and EHRentered data, we were able to assign approximately 49%
(n=135,503) of white, 46% (n=13,652) of black, and 41%
(n=13,239) of English-speaking Latino members of Kaiser
Permanente Northern California (KPNC), 65–79 years of
age, in the KPNC DECKA2016 study cohort to an education
category (did not graduate high school [<HSG], high school
graduate [HSG], some college [SC], or college graduate
[CG]). We then used EHR-derived data to produce and
compare age, sex, and age‐standardized prevalence of health
risks (current and ever smoking, body mass index [BMI]
of ≥30, body mass index [BMI] of ≥35), diagnosed chronic
conditions (diabetes, hypertension, coronary artery disease,
heart failure, chronic obstructive pulmonary disease), diabetes
and hypertension control quality metrics, and patient portal
use (having an activated www.kp.org patient portal account,
sending 1 or more secure message, and viewing 1 or more
online lab result) by level of education for white, black, and
Latino women and men.
Results: Compared with <HSG, HSG, and, in many
instances, SC adults, CGs in all race/ethnic groups (overall
and by sex), had lower prevalence of smoking (current and
ever), obesity (BMI of ≥30, BMI of ≥35), and all 5 chronic
conditions. Having an activated patient portal account and
using patient portal features increased as level of education
increased. Educational attainment was not associated with
diabetes or hypertension control quality metrics. Race/ethnic
and sex differences were frequently observed within the same
level of education.
www.aurora.org/jpcrr
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Conclusion: Educational attainment is associated with
disparities in health risks, health conditions, and patient
portal use within and across racial/ethnic groups. Promoting
systematic capture of education as a categorical EHR data
element could help improve clinical care delivery, population
health management, and research.

DATA SCIENCE, INFORMATICS, AND
COMMON DATA MODELS
OA9.01
Putting the Virtual Into the Virtual Data Warehouse:
Developing New Encounter Types for Virtual Care
Heather Tavel,1 Daniel Ng2
Kaiser Permanente Colorado, Denver, CO; 2Kaiser
Permanente Northern California, Oakland, CA
1

Background: The delivery of health care is changing
rapidly, with increasing use of “virtual” care encounters
using different modes of technology-mediated interaction
between patients and providers, for example, video visits,
online chats, and e-visits. Updating the HCSRN virtual data
warehouse (VDW) data model to accurately represent these
new types of encounters is vital to HCSRN research. The
VDW Utilization Workgroup is exploring the available data
within HCSRN sites to inform the creation of new encounter
types and subtypes to enable research on these emerging
methods of delivering care.
Methods: An exploratory program was written and
distributed to HCSRN sites to collect and summarize
electronic medical record (EMR) encounter data, from 2015
through 2018, that may be potentially classified as virtual
care. Text string searches were used to capture a wide
range of potential encounter types. Encounter types falling
outside the text search were manually reviewed to capture
additional potential encounter types. Individual sites were
asked to investigate ambiguous encounter types. Methods of
identifying virtual care from billing data also were examined.
The results were compiled to demonstrate similarities and
differences in how virtual care is represented in EMR source
systems throughout the research network.
Results: Eleven HCSRN sites returned results. All 11 sites
had encounter types for telephone visits and emails; 9 sites had
e-visits and video visits. Only 2 sites had an encounter type
for online chat with a provider. There was a lot of variation in
source systems’ descriptions of encounter types. Volumes of
virtual care have been growing steadily at all sites since 2015.
Conclusion: Virtual care encounter types are increasingly
becoming standard practice among HCSRN sites. Within our
current VDW data model, more granularity may be needed to
support research involving the various modes of virtual care.
In addition, our definitions of what constitutes an “encounter”
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may require changes to tease out specific types of virtual care,
for example, telemedicine. Further analysis and discussion
are needed to understand how best to represent these care
methods to support research needs in our rapidly evolving
landscape of health care delivery.
OA9.02
Early Detection of Hospital-Acquired Acute Kidney
Injury From Electronic Health Record Data Using
Machine Learning
Yirui Hu,1 Gurmukteshwar Singh,1 Kunpeng Liu,2 Sara
Saunders,1 Dave Riviello,1 Jason Brown,1 Kevin Ho,3
H. Lester Kirchner1
Geisinger Health, Danville, PA; 2University of Central
Florida, Orlando, FL; 3Sanofi Genzyme, Cambridge, MA
1

Background: Hospital-acquired acute kidney injury (HAAKI) is a common syndrome associated with increased risk
of morbidity and mortality. Early prediction of HA-AKI
using electronic health record data is desirable, as it enables
clinicians to match appropriate treatment to minimize risk
and severity.
Methods: All inpatient admissions from July, 13, 2012,
to July 11, 2018, who had serum creatinine measured at
Geisinger Health were included. Patients with end-stage renal
disease, length of stay of <48 hours, and acute kidney injury
on admission were excluded. A validated algorithm was used
to determine baseline renal function. Acute kidney injury was
defined according to KDIGO guidelines. Machine learning
algorithms were implemented to predict encounters where
the patient developed HA-AKI beyond the initial 24 hours
of admission. Fifty input variables, including demographics,
initial laboratory values taken within the first 24-hours of
admission, active medications at time of admission, and
prevalent comorbidities, were entered into machine learning
algorithms (random forest, XGBoost, logistic regression).
Multiple imputation by chained equations was implemented
for missing variables. Univariate feature selection was
implemented wherein variables were ranked by evaluating
contribution to classification outcome. Randomized search
strategy was performed to obtain the optimal hyperparameter
set for each algorithm. Models were evaluated using a mean
area under the receiver operating characteristic curve (AUC)
over 5-fold cross-validation.
Results: Among 209,300 inpatient admissions, 26,410
(12.6%) developed HA-AKI. For acute kidney injury
prediction, the AUC of the full model was 0.88 for both
random forest and XGBoost and 0.86 for logistic regression.
To balance the trade-off between model simplicity and
performance, 23 variables from univariate feature selection
evaluated using random forest were selected in predicting
HA-AKI (AUC: 0.87). The probability cut-off point of acute
kidney injury prediction outcome was determined using
Youden’s index based on the balance between false positives
Supplement

and false negatives. A probability cutoff of >0.23 provided
sensitivity and specificity of 0.78 and 0.81, respectively.
Conclusion: Our machine learning algorithm applied at 24
hours of admission identifies patients at risk for HA-AKI with
high accuracy. Significant variables included in this algorithm
should be monitored in real time to allow early identification
and preventive interventions in patients at risk for HA-AKI.

incorporating prior medication and socioeconomic status
variables led to small, statistically significant improvements
in model discrimination while maintaining good calibration
for published models to predict readmission. However,
overall performance improvements are needed to increase
the utility of these published risk calculators for readmission
after discharge from a HF hospitalization.

OA9.03
Recalibration and Additional Data Domains Lead to
Modestly Improved Performance of Risk Calculators
for Heart Failure Readmission

OA9.04
Building Medical Device Identifiers Into Longitudinal
Data: The BUILD Distributed Data Network

Samuel Savitz, Keane Lee, Jamal Rana, Thomas
Leong,1 Sue Hee Sung,1 Grace Tabada,1 Alan Go1
1

1

1

Kaiser Permanente Northern California, Oakland, CA

Jove Graham,1 Joseph Muhlestein,2 James Tcheng,3
Andrew McKinnon,4 Stacey Knight,2 Heidi May,2 Tami
Bair,2 Kevin Capatch,1 Joseph Drozda4
Geisinger Health, Danville, PA; 2Intermountain
Healthcare, Salt Lake City, UT; 3Duke University,
Durham, NC; 4Mercy Health System, Chesterfield, MO

1

1

Background: Heart failure (HF)-related hospitalizations
are a growing public health burden, especially among older
adults. We evaluated the performance of several published
risk calculators for predicting 30-day readmission after heart
failure hospitalizations: 1) using the original coefficients for
the existing risk calculators; 2) updating the coefficients based
on data from a new, ethnically diverse HF population; and
3) developing a new model that incorporates additional
variables in addition to updated coefficients for the original
variables. We hypothesized that recalibrating model
coefficients for the new HF population and incorporating
additional variables would improve the performance of
these existing 30-day readmission risk calculators.
Methods: We identified 45,059 adults hospitalized for HF
during 2012–2017 within Kaiser Permanente Northern
California, an integrated health care delivery system.
We used an 80%/20% split sampling for development
and validation testing. The risk calculators tested included
LACE index, LACE+ Index, and Yale CORE. For the model
with additional variables, we included all variables used
in the original models plus additional variables, including
cardiovascular medication use and socioeconomic status.
We used gradient boosting with k-fold cross-validation to
avoid overfitting. We assessed model performance using
area under the curve (AUC) and calibration plots.
Results: Discrimination (AUC) was poor using original
models: LACE (0.58 [95% CI: 0.57–0.60]), LACE+ (0.56
[95% CI: 0.54–0.58]), and Yale CORE (0.55 [95% CI:
0.54–0.57]). Recalibrating variable coefficients in these
models resulted in small improvements in discrimination
for LACE+ (0.58 [95% CI: 0.57–0.60]) and Yale CORE
(0.58 [95% CI: 0.57–0.60]), but not for LACE. Including
the additional variables also resulted in a small improvement
in AUC for the model using gradient boosting (0.61 [95%
CI: 0.59–0.62]). Calibration plots showed generally good
calibration across all models except for the Yale CORE
model that used the original variable coefficients.
Conclusion: Recalibrating variable coefficients and

Background: Drug eluting stents are a standard of care for
percutaneous coronary intervention (PCI), but limited data
exist to guide drug-eluting stent choice. In 2014, the U.S.
Food and Drug Administration began requiring manufacturers
to label medical devices with unique device identifiers
(UDIs), similar to National Drug Code numbers for drugs,
which potentially enables large-scale observational studies of
medical devices that were not previously possible. Three large
health systems — Mercy, Geisinger, and Intermountain —
collaborated to create the Building UDI into Longitudinal Data
(BUILD) network to provide real-world evidence on medical
devices. Modeled on other distributed data networks such as
the HCSRN virtual data warehouse, BUILD combines device,
registry, and other patient data via a common data model and
allows common queries to be programmed and distributed to
all participating sites without sharing of identifiable patient
data among systems. The purpose of this study was to perform
an outcomes analysis across the network, comparing 1-year
outcomes for patients with two types of drug-eluting stents.
Methods: We performed a retrospective analysis of patients
receiving zotarolimus- or everolimus-eluting stents from
2012 to 2019. The distributed analysis examined 32 baseline
covariates, created propensity-matched cohorts at each site,
assessed these cohorts for confounding, and compared 1-year
events such as subsequent PCI procedures, death, and a
composite endpoint including acute myocardial infarction,
stroke, reoperation, or death. Cox proportional hazards (ie,
survival) analysis was used, with SAS 9.4 software and
P-values less than 0.05 considered statistically significant.
Results: We identified 9,045 patients (4859 Mercy, 4059
Geisinger, 127 Intermountain; mean age: 65 ± 12 years; sex:
69% male; stent: 23% zotarolimus). Estimates of hazard ratios
(zotarolimus vs everolimus) at the 3 sites ranged from 0.85 to
4.86 for subsequent PCI (P ranged from 0.10 to 0.35), 1.06 to
2.12 for death (P ranged from 0.16 to 0.78) and 0.94 to 3.02
for the composite endpoint (P ranged from 0.16 to 0.53). In
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summary, there were no significant differences in the hazards
of these outcomes, consistent with what was suggested by the
early clinical trial data for these drug-eluting devices.
Conclusion: This large real-world, multicenter study showed
no statistical differences in 1-year outcomes of patients
receiving zotoralimus and everolimus stents — results similar
to other randomized controlled studies. This demonstration
project shows that multi-institutional data networks can
provide and advance clinically relevant real-world evidence.

algorithm had a lower PPV of 78% and NPV of 100%.
Conclusion: Computable phenotypes facilitate standardized
data queries across electronic health records. We developed
an algorithm utilizing diagnosis codes and urine lab values
that accurately identifies hematuria cases and categorizes
each into gross or microscopic hematuria. This algorithm will
enable researchers and clinicians to identify hematuria cases
and determine downstream patterns of care and outcomes for
this common condition.

P5.01
Performance Characteristics of a Computable
Phenotype Algorithm to Identify Patients With
Hematuria in Electronic Health Records

P5.02
Privacy Preserving Fuzzy Patient Matching Using
Homomorphic Encryption

Tullika Garg, Mudit Gupta, Matthew Nielsen, H.
Lester Kirchner1
1

1

2

Geisinger Health, Danville, PA; 2University of North
Carolina at Chapel Hill, Chapel Hill, NC
1

Background: Two million patients per year are referred
to urologists for hematuria (blood in the urine). Current
American Urological Association hematuria evaluation
guidelines recommend multiphase computed tomography
(CT) and flexible cystoscopy. However, multiphase CT is
associated with a high risk of secondary malignancies from
imaging-related radiation exposure. To better understand
population-based patterns of CT imaging associated with
hematuria evaluations, we sought to develop a computable
phenotype to accurately identify hematuria cases from
electronic health records.
Methods: We developed rules to identify patients with
hematuria and to differentiate between gross and microscopic
hematuria using a combination of ICD-9 and ICD-10
diagnosis codes, urine color values, and urine red blood cell
microscopy values. We used an iterative process to refine the
algorithm on a gold-standard, chart-reviewed cohort of 3095
hematuria cases. We then applied the algorithm to all Geisinger
Health patients who were 35 years or older and had at least
3 completed visits within a 3-year window. We conducted a
chart review to determine performance characteristics of the
computable phenotype algorithm.
Results: We identified 767,209 patients who met inclusion
criteria. After applying the computable phenotype, we
identified 37,332 hematuria cases, 511,177 controls, and
218,700 indeterminate cases. Of the hematuria cases, 11,924
were categorized as gross, 24,555 as microscopic, and 853
as uncategorized due to diagnosis codes for both gross and
microscopic hematuria. Indeterminate had a signal in the form
of a single diagnosis code, urine color, or urine microscopy
value, but without adequate additional information to
categorize. The positive predictive value (PPV) of identifying
hematuria cases was 100%, and the negative predictive value
(NPV) was 99%. The gross hematuria algorithm had a PPV
of 100% and NPV of 99%. The microscopic hematuria
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Shiva Ashish Thumparthy,1 Ilya Sher2
Brainlab AG, Munich, Germany; 2Beame.io, Tel Aviv,
Israel
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Background: Medical record interoperability has been a
focus of health care systems for purposes of providing better
patient outcomes. However, in an age of increasing privacy
and confidentiality concerns, comparison of unencrypted
patient demographics is obsolete due to strict guidelines
mandating protection of sensitive patient information.
In addition, while dealing with data from multiple
sources, demographics are subject to errors (eg, character
transpositions) and changes (eg, address relocations, lastname changes. Therefore, an important step in realizing
this interoperability goal is identifying patients with records
across facilities through record linkage algorithms, in a
privacy-preserving fashion that is resilient to data entry
inconsistencies, ie, in a fuzzy and probabilistic manner.
Methods: A common building block to encode patient
attributes is a Bloom filter. Bloom filters represent a digest
of information without containing any original information in
plain text. However, Bloom filters were subject to scrutiny
due to brute force and frequency attacks. Homomorphic
encryption is a form of encryption that allows computation on
encrypted data. The result of the computation, when decrypted,
is the same as if the operations had been performed on
unencrypted data. Homomorphic encryption of Bloom filters
and subsequent comparison is, therefore, resilient to these
attacks. Our primary contribution is a method of matching
a list of encrypted patients at once as opposed to pairwise
comparisons of encrypted Bloom filters. This significantly
reduces computational complexity and communication
overheads. We achieve this using homomorphic encryption
ciphertext packing techniques, which allow for encrypting
large volumes of data into a single ciphertext. This allows
for computations on entire matrices of data as opposed to
individual row vectors.
Results: The optimized matching algorithm yields a
conservative preliminary speedup of 7 times during encryption
and 266 times during matching by multiplication on 16*16
matrices, while generating 1 ciphertext per matrix as opposed
Supplement

to the previous state-of-the-art of 1 ciphertext per row vector.
Conclusion: We take real-world limitations into consideration
while designing a privacy-preserving patient matching
solution using homomorphic encryption that significantly
lowers computational costs and communication overheads.
Future findings will include statistics for larger matrices.

P5.04
Tools for Virtual Data Warehouse Master Data
Management
John Weeks,1 Dustin Key,1 David Cronkite1
Kaiser Permanente Washington, Seattle, WA

1

P5.03
Changes in Population Demographics From
Expanding the Virtual Data Warehouse to Multiple
Sites in a Large Integrated Health Care Network
Satish Mudiganti,1 Pragati Kenkare,1 Kevin Hays,1
Robert Romanelli,1 Alice Pressman1
Sutter Health, Walnut Creek, CA

1

Background: Our existing virtual data warehouse (VDW)
is confined to a single site in a large integrated health care
network in Northern California. We sought to expand our
VDW to multiple sites to incorporate data on a more diverse
population. This allows our researchers to study a variety
of data and collaborate with health care systems across the
nation and within HCSRN.
Methods: Our VDW is based on an existing data warehouse
that was built using a Star Schema model (specifically
Kimball methodology). We built the schema for 1 site that
has outpatient clinics covering approximately 1 million lives
each year. We utilized the existing curated data warehouse
to transform the data to meet VDW specifications. Records
from multiple sites were de-duplicated. Billing records and
encounters were used to impute utilization and enrollment.
The single-site VDW resided on a virtual server. Because
the extract, transform, load (ETL) processes for data from 5
sites consumed much larger quantities of memory than the
processes required for a single site, the virtual server was no
longer adequate. Therefore, we required a dedicated physical
server to host our large-scale VDW development.
Results: After adding 4 other sites, for years 2000 through
2018, total enrollment count based on utilization increased
by 120%. Total HMO count increased by 72%. Proportions
of patients self-identifying as African American, other race,
and white race increased by 2, 5, and 12 percentage points,
respectively, while those proportions for patients identifying
as Asian decreased by 7 percentage points. Hispanic and nonHispanic population increased by 5 and 8 percentage points,
respectively. There was no difference in the proportion of
patients’ age group and gender with the addition of new sites.
Conclusion: The expanded VDW now provides a much
larger, more diverse data set for researchers. We have
enhanced capabilities to do studies on diverse populations
and collaborate with other sites across the nation. Next steps
are to incorporate hospital inpatient data.
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Background: At Kaiser Permanente Washington’s Health
Research Institute, we have built a set of tools that work
with HCSRN’s virtual data warehouse (VDW) to provide
ontologies and mechanisms for our counters and data marts
based on models like i2b2 and OMOP to be exported from our
VDW master data management. We would like to share our
work in building a proactive master data management set of
tools for our organization.
Methods: The VDW codes and relationship hierarchy
ontologies are built using SAS. SAS is also the tool that
generates the i2b2 and OMOP common data models. The
counter interface is built using Python. We use these tools
to make our data more flexible and accessible to the larger
research community.
Results: After building the VDW master data management
model, we used the infrastructure to empower us to generate
several useful tools that have broad applications and support.
Besides being able to present our VDW data in a clinical
context, we are also able to generate counts that are useful
in preparation for research. We also use this infrastructure
to generate external data models such as i2b2 and OMOP
common data models.
Conclusion: We have been able to illustrate the value of the
improvement of our VDW master data management model
and are excited to share the work that we have done with the
HCSRN.
P5.05
Sex, Gender, and Sexual Minorities: New Virtual
Data Warehouse Demographic Data
Roy Pardee,1 Catherine Cleveland,2 Don Bachman,2
Mark Schmidt2
Kaiser Permanente Washington, Seattle, WA; 2Kaiser
Permanente Northwest, Portland, OR
1

Background: Since its inception, virtual data warehouse
(VDW) conflated the concepts of sex and gender in a single
variable, which is explicitly defined as an opaque combination
of those concepts. As a result, end-users have not known what
concept the table captured for any given patient. As the science
of medicine and society begin to recognize the importance of
these distinctions to patient care, new clinical workflows are
making more nuanced data available at HCSRN organizations.
This provides opportunity to at once cure a defect and enable
new types of research with the VDW.
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Methods: After much discussion, research, and
reconnaissance both of existing standards and data
at member organizations, the VDW’s Enrollment/
Demographics workgroup put together a package of data
changes that disentangle these disparate concepts.
Results: The change proposal affects only the demographics
table and consists of 2 parts: 1) deprecation and removal of
the existing “gender” variable; and 2) adding 3 new variables
to hold a) sex assigned at birth, b) administrative or legal
sex, and c) gender identity. Sex assigned at birth is the only
concept that is static — the other two can change over time.
Because the VDW demographics table is not suited to tracking
those changes, all 3 new variables hold the information as of
the latest ascertainment (ie, the last time the table was rebuilt
or updated).
Conclusion: In designing research data structures, there is
a tension between adhering to established standards like the
ones provided by Logical Observation Identifiers Names
and Codes (LOINC) and the Centers for Disease Control
and Prevention (CDC) Public Health Information Network
Vocabulary Access and Distribution System (PHIN VADS)
versus closely accommodating the data in hand at member
sites. For this effort we favored the latter. As a result, only
the gender identity variable is fully compatible with standards
propounded by LOINC and the CDC. The new design makes a
place for the data HCSRN organizations are actually collecting
and should serve as a solid foundation going forward for both
general purpose and sexual minority research projects.
P5.06
Development of a Venous Thromboembolism (VTE)
Data Phenotype to Retrospectively Identify Cancer
Patients With VTE
Benjamin Andrick,1
Baughman1

Jesse

Manikowski,1

Anna

Geisinger Health, Danville, PA
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Background: Venous thromboembolism (VTE) remains
a major cause of morbidity and mortality in patients with
cancer warranting further research. Yet retrospective
identification of VTE events in electronic medical records
(EMR) remains problematic due to inaccuracies of
administrative coding alone. Previous studies demonstrated
the addition of an ambulatory anticoagulant prescription
criterion increases the likelihood of identifying true VTE
events. We piloted the application of such a VTE data
phenotype (VTE-related ICD coding and text + outpatient
anticoagulation prescription) for patients with cancer.
Methods: Patients with cancer were primarily identified
using the Oncology Cancer Registry, which is a statemandated electronic database of cancer cases extracted from
the institutional EMR by certified tumor registrars. Inclusion
criteria further required at least one computed tomography
(CT) scan within 5 years of cancer diagnosis. This criterion
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was intended to mitigate the influence of incidental VTEs
on true events. Subsequently, the VTE data phenotype was
applied utilizing a combination of text and ICD codes to
identify VTE-related diagnoses. Documentation of the VTE
diagnoses was required on more than 2 distinct instances.
Lastly, the VTE data phenotype required documentation of an
ambulatory anticoagulation prescription within 30 days of the
first documented VTE diagnosis. This provided two cohorts:
patients with cancer with or without a VTE event. In order to
be 80% confident that the percentage of patients within the
cancer VTE group who truly experienced a VTE event was
>95%, 30 random charts were extracted from each cohort for
confirmation by manual chart adjudication.
Results: 54,612 patients were identified with cancer and a
CT scan within 5 years of diagnosis between 2008 and 2018.
Application of the above VTE data phenotype yielded 3176
cancer patients with and 50,388 without a VTE event. Manual
chart review demonstrated a positive predictive value of 93%
(28 of 30) for the cancer with VTE cohort and a negative
predictive value (NPV) of 100% (30 of 30) for the cancer
without VTE cohort.
Conclusion: The combination of VTE-related administrative
coding and text searches for VTE-related diagnoses with an
ambulatory anticoagulation prescription can be utilized to
increase the accuracy of retrospective identification of cancer
patients with and without a VTE event.
P5.07
Clinical Needs and Resource Use Among Patients
With Cardiometabolic Conditions
Xiaowei (Sherry) Yan,1 Sukyung Chung,1 Zijun Shen,1
Hannah Husby,1 Jake Delatorre-Reimer,1 Farah Refai,1
J.B. Jones1
Sutter Health, Walnut Creek, CA

1

Background: Health care organizations often rely on cost of
care as a measure to identify target populations for chronic
disease management outreach. We previously developed a
segmentation model using measures of clinical need to group
patients with cardiometabolic conditions (ie, hypertension,
hyperlipidemia, diabetes) into clinically meaningful, distinct
segments. Segment 1 represents 10% of the cardiometabolic
patient population with the highest prevalence of
cardiovascular disease (CVD) risk and Segment 4 (50%
of cardiometabolic patients) the least. Segment 3 (25% of
cardiometabolic patients) had relatively low CVD risk but the
highest prevalence of mental health conditions (ie, anxiety or
depression) (34% vs <20% in other segments). In this study,
we examined whether high clinical needs, represented by
segments, are associated with higher costs of care among
patients with cardiometabolic conditions.
Methods: The study sample included 30,816 individuals who
had 1) any cardiometabolic condition, 2) HMO insurance in
2016, and 3) were patients from Sutter Health, a large mixedSupplement

payer health care system in Northern California. Outpatient
costs were measured with total relative value units (tRVUs),
a standard measure used by Medicare and other payers in
calculating reimbursement for physician services. Inpatient
utilization was measured by the likelihood of hospitalization
for any reason during the year. We compared average tRVUs
and hospitalization rate per patient across the 4 segments.
Results: Segment 3 had the highest tRVUs (mean: 36.6
[standard deviation: 46.1]) followed by Segment 1 (32.1
[34.4]). Segment 2, despite its distinctly lower CVD risk
compared to Segment 1, had only slightly lower tRVU (30.7
[47.5]) than Segment 1. Similar patterns were observed
in hospitalization rates — highest in Segment 3 (18.1%),
followed by Segment 1 (16.8%) and Segment 2 (13.8%).
Costs of care for Segment 4 were lowest, less than half of
Segment 2 in both tRVUs (15.2 [20.8]) and hospitalization
(5.9%). All the differences in tRVUs and hospitalization rates
across segments were statistically significant (P<0.01).
Conclusion: In this population of patients, clinical needs,
as determined using our segmentation model, are strongly
associated with health care costs. Mental health needs, in
addition to CVD risk factors, should be recognized and
addressed as they are a major contributor to our measured
costs.

edition, AJCC 8, for cancers diagnosed 2018 or later.
Incorporating biological factors began with AJCC 6 in 2004
and has expanded with successive editions as treatment
and surveillance move toward a personalized perspective.
Expanding prognostic elements beyond strictly anatomic
descriptions results in site-specific factors and provides data
for evaluation of new and future therapeutic targets. AJCC
8 includes additional tumor characteristics required for
precision medicine standards. These factors add complexity
to AJCC staging.
Conclusion: Incorporating prognostic factors with anatomic
measurement for staging is mandatory. Tumors with identical
anatomic characteristics and different hormone receptors
would receive different treatment regimens and most likely
exhibit different outcomes. The standards for staging that
encompass all the information to characterize a tumor with
respect to therapy and survival will continue to expand to a
targeted treatment approach, while retaining original TNM,
and need to be applied to VDW.

P5.08
In the Beginning Was T, N, M...
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Background: Cancer staging provides a detailed descriptive
classification of tumors in a simple manner, showing tumor
size, lymph node involvement, and spread to distant sites.
Surveillance, Epidemiology, and End Results (SEER) extent
of disease is derived from clinical, radiologic, and pathologic
components producing a scaled numeric value that convey
information regarding invasiveness using the T, N, M local/
regional/distant classification (TNM). However, staging of
cancer is not a fixed science, and while SEER TNM-based
staging has remained constant since 1973, American Joint
Commission on Cancer (AJCC) stages have changed and
expanded over time. The objective is to illustrate how AJCC
stages have evolved and to formulate a plan for incorporating
the latest AJCC staging criteria (version 8) into the virtual
data warehouse (VDW).
Methods: Two cancer sites will be used to illustrate required
elements for AJCC staging across versions. Specific inputs
of each version will show how the evolution of clinical care
necessitates stage revision. The current VDW tumor table
data structure will be assessed to determine what changes will
be needed to accommodate the current AJCC structure.
Results: The first edition of the AJCC staging manual was
published in 1977, for diagnoses 1978–1983. Subsequent
revisions took place every 5 to 7 years with the most recent
Supplement

P5.09
Which Method Wins in a Battle of Clinical
Prediction Tools? Machine Learning Versus
Traditional Statistics

Geisinger Health, Danville, PA; 2Medial EarlySign,
Aurora, Colorado
Background: Health care systems are increasingly
developing and adopting analytical strategies to identify
populations with biological and social determinants of
chronic disease. As the field of data science matures, the
variety of analytical tools expands and quality of methods
used for developing clinical prediction tools improves.
Traditional statistical methods may result in simple tools that
are easy to develop, whereas machine learning methods may
be more complex. Each method requires variable investment
of workforce and technology resources in the development
and implementation stages to produce health outcomes and
cost savings. This study compares tools derived from both
methods and reviews situations in which you might choose
one method over the other.
Methods: Clinical prediction tools were independently
applied on the same study cohort using traditional statistical
methods and machine learning. Study outcomes included
measures of diagnostic test accuracy (sensitivity, specificity,
accuracy, area under the curve) and measures of agreement
for person-level predicted probabilities.
Results: The results are a work in progress. Preliminary
results suggest improved accuracy for a tool derived from
machine learning. Predicted probabilities will be assessed to
determine the frequency of disagreements that were greater
than clinically accepted limits.
www.aurora.org/jpcrr
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Conclusion: Machine learning and traditional statistical
methods are both useful for creating clinical prediction
tools. The choice of method likely depends on how the
tool is implemented in clinical practice. Simple tools may
be integrated directly into care to engage patients and
providers in personalizing treatment decisions and offer
whole population benefit over time. Machine learning tools
that more accurately identify high-risk populations may be
critical in comprehensive health care system initiatives that
aim to efficiently and effectively improve health outcomes in
the short term. Understanding the strengths and limitations
of each method will guide future research methodology and
ultimately improve care, health outcomes, and offer cost
savings.

MATERNAL, CHILD & FAMILY HEALTH
OA10.01
Teaching Appropriate Gestational Weight Gain
A. Dhanya Mackeen,1 Danielle Downs,2 Vonda
Hetherington,1 Vani Movva,1 Jennifer Savage,2 Amanda
Young,1 Lisa Bailey-Davis1
Geisinger Health, Danville, PA; 2Penn State University,
State College, PA

There were no significant differences between the groups
regarding the percentage of patients that gained less than or
equal to 20 pounds in pregnancy: 40% in the EC arm vs 45%
in the UC arm (P=0.49). This persisted regardless of adjusting
for covariates. There were no significant differences between
the groups with regards to GWG of 11–20 pounds (22% EC
vs 26% UC, P=0.53). Total GWG did not differ between the
groups (21 pounds EC vs 17 pounds UC, P=0.19).
Conclusion: Enhancing prenatal care for appropriate GWG
did not result in a greater percentage of patients gaining
within the guidelines as compared to usual care, potentially
explained by non-study-related exposure to registered
dietitian nutritionists. Future planned analyses will evaluate
effects on proximal outcomes and whether the intervention
worked for subsets of the sample, accounting for potential
moderating factors (eg, stress, sleep, food insecurity).
OA10.02
Use of Electronic Health Records to Assess
Prevalence of Anemia and Iron Deficiency in
Pregnancy: A Pilot Study With Kaiser Permanente
Northwest
Joanna Bulkley,1 Kimberly Vesco,1 Anne Williams,2
Nicole Ford,2 Lindsay Jenkins1 Andrea Sharma2

1

Background: Excessive gestational weight gain (GWG) is
associated with adverse pregnancy outcomes (eg, gestational
diabetes, cesarean), yet few women report awareness of
appropriate GWG. We tested a health intervention designed
to improve awareness and achievement of appropriate GWG.
Methods: A randomized controlled trial was conducted at
Geisinger Health in Pennsylvania where excessive GWG is
common among women with preconception obesity. Eligible
consenting participants with prepregnancy body mass index
of >30.0 kg/m2 were randomized (1:1) to: 1) usual care (UC),
consisting of written educational materials and counseling
by their provider; or 2) enhanced care (EC) — UC plus a)
personalized letter from a physician detailing appropriate
GWG, b) exposure to individualized GWG chart via the
patient portal, and c) registered dietitian nutritionist telehealth
counseling (initial consult plus 10–20 minutes/1–2 weeks)
until delivery. The primary outcome was the proportion
of women that gained less than or equal to 20 pounds in
pregnancy, per guidelines. We also assessed the number of
patients that gained 11–20 pounds and total GWG.
Results: A total of 224 women were analyzed: 110 in EC
and 114 in UC. Groups were similar according to baseline
characteristics: <30 years of age, white race, non-Hispanic
ethnicity, college-educated, <$75,000 annual income, and not
nulliparous. Of EC participants, 69% received study-related
registered dietitian nutritionist counseling; additionally, 25%
of EC and 30% of UC participants received non-study-related
registered dietitian nutritionist care (eg, gestational diabetes).
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Kaiser Permanente Northwest, Portland, OR; 2Centers
for Disease Control and Prevention, Atlanta, GA
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Background: Anemia and iron deficiency are known to
increase during pregnancy, but surveillance data necessary
to target and evaluate interventions are lacking. Electronic
health record laboratory data may serve as a data source for
surveillance. Among first trimester pregnancies, we sought
to describe the availability of laboratory test results from
anemia screening and iron status evaluation and to estimate
population prevalence of anemia, iron deficiency, and irondeficiency anemia (IDA; ie, presence of both anemia and iron
deficiency).
Methods: We identified pregnancies to women, ≥18 years old,
that began and ended between 2005 and 2016. To assess first
trimester screening and subsequent diagnostic testing of iron
status, we analyzed pregnancies for which 1) prenatal care
started in the first 14 weeks gestation, and 2) the woman was
continuously enrolled in Kaiser Permanente Northwest for the
first 20 weeks or entire pregnancy if ended before 20 weeks
gestation (n=41,991). From clinical and research laboratory
databases, we selected the earliest lab result for hemoglobin
or hematocrit within 14 weeks gestation and the earliest
lab result for ferritin within 20 weeks gestation. Anemia
was defined as hemoglobin of <11.0 g/dL or hematocrit of
<33.0%. Iron deficiency was defined as ferritin of <15.0 ug/L.
Results: Among eligible pregnancies, 93% (n=38,923) had
hemoglobin and hematocrit test results. The first prenatal
visit and hemoglobin/hematocrit test result were both at 8.7
weeks on average. Anemia prevalence was 3% (n=1045).
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Few eligible pregnancies had laboratory test results for
ferritin. Among pregnancies with anemia, 15% (n=156) had
a ferritin result; of these, 49% had iron deficiency. Only 3%
of pregnancies without anemia had a ferritin result (n=1112);
of these, 24% had iron deficiency. Based on 1268 pregnancies
with both anemia and iron deficiency assessed, prevalence of
iron deficiency and IDA was 23% and 6%, respectively, but
estimates may not be representative due to selective screening.
Conclusion: Because anemia screening is nearly universal
at prenatal care onset, electronic health record data has the
potential to monitor anemia prevalence and trends. However,
few women were evaluated for ferritin, limiting the ability
to obtain representative estimates of iron deficiency or IDA.
Additional efforts are needed to determine if evaluation of
iron deficiency can be improved at the health system level
and whether this improves health outcomes.
OA10.03
Prioritizing Distal Determinants of Maternal Health
and Improving Their Measurement Through
Validation Research in Argentina, Ghana, and India

of facility-level patient and administrative data, and crosssectional review of secondary policy, legal, and regulatory
data. A specific methodology is articulated for validating each
indicator, based on the underlying construct it measures and its
specific metadata. We will present the methodology for each
validation exercise from the research protocol in finalization.
Results: Validation research on health system- and policylevel indicators is not common, therefore, this work
contributes new knowledge on validation methodology
to the field as well as helps to substantiate the definitional
framework and guidance under development by WHO’s
MoNITOR expert working group. For each indicator, specific
methods have been designed to explore validation questions
directed at testing various types of validity: construct validity,
content validity, and convergent validity.
Conclusion: Improving measurement is a crosscutting action
required to improve health systems to end all preventable
maternal deaths. However, developing robust indicators is a
challenge; indicator validation research is important in this
era of increased demand for quality, reliable data to measure
distal determinants of maternal health.

Rima Jolivet,1 Richard Adanu,2 Eduardo Bergel,3 Niranjan
Saggurti,4 Delia Bandoh,2 Amanda Mabel Berrueta,3
Suchandrima Chakraborty,4 Julia Cohn,1 Sarah HuberKrum,1 Magdalene Odikro,2 Veronica Pingray,3 Sowmya
Ramesh,4 Ernest Kenu,2 Ana Langer,1 Jewel Gausman1

OA10.04
Development of an Equity Dashboard to Monitor
Health Disparities in Women’s Health

1

Women and Health Initiative, Harvard T.H. Chan
School of Public Health, Boston, MA; 2School of Public
Health, University of Ghana, Accra, Ghana; 3Instituto de
Efectivdad Clinica y Sanitaria, Buenos Aires, Argentina;
4
Population Council India, New Delhi, India
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Background: In 2015, the World Health Organization
(WHO) released “Strategies toward ending preventable
maternal mortality” (EPMM Strategies), which elaborates 11
key themes, emphasizing a systemic approach and increased
attention to the full spectrum of determinants of maternal
health and survival. Following the release of the EPMM
Strategies, a set of indicators to track progress in these areas
was identified to measure key leverage points at the health
system, health policy, and population levels for tracking
progress toward achieving the strategic objectives outlined in
the EPMM Strategies (Jolivet et al, 2018). This presentation
describes research to validate 10 policy and health systemlevel indicators from the EPMM monitoring framework.
The specific aim of this study is to improve maternal health
indicators that are not routinely collected and reported
at a national level in 3 countries using a mixed-method,
observational study design. The research is being carried
out by the Harvard T.H. Chan School in collaboration with
partners in Argentina, Ghana, and India.
Methods: This observational study utilizes a mixed-methods
research approach, including quantitative and qualitative
primary prospective data collection, retrospective review

Background: The American College of Obstetrics and
Gynecology has identified at least 15 areas of inequities in
women’s health and health care among minority women.
Identifying disparities via measuring and monitoring health
outcome data is fundamental to ensuring quality and
informed care. Clinical dashboards are used to display
outcome data in a visual, concise format that allows for
the identification of gaps in care. Information gleaned from
dashboards can be used as a tool to guide institutional action
and aid in mobilizing health care providers to improve care.
Safety-net hospitals serving vulnerable populations tend to
have limited fiscal resources and would have the most to gain
from such information. Discovering previously unknown
gaps in care also has cost savings potential, as improving
outcomes can prevent costly downstream consequences of
delayed or inadequate health care.
Methods: We developed a dashboard that evaluates
disparate health outcomes and access across 6 indicators of
vulnerability: race, ethnicity, gender, age, language, and zip
code. The areas measured include rates of preterm birth,
fetal demise, cesarean sections, cervical cancer, minimally
invasive hysterectomy and myomectomy, and receipt of longacting reversible contraception. Where possible, the data are
reported alongside the county, state, and national average.
Results: Among African American women, the preterm birth
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rate ranged from 9.6% to 13.0%; the rate was highest among
African American women at all time points. The cesarean
section rate ranged from 28.7% to 33.3%; similarly, the rate
was consistently highest among African American women.
On average, both the rates of preterm birth and cesarean
section were 34% higher than the rate of all other women
from 2014 to 2019 (8.3% and 22.9%, respectively).
Conclusion: The equity dashboard provides a concise view
of key health inequities that allows us to identify trends, gaps,
and opportunities to improve patient outcomes and access
to services with the overall goal of eliminating disparities
within our institution. In the future, these data could be further
stratified by other measures, such as income, migratory
status, education, and housing security, to guide future quality
improvement projects and find more opportunities to creating
equal care for all.

[95% CI: 1.05–1.55]), and Arab Americans (OR: 1.46 [95%
CI: 1.20–1.78]) and lower in African Americans (OR: 0.64
[95% CI: 0.56–0.74]), as compared to whites.
Conclusion: Compared to whites, Asians, Hispanics, and
Arab Americans have higher risk and African Americans have
lower risk of a GDM diagnosis. Delivery at an older maternal
age increases the risk of GDM diagnosis. Race/ethnicity
moderates the association between older maternal age and
risk of GDM diagnosis. This study provides information for
public health professionals, health practitioners, and pregnant
women to be aware of and better understand the risk of GDM
as related to race/ethnicity and maternal age.

P11.01
A Retrospective Analysis of the Relationship
Between Race/Ethnicity, Age at Delivery, and the
Risk of Gestational Diabetes Mellitus

Shannon G. Mitchell,1 Anjali R. Truitt,2 Lauryn Davin,2
D. Brad Rindal2

Bin Liu,1 Lois E. Lamerato,1 Dawn Misra2
Henry Ford Health System, Detroit, MI; 2Wayne State
University, Detroit, MI
1

Background: Many factors have been reported to be
associated with developing gestational diabetes mellitus
(GDM); however, few have been studied in depth. This study
aimed to investigate the relationship between maternal race/
ethnicity, age at delivery, and the risk of GDM.
Methods: Patients of Henry Ford Health System who
delivered a live singleton child and were diagnosed with or
without GDM during 2010–2015 were included. Maternal
race/ethnicity, age, body mass index (BMI), parity, GDM
in previous pregnancy, smoking status, and insurance
membership were collected from the electronic health records.
Neighborhood median family income data were obtained
from U.S. Census Bureau. Logistic regression analysis was
performed to explore the effects of maternal race/ethnicity
and age at delivery on the GDM outcome after adjusting for
covariates, including BMI, parity, previous GDM, smoking
status, and neighborhood family income.
Results: There were 16,258 women included in the study.
Of those, 1801 women (12.5%) were diagnosed with GDM.
Delivery at an older age (≥23 years) was associated with a
significantly higher risk of a GDM diagnosis than at a younger
age (<23 years) — odds ratio (OR): 2.24 (95% CI: 1.84–2.73)
vs OR: 5.02 (95% CI: 4.18–6.03) — however, the risk was
not as profound in African American women (OR: 1.65)
compared to non-African American women (OR: 2.07). In a
multivariable model controlling for age, BMI, parity, previous
GDM, smoking status, and neighborhood family income,
the risks of a GDM diagnosis were significantly higher in
Asians (OR: 2.81 [95% CI: 2.28–3.48]), Hispanics (OR: 1.27
122 JPCRR • Volume 7, Issue 1 • Winter 2020

P11.02
Pain Management Related to Wisdom Teeth
Extractions: Interviews With Teens and Parents

Friends Research Institute, Inc., Baltimore, MD;
HealthPartners, Bloomington, MN
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Background: Despite growing concern about the opioid
epidemic, the number of opioid prescriptions for 11–18-yearold dental patients increased from 2010 to 2015. Prescribed
opioid use before completing high school graduation is
independently associated with future opioid misuse among
low-risk children. The majority of dental providers report
prescribing opioid medications following wisdom teeth
extractions. This study explored how adolescent patients and
their parents/guardians make decisions about opioid use for
pain management after dental extractions.
Methods: Participants were identified based on age and recent
dental extraction procedure. A notification letter was sent to
the parent/guardian of the patient, and a follow-up call was
made a week later. Verbal consent by the parent/guardian and
verbal assent by the patient was obtained. A trained interviewer
conducted paired structured interviews with interview guides
tailored to the respondent (eg, parent/guardian or patient).
Interview guides addressed patient- and family-centered
decision-making related to pain management. All interviews
were conducted by phone, audio-recorded, and transcribed.
De-identified data were analyzed using qualitative analysis
software using a directed content analysis approach.
Results: All participants interviewed (15 patients, 15
parents) reported receiving an opioid prescription following
wisdom teeth extractions. Of those who did take the opioid
prescription, most only took it the day of the extraction and up
to 2 days following. This appeared to be common regardless of
whether the adolescent, parent, or a shared pain management
decision-making approach was taken. Few patients took all
of it, and several took none. In addition to conversations
with their dentist, most patients and their parents discussed
pain management plans before or following the extraction,
which included nonmedication options, over-the-counter
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medications, and opioid prescriptions as needed. No one
reported significant side effects from any of the options.
Most patients and their parents felt that the over-the-counter
medication was adequate in managing pain.
Conclusion: Opioid prescribing is common following
wisdom teeth extractions. Providers may have an opportunity
to reduce the number of days for which opioids are prescribed
and reduce the number of opioid prescriptions. When opioids
are prescribed, providers should educate patients and their
parents/guardians about safe disposal to mitigate the potential
for diversion.

HEALTH CARE DELIVERY & COVERAGE
OA12.01
Adherence to Best Practices for Medication
Reconciliation Identified Through Observations in
Primary Care Practices
Michael Gionfriddo,1 Allison Middernacht,1 Vanessa
Duboski,1 Melissa Kern,1 Eric Wright1
Geisinger Health, Danville, PA

to verify current medications (99%), verify if patients take
medications as prescribed (99%), and review the names
of medications (99%). Few staff used EHR functionality
to view medications from other locations (ie, reconcile
outside medications [7.6%]) or queried the patient about
non-Geisinger Health medications (26%), over-the-counter
(36%) or as-needed medications (24%), adherence (5%),
side effects (12%), and portions of SIG instructions (eg,
route [2%], indication [13%]).
Conclusion: Medication reconciliation is highly variable,
and several of the components of conducting a thorough
medication reconciliation are not routinely collected within
a primary care visit with rooming staff. Future studies
should assess reasons for the lack of completion.
OA12.02
“6-Clicks” Short Forms: Effects on Discharge
Location, Length of Stay, and Readmission in
Hospitalized Acute Care Patients Receiving
Rehabilitation
Melissa Harry,1 Theo Woehrle,1 Colleen Renier,1
Margaret Furcht,1 Michelle Enockson1

1

Background: Medication lists contained within electronic
health records (EHR) should reflect patients’ current
medications; however, these lists are rarely complete and
accurate. Best practices for medication reconciliation exist,
but fidelity to these procedures in primary care settings by
staff rooming patients and providers are unclear. We sought
to quantify the extent to which best practice procedures for
medication reconciliation are followed in routine primary
care practices.
Methods: We conducted an ethnographic study of nurses
and medical assistants rooming patients in primary care
clinics in a health care delivery network from June through
September 2019. Practice sites and rooming staff were
selected in collaboration with clinic leadership on a volunteer
basis. All sites that volunteered were included. Convenience
sampling was used to conduct individual observations.
Staff at the sites were not blinded to observations. Study
team members documented time spent on medication
reconciliation and actions of rooming staff conducting
medication reconciliation using a predeveloped checklist of
best practices collected from a search of the literature.
Results: We observed 170 patient encounters with 43 nurses/
medical assistants across 15 primary care clinics. On average,
the staff took approximately 2 minutes (standard deviation:
2 minutes; range: <1 minute–14 minutes) to conduct a
medication reconciliation and completed approximately 50%
(range: 30%–80% adherence) of the behaviors considered
to be part of an optimal medication reconciliation. In all
encounters observed, staff accessed the medication list,
reviewed medications, and documented that they reviewed
the medication list, with nearly all staff querying patients
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Background: Accurately predicting appropriate discharge
location for hospitalized patients may help reduce costs related
to rehabilitation and hospital readmissions. The Activity
Measure for Post-Acute Care (AM-PAC™) “6-Clicks”
Inpatient Basic Mobility and Daily Activity Short Forms
are standardized functional assessment tools that may assist
physical and occupational therapists with better determining
patient discharge location when implemented in clinical care
during a hospital stay. The aim of this study was to evaluate
the effect of 6-Clicks usage on discharge location, length of
stay, and 30-day readmissions for adult patients receiving
rehabilitation services during an acute inpatient hospital stay
in 5 Essentia Health hospitals. Essentia is a predominantly
rural integrated health care system with locations in
Minnesota, North Dakota, and Wisconsin.
Methods: This retrospective observational study used
electronic health record data. The sample included 12,314
hospital admissions (10,316 patients) from the 12 months
prior to 6-Clicks implementation (June 1, 2015–May 31,
2016) and 13,241 hospital admissions (10,931 patients)
from the year after full 6-Clicks implementation (January
1, 2017–December 31, 2017) within 5 Essentia hospitals.
Analyses included descriptive statistics, areas under the
receiver operating characteristic curves (AUC), logistic
regression for initial hospitalizations, and negative binomial
and binary logit-linked generalized estimating equations for
correlated data.
Results: In 4 randomly drawn samples, the AUC for Basic
Mobility and Daily Activity scale scores were 0.86 and 0.84–
0.85, respectively, for discharge to home or to an institution,
www.aurora.org/jpcrr
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including skilled nursing facilities. Scores also independently
correctly classified more discharges to home than to other
institutions. A 1-point increase in Basic Mobility and Total
Activity scale scores was significantly associated with higher
likelihoods of patients being discharged home, regardless of
model tested. However, few significant differences were seen
regarding length of stay or 30-day readmissions between preand post-6-Clicks cohorts, including by individual hospital.
Conclusion: The AM-PAC 6-Clicks Basic Mobility
and Daily Activity Short Forms performed similarly to
research published by the developers when distinguishing
between discharge locations, supporting use by physical
and occupational therapists in discharge planning. Future
research could assess where additional intervention or staff
training on the use of 6-Clicks may be needed to reduce
length of stay and 30-day readmissions for hospitalized
acute care patients receiving rehabilitation services.
OA12.03
Association
Between
All-Cause
Hospital
Readmissions and Routine Vaccination Among
Persons With Chronic Obstructive Pulmonary
Disease in the LEAP Study
Djeneba Audrey Djibo,1 Jessica Stempel,1 Andres Mora
Carpio,1 Darina Chudnovskaya,1 Jean G. Ford1
Einstein Healthcare Network, Philadelphia, PA
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Background: Poorly managed chronic obstructive pulmonary
disease (COPD) can lead to repeated exacerbations and
frequent acute hospital stays. Recommended vaccinations,
such as the yearly influenza vaccine and the pneumococcal
vaccine, while preventing or lowering the severity of the
disease, also reduce the number of acute episodes. Identifying
missed opportunities for upstream prevention of excess acute
health care utilization in a vulnerable population is key to
improving outcomes.
Methods: The LEAP study developed a retrospective cohort
of asthma/COPD patients in a large urban safety-net hospital
to examine environmental and social factors affecting health
care utilization and to identify opportunities for intervention.
Electronic health records were used to identify COPD cases
using disease-specific ICD-9 and ICD-10 codes. Demographic
information including male/female sex, ethnic group, and
age also were collected. Information on hospital admissions
was collected for 2008–2018, evidence of influenza and
pneumococcal vaccination was recorded, and 30-day all-cause
hospital readmissions were identified. Logistic regression was
used to examine the association between readmission and
vaccination status.
Results: COPD cases (N=1,068) were 60% female, were
80.3% African American, and had median age of 67 years.
Evidence of influenza and pneumococcal vaccination was
found in 64.2% and 60.5% of cases, respectively. Female
COPD cases were more likely to have received influenza
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vaccination compared to male COPD cases, 67.8% vs 59.2%
(P=0.006); however, there were no gender differences in
the receipt of pneumococcal vaccination. Pneumococcal
vaccination was not independently associated with 30day readmission (P=0.1). However, evidence of influenza
vaccination was independently positively associated with
decreased odds of 30-day hospital readmission (P=0.04).
After controlling for age, gender, and ethnicity, the odds of
readmission remained lower among those who had received
influenza vaccination (P=0.007).
Conclusion: There is clear evidence that primary preventive
measures, such as recommended vaccinations, may help
reduce acute health care utilization among individuals with
COPD. However, our study showed that the protective
effects of pneumococcal vaccination do not extend to the
risk of readmission. Further investigation of the differences
observed, including the effects of social environment, will
help understand the determinants of readmission to this urban
safety-net hospital.
OA12.04
Improving Care Transitions Between Hospital and
Home: How Do High-Performing Hospitals Do It?
Kimberly Fisher,1 Susanne Muehlschlegel,2 Timothy
Konola,1 Sarah Bloomstone,1 Sybil Crawford,1 Kathleen
M. Mazor1
Reliant Medical Group/University of Massachusetts
Medical School/Fallon Health, Worcester, MA; 2University
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Background: The transition from hospital to home is an
extremely high-risk time, with many patients experiencing
adverse events. We sought to identify approaches used by
hospitals that consistently achieve excellent care transitions
(high-performers) but not by low-performing hospitals.
Methods: We conducted in-depth interviews with key
stakeholders from nonspecialty acute care hospitals. Hospitals
were classified as high- or low-performers based on the care
transition measure (CTM-3) from the Hospital Consumer
Assessment of Healthcare Providers and Systems (HCAHPS)
Survey. Interviews were audio-recorded and transcribed
verbatim. Themes were identified through iterative readings
of the transcripts, generation of preliminary lists of themes,
and discussion until the team reached consensus that all
important themes had been identified. All transcripts were
coded by 3 researchers. Differences in coding were discussed
until consensus was achieved.
Results: A total of 39 stakeholders from 9 high-performing
hospitals and 9 stakeholders from 3 low-performing hospitals
participated. Hospitals were diverse with regard to size,
teaching status, and geographic location. Participants had
varied roles (frontline [n=11], manager/director [n=27],
senior leadership [n=10]) with backgrounds in nursing,
social work, case management, administration, pharmacy,
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and medicine. Qualitative analyses revealed 3 domains that
characterized care transition practices: processes, structural
elements, and contextual factors. Each domain was comprised
of several themes. Care transition processes that distinguished
most high- from low-performers included assessment of
discharge needs among all or nearly all patients; targeting
intensive care transition initiatives to patients at higher risk
of readmission or death; emphasis on patient education;
and pharmacy involvement in medication reconciliation,
medication education, and ensuring patients receive
discharge medications. Structural elements included staffing,
availability of resources in the community, and hospital
features such as size. Preliminary analysis suggests that
contextual factors are especially important in distinguishing
high- from low-performing hospitals. High-performing
hospitals were characterized by an extremely patient-centered
culture, a nonhierarchical and collaborative workplace, and
a commitment to continual improvement in which frontline
staff are consistently engaged. Hospital leaders were viewed
as playing an important role in fostering these contextual
factors.
Conclusion: These findings illustrate care transition
practices that characterize high-performing hospitals that
could be used by hospitals seeking to improve their own
care transition performance.
P8.01
Knowledge and Awareness of a Value-Based
Insurance Design Benefit Program for Diabetes
Patients
Vanessa Simiola,1 Tiana N. M. Koch,1 Andrea Altschuler,2
Timothy B. Frankland,1 Alyce S. Adams,2 Deborah
Taira,3 Dennis Ross-Degnan,4 Connie Trinacty1
Kaiser Permanente Hawaii, Honolulu, HI; 2Kaiser
Permanente Northern California, Oakland, CA;
3
University of Hawai’i at Hilo, Hilo, HI; 4Harvard Pilgrim
Health Care, Boston, MA
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Background: Increasingly popular value-based insurance
designs (VBIDs) have been shown to improve short-term
adherence to medications for chronic illness with no increase
in total spending. Kaiser Permanente Hawaii (KPHI) offers
WellRx — a drug rider benefit that automatically waives all
copays for essential medications and supplies for diabetes —
to select large employer accounts. Gaps in knowledge and
awareness of these programs may lead to variation in program
efficacy. This multimethod study evaluates the knowledge
and awareness of a real-world VBID program at the employer
and employee levels.
Methods: Semi-structured interviews were conducted with
11 employer representatives from 6 KPHI accounts that
participate in WellRx. Eligible employer participants were
primary decision makers for health care benefits or advocates
for health and wellness for their employees. Responses
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were reviewed independently by 3 of the authors. Thematic
analysis was used to evaluate the employers’ awareness of
WellRx, methods for disseminating information about the
program to employees, and the value of health and wellness.
Mailed surveys were collected from 316 WellRx enrollees
with diabetes currently receiving benefits from an interviewed
employer account. Patients were asked about their knowledge
of receiving a zero-dollar copay for diabetes medication.
Results: One-third of employer representatives were unaware
of the WellRx benefit in their service agreement with KPHI.
Prioritization of health was less frequent among these employer
groups, particularly when compared to their perception of
the importance of costs for health benefits. These employers
less frequently reported engaging in discussions with their
employees about health benefits and overall wellness. Of
employer representatives who were aware of offering WellRx,
several noted obstacles in distributing information about the
program to their employees directly (ie, lack of employee
engagement, low health literacy, communication barriers).
About 30% of surveyed WellRx beneficiaries were unaware
of filling their diabetes medications without paying copays.
Conclusion: Knowledge and awareness of available health
care benefits vary at both employer and employee levels.
Barriers to dissemination of information about health benefits
by employers and gaps in patient-reported knowledge of a
zero-copay program may be limiting, but common, factors
in evaluating real-world VBID programs. System-based
strategies may address variations in knowledge dissemination
across consumer, payer, and organizational contexts.

EPIDEMIOLOGY AND POPULATION
HEALTH IMPROVEMENT
P6.01
Prescription Opioid Use and Incident Psychiatric
Disorders: An HCSRN Partnered Research Protocol
Lisa Matero,1 Brian Ahmedani,1 Lynn DeBar,2 Sarah
Gebauer,3 Joanne Salas,3 Patrick Lustman,4 Mark
Sullivan5
Henry Ford Health System, Detroit, MI; 2Kaiser
Permanente Washington, Seattle, WA; 3Saint Louis
University, St. Louis, MO; 4Washington University
School of Medicine, St. Louis, MO; 5University of
Washington, Seattle, WA
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Background: Opioid analgesic use (OAU) is associated with
an increased risk for depression even after controlling for
the contributions from pain. Herein we describe a research
collaboration between Saint Louis University and Henry Ford
Health System that aims to determine the risk factors, either
preceding or following OAU, that increase risk for incident
depression and to systematically characterize the depression
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profile (ie, major depressive episode, dysthymia, bipolar,
anhedonia, and vital exhaustion) associated with OAU and
opioid use disorder.
Methods: This is a prospective cohort study of 1500 (750 Saint
Louis, 750 Henry Ford) adult (age: 18–70 years) prescription
opioid users invited to participate when they completed a new
period (no OAU in previous 3 months) of 30-day OAU and
have prescriptions allowing for 60 days of continuous opioid
use. Targeted subject recruitment using electronic health
record data is used to identify eligible subjects. Baseline,
6- and 12-month web or telephone survey will obtain data
on lifetime and current psychiatric diagnoses, trauma, sleep
disorder, social support, noncancer pain, and OAU. Subjects
will be asked to complete 12 monthly assessments measuring
pain-related functioning, depression symptoms, and OAU.
Results: Efforts to reduce morbidity and mortality associated
with the opioid epidemic have led to significant declines in the
number and duration of new opioid prescriptions written in the
United States. These changes have challenged our ability to
identify eligible subjects and required adapting the eligibility
criteria to reflect current prescribing patterns. We now allow
tramadol to count as an eligible opioid and do not require a
chronic pain diagnosis. We have completed programming of
a diagnostic interview in RedCap, making it the first available
web-based, lay-administered, psychiatric diagnostic survey.
Recruitment is scheduled to begin November 2019.
Conclusion: Restrictions on type of opioid and duration
of new opioid prescriptions have dramatically increased
the difficulty involved in obtaining eligible patients. Fewer
eligible subjects per week has led to allowing for a 24-month
baseline enrollment period. Allowing tramadol to count
toward OAU greatly increased the number of subjects eligible
for study and ensures that results will be relevant to current
prescribing practices. Preliminary recruitment information
and lessons learned will be discussed.
P6.02
Long-Term Trends and Risk Factors of Deaths
From Traumatic Injuries at a Rural Wisconsin Level
2 Trauma Center
David McClure

1

Marshfield Clinic, Marshfield, WI
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Background: Most studies of deaths from traumatic injury
are from urban level 1 trauma centers. In contrast, rural
areas have higher incidence of traumatic fatal injuries than
urban areas. Nationally, there is also a recent overall trend of
increasing numbers and rates from deaths due to traumatic
injury. Therefore, the objective was to describe trends
of trauma mortality and risk factors from a largely rural
population.
Methods: This was a retrospective cohort study of injured
patients admitted to a rural Wisconsin level 2 trauma center
from 2000 through 2018. Details on medically attended
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injuries and deaths were obtained from the trauma registry.
Fatality counts and proportions were described by year,
gender, age, mechanism of injury, intent of injury, injury
severity score (ISS), and length of hospital stay (in days).
Survival analysis was used to explore major risk factors
related to injury mortality.
Results: There were 17,556 events among 16,696 patients
admitted from 2000 through 2018. The proportion of injuries
caused by falls increased from 35% in 2000–2005 to 52% in
2014–2018. The proportion caused by motor vehicle crashes
decreased over time, from 31% to 18%, respectively. The
proportions due to other injury mechanisms were relatively
stable, with very few due to firearms (<1%). Overall fatality
rates at the trauma center were 6% from 2000 to 2004 and
decreased to 4%–5% thereafter. The highest fatality rates were
patients with ISS of >15 (fatality: 14%) and those caused by
firearms (fatality: 25%). In the survival analysis, major risk
factors for death were age of >64 years (hazard ratio [HR]:
2.4, 95% CI: 1.3–4.3); ISS of >15 (HR: 6.9, 95% CI: 5.4–8.9),
falls (HR: 2.5, 95% CI: 1.6–3.7), and firearms (HR: 10, 95%
CI: 6.2–17).
Conclusion: Long-term trends of traumatic injury mortality
were similar to national trends, particularly in increasing
proportion due to falls. However, the proportion of firearms
deaths at this rural trauma center was low compared to urban
or other rural centers. There were limitations of no available
information on immediate deaths at the scene and loss to
follow-up after discharge date. These will be addressed in a
population-based follow-up study.
P15.01
Effects of a Pharmacist-led Program to Reduce
Opioid Use: Results from a Natural Experiment
John Dickerson,1 Jennifer Kuntz,1 Xiuhai Yang,1
Mathew Slaugher,1 Jennifer L. Schneider,1 Alison
Firemark,1 Dea Papajorgji-Taylor,1 Katherine Reese,1
Lou Ann Thorsness,1 Mark Sullivan,2 Lynn DeBar,3
David H. Smith1
Kaiser Permanente Northwest, Portland, OR;
Psychiatric and Behavioral Sciences, University of
Washington School of Medicine, Seattle, WA; 3Kaiser
Permanente Washington, Seattle, WA
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Background: Levels of opioid prescribing and the attendant
risks have become an urgent national concern. To address
this, Kaiser Permanente Northwest (KPNW) implemented
a pharmacist-led program (“STORM”) in 2010 that held
individual training for primary care providers (PCP) on
contemporary opioid prescribing and STORM services. Once
trained, PCPs could access STORM services to assist patients
with opioid-exposure reduction. The PCP training was rolled
out nonsystematically, allowing an opportunity to estimate
causal effects of the program on PCP panel-level outcomes
across time.
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Methods: Using KPNW electronic health record data and
training records, we identified 331 PCPs who had active
panels (≥100 patients) and were employed at some time during
the STORM training roll-out (2010–2012). We identified
379,378 adult patients paneled to these PCPs between 2007
and 2015 and assigned their monthly data to their paneled
PCP. We then constructed a monthly PCP-level dataset with
summary outcome measures (eg, average daily morphine
equivalent [MED]), potential confounders (eg, proportion
of patients with chronic pain), STORM training details (eg,
trained or not, months since training), and calendar time (to
estimate secular trends). In order to empirically evaluate the
nonsystematic dissemination, we estimated standardized
differences between trained and untrained PCPs over time
for likely confounders, specifically, the proportion of patients
with chronic pain and average MED. We used generalized
estimating equations to fit population-averaged models.
Results: We found standardized differences to be consistently
below 0.2 between 2010 and 2012, offering reassurance
of a nonsystematic dissemination. For average MED, we
found an immediate effect following STORM training (β:
-0.301, P<0.001), average monthly reduction in the first
year following training (β: -0.051, P<0.001), and an average
monthly reduction after the first year following training
(β: -0.052, P<0.001). The estimated panel average MED 2
years after STORM training was 31.2% lower for trained
PCPs compared to untrained PCPs. Other opioid summary
outcomes showed similar results.
Conclusion: Our findings demonstrate that the STORM
program is effective at reducing the average panel’s opioid
use. Next steps include examining subgroup effects and
performing an economic evaluation.
P15.02
Oral Health: An Important but Often Absent
Component of Total Health Care
Nancy P. Gordon1
Kaiser Permanente Northern California, Oakland, CA
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Background: Oral health is in an important component of total
health. Poor oral health can lead to gum disease and chronic
inflammation, increasing oral cancer risk and exacerbating
management of cardiovascular conditions. Poor oral health
can lead to tooth loss, making eating and speaking difficult
and affecting emotional health. Despite the importance of
oral health, health plans generally don’t consider preventive
dental care (PDC) as part of total health care. Patients are not
routinely asked whether they are getting their teeth cleaned
and examined or being advised to do so. Doctors seldom look
into patients’ mouths, let alone inspect teeth and gums for
problems. Adults are recommended to get their teeth cleaned
and examined at least annually, more often if at higher risk
for oral health problems This study estimated the proportion
of health-insured adults that did not receive PDC in the past
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12 months and identified factors associated with lack of PDC.
Methods: Pooled data from the 2011 and 2014/2015 cycles
of the Kaiser Permanente Northern California (KPNC) adult
Member Health Survey, weighted to the age-sex composition
of 2014 KPNC membership, were used to estimate the
percentages of adults, 25–34, 35–64, 65–74, and 75–85 years
of age, with no PDC in the past 12 months. Lack of recent
PDC was compared by sex, race/ethnicity, income, education,
and health characteristics.
Results: Approximately 26% of adults in the 25–34 and 75–
85 age groups and 18% of adults in the 35–64 and 65–74 age
groups reported no PDC in the past year. Demographic and
health factors were similar across age groups. Lack of PDC
was more prevalent among blacks and Latinos than whites
and increased as income, education, and self-rated health
decreased. No recent PDC was reported by more than onethird of adults 65–85 years of age with oral health problems
that interfered with eating or talking, by one-third among
35–85-year-olds, by approximately 30% of adults with
diabetes, by 24% with heart disease and hypertension, and by
40% of smokers.
Conclusion: Many adults are not routinely getting preventive
dental care, which may pose a health risk. Even when health
plans are not offering this care, patients should be encouraged
to get it and be given referrals to low cost services if needed.
P15.03
Standardized Reporting of Chest Computed
Tomography Results Improves Detection of Lung
Cancer
Jennifer Dusendang,1 Thomas Urbania,1 Stacey
Alexeeff,2 Douglas Corley,1 Todd Osinski,1 Lori Sakoda,1
Lisa Herrinton1
Kaiser Permanente Northern California, Oakland, CA;
Kaiser Permanente Mid-Atlantic States, Rockville, MD
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Background: The number of chest computed tomography
(CT) scans performed each year is increasing, and
standardization of the management of incidental lung nodules
as recommended by the Fleischner Society remains important.
Between 2015 and 2017, Kaiser Permanente Northern
California rolled out a standardized reporting system that uses 7
tags (#PUL0–#PUL6) applied to chest CT reports to concisely
convey nodule findings and recommended follow-up.
Additionally, the tag “#PUL5” indicates “suspicious for
lung cancer” and automatically forwards the report to an
expert multidisciplinary committee for case review.
Methods: To assess the effectiveness of the standardized
reporting system, we performed a stepped-wedge analysis to
retrospectively compare the incidence of lung cancer between
patients with chest CT whose scan results were tagged
versus those not tagged. We also computed performance
characteristics of the #PUL5 tag and performed chart review to
assess potential areas for improvement in the reporting system.
www.aurora.org/jpcrr
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Results: We identified 99,148 patients with a chest CT
between January 2015 and July 2017. Of these patients,
40% (n=39,409) had a tag applied to their radiology report,
of which 2255 (5.7%) were #PUL5. Within 120 days of
the initial CT scan, 2856 patients (2.9%) were diagnosed
with new primary lung cancer. Adjusting for patient
demographics, Charlson comorbidity score, smoking status,
previous cancer diagnosis, 6-month calendar period, and
medical center, the odds of lung cancer diagnosis increased
by 9% (95% CI: 0–18%) in the patients with tagged (vs
untagged) reports. The odds of early stage lung cancer
diagnosis increased by 24% (95% CI: 9%–41%). Among
patients with tagged reports, #PUL5 had a sensitivity of
74%, specificity of 96%, and a number needed to diagnose
of 2.7 for lung cancer. Opportunities for improvement
related to too-literal distinctions between “nodule” and
“mass” and limited radiologist knowledge of the patient’s
clinical context.
Conclusion: Standardized reporting and management of
lung nodules was associated with an increased likelihood of
diagnosing lung cancer, especially early stage lung cancer
compared with prior unstructured reporting. Integrated
health care systems have a unique opportunity to automate
and standardize the management of suspicious findings on
CT scans.
P15.04
Coordinator-Supported Hepatocellular Carcinoma
Surveillance in Kaiser Permanente Mid-Atlantic
States
Lauren Williamson, Venus Alert, Cabell Jonas, Eric
Watson,1 Sundeep Basra,1 Michael Horberg1
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Background: Cirrhosis is a leading risk factor for
hepatocellular carcinoma (HCC). Populations at risk for
HCC that are candidates for surveillance generally include
hepatitis B (HBV), hepatitis C, liver cirrhosis, nonalcoholic
cirrhosis, and advanced liver fibrosis. The goal for HCC
screening is to detect subclinical diseases at an earlier stage
for at-risk patients through use of imaging results, which
has a favorable effect on overall patient care outcomes and
treatment options. Literature identifies barriers in adherence
to HCC surveillance, which the Mid-Atlantic Permanente
Medical Group (KPMAS) decided to act on when developing
and building its HCC surveillance program. KPMAS’s goal
aims to determine how effectively a coordinator-supported
approach with assisting physician improves adherence to not
only HCC surveillance but to other chronic health programs.
Methods: If eligible as a high-risk patient for developing
HCC, a gastroenterologist (GI) will place a unique initial
order to designate which lab work (eg, alpha-fetoprotein,
hepatic function, or HBV DNA viral load) and imaging
exam (ultrasound, magnetic resonance imaging, or computed
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tomography scan) to complete every 6 months. Two months
prior to due date, coordinators will call patients to assist with
scheduling ultrasound exam. Once ultrasound and labs are
completed, GI physician will interpret the results to create
plan of care (continue with pathway or removed).
Results: Since January 2019, the coordinators have contacted
more than 600 patients to complete their HCC surveillance
orders. Approximately 92% of patients participating had at
least 1 ultrasound and lab work ordered and completed; 15%
of those patients had no evidence of an ultrasound scheduled
in the past year, indicating they were not in a regular
surveillance program.
Conclusion: KPMAS’s approach to surveillance for HCC
is consistent with most society guidelines for monitoring
adult patients at high risk for developing HCC; however,
the program has the added benefit of using coordinators to
increase patient adherence to the recommended screening,
which is a known gap in care. Early results indicate the
program is succeeding in ensuring most patients with the
HCC surveillance order complete the imaging/labs, and that
patients previously out-of-care (no ultrasound in past year)
have been reengaged with the recommended testing.
P15.05
Insights Into Statewide Payment and Delivery
System Reform: Lessons From the Iowa State
Innovation Model Evaluation
Tessa Heeren1
Public Policy Center, University of Iowa, Iowa City, IA
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Background: In 2015, the Iowa Department of Human
Services received a 4-year, $43 million State Innovation
Models (SIM) grant to improve the quality of care and
population health while simultaneously reducing health
system costs. During the 4-year tenure of the Iowa SIM,
various health system interventions were pursued, most of
which were implemented in preceding SIM grantee states
and endorsed by the Center for Medicare & Medicaid
Innovation. Specific Iowa SIM efforts included payment
reform (value-based purchasing), building a statewide
unifying infrastructure (statewide admission, discharge,
and transfer [ADT] alerting), and establishing multisector
referral networks (accountable communities of health).
Methods: Qualitative (eg, key informant interviews, meeting
minutes) and quantitative sources (eg, survey data and
reported outcome measures) of evidence will be used to
examine process and outcome measurement. Original SIM
goals and the status at the conclusion of the Iowa SIM will
be contrasted and interpreted for 3 main initiatives — valuebased purchasing, statewide ADT alerting, and accountable
communities of health.
Results: Original outcome measures of progress towards
Iowa SIM goals were impacted by the context of the state
and federal health landscape. For instance, enrollment goals
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for value-based purchasing contracts were complicated by
the introduction and turnover of managed care organizations
in the state. In addition, changes in SIM and state leadership
impacted the vision and continuity of implementation. These
factors had a significant impact — causing program drift
and a momentum slump, which created a new challenge of
engaging new stakeholders and maintaining the investment
from original stakeholders.
Conclusion: Thoughtful development and careful
documentation of process outcomes should be required to
measure progress in large-scale systems-change initiatives
and be used to interpret the summative outcomes of grants.
By emphasizing the context and foundational benchmarks
of meeting overarching goals, setbacks can be differentiated
from “failures” and can inform and motivate the sustainment
of grant programming beyond funding.
P15.06
The Northwest Biobank and Tissue Library: A
Valuable Resource for Collaborative Research
Joanna Bulkley,1 Jessica Hunter,1 Don Freel,1 Allison
Naleway,1 Charisma Jenkins,1 Shawn Westaway,1 Lisa
Portela-Justice,1 Yolanda Prado,1 Sheila Weinmann1
Kaiser Permanente Northwest, Portland, OR
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Background: The Kaiser Permanente Center for Health
Research in Portland, Oregon, houses the Northwest Biobank
and Tissue Library (NWBTL), unique biorepositories of
blood and tissue specimens linked to clinical, pharmacy, and
self-report data from Kaiser Permanente Northwest (KPNW)
health plan members. These specimens are available for
research projects in collaboration with Center for Health
Research investigators.
Methods: Specimens were gathered during research studies
and by retaining specimens after usual clinical care with
members’ permission. Blood-derived specimens include
whole blood, plasma, DNA extracted from whole blood,
and buffy coat that can be used to obtain genomic data.
Tissue specimens include individual formalin-fixed paraffinembedded normal and tumor tissue blocks dating to 1971
as well as associated hematoxylin and eosin (H&E)-stained
slides. Tissue slides can be sectioned to meet thickness, slide
type, and staining requirements, and DNA can be extracted.
Cervicovaginal lavages collected during pap smears in
1989–1990 also are available. Specimens are linked to each
patient’s electronic health record, which documents the full
scope of our members’ medical care. Specimens are also
linked to pharmacy and administrative data, the KPNW
tumor registry, pathology reports, and genomic data. Some
specimens also link to survey data.
Results: The NWBTL contains more than 60,000 bloodderived specimens from more than 40,000 individuals,
the majority of whom are female (56%) and white (83%).
Approximately 10% were collected from patients 80 years of
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age or older and 9% from patients younger than 40. Large
disease cohorts include diabetes (>5000), cardiovascular
disease (>3000), cancer (>2800 breast, prostate, and lung),
and clinical depression (>1300). Others include hypertension,
hemochromatosis, hip fracture, cerebrotendinous xanthoma
(a rare disorder), and human papillomavirus. There are more
than 3.5 million normal and tumor tissue blocks and H&E
slides.
Conclusion: Linking KPNW’s clinical data with DNA
and other biological specimens creates a powerful research
resource. NWBTL specimens can be used for a wide range
of studies, including studies of molecular and genetic
factors associated with disease incidence and progression;
pharmacogenetic studies; and disease detection, prevention,
or treatment studies. Specimens have been used to predict
response to tamoxifen in breast cancer treatment, evaluate
the pharmacogenetics of CYP2C19 in proton pump inhibitor
use, and identify genetic risk factors for aggressive prostate
cancer.
P15.07
Demographic Differences Between Patients Tested
Through the Hepatitis C Pathway Versus Usual
Care (non-Pathway)
Fariha Sarwar,1 Halina Williams,1 Cabell Jonas,1 Eric
Watson,1 Sundeep Basra,1 Michael Horberg1
Kaiser Permanente Mid-Atlantic States, Rockville, MD
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Background: An estimated 2.4 million people in the United
States are living with the hepatitis C virus (HCV). For some
people, HCV is a short-term illness, but for 70%–85% of
people, it becomes a chronic infection. Most infected persons
might not be aware of their infection because they are not
clinically ill and have no symptoms. There is no vaccine for
HCV. The best way to prevent HCV is by avoiding behaviors
that can spread the disease. Coordinated care has the potential
to improve access to care/treatment for individuals with HCV
who are newly diagnosed, have fallen through the cracks, and
are naïve to care and treatment.
Methods: The Hepatitis C Pathway program was developed
by the Mid-Atlantic Permanente Medical Group (KPMAS)
to close the gaps in diagnosis and care for patients with HCV
infection. All Permanente physicians may order the HCV
screening pathway. HCV coordinators will communicate
these results and schedule follow-up tests to assess current
liver health. The coordinators communicate the F-score
results to the patients and schedule a consultation with a
gastroenterologist to discuss results and treatment options.
Results: We examined Hepatitis C Pathway and nonPathway patients tested from January 2015 to January 2019.
Demographic breakdowns showed differences by sex and
minor differences by race/ethnicity among those tested. We
also examined the differences, by demographics, of those
diagnosed with HCV (data not yet available) and those who
www.aurora.org/jpcrr
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had HCV tests ordered but not resulted. More patients tested
through the Hepatitis C Pathway had the recommended
HCV RNA testing.
Conclusion: The KPMAS Hepatitis C Pathway, a model
for HCV screening, was shown to be particularly effective
in ensuring screening among those born from 1945 to 1965
(the Baby Boomer population), which is a U.S. Preventive
Services Task Force recommendation. This analysis confirms
that patients tested through the Hepatitis C Pathway had
closed gaps in care, notably, more had received HCV RNA
testing than patients not tested through the program. There do
appear to be demographic differences between patients tested
via the HCV Pathway versus non-Pathway patients.

GENETICS, GENOMICS, AND PRECISION
MEDICINE
P7.01
“Go Ahead and Screen” — Advice to Health
Systems About Regularly Screening for Lynch
Syndrome: Interviews With Newly Diagnosed
Colon Cancer Patients
Jennifer L. Schneider,1 Alison Firemark,1 Jim Davis,1
Sara Gille,1 Andrea Burnett-Hartman,2 Laurie Jenson,3
Jan Lowery,3 Jessica Ezzell Hunter,1 Alanna Kulchak
Rahm4
Kaiser Permanente Northwest, Portland, OR; 2Kaiser
Permanente Colorado, Denver, CO; 3Catholic Health
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Background: Lynch syndrome (LS) is an inherited cancer
syndrome with increased risk for colorectal and endometrial
cancers. First-degree relatives of patients with LS have a 50%
chance of also having LS. Universal tumor screening (UTS)
for LS among all newly diagnosed cases of colorectal and
endometrial cancer is recommended; however, not all health
systems have implemented UTS programs. We explored
perspectives of patients with colorectal cancer in different
health systems on the perceived importance of UTS for LS
and their recommendations to health systems.
Methods: To date, we have completed 39 semi-structured
telephone interviews among individuals newly diagnosed
with colorectal cancer at 4 diverse health care systems.
Interviews lasted approximately 60 minutes and were audiorecorded and transcribed for coding and content analysis.
Results: We interviewed 20 males and 19 females, with an
average age of 60 years. Most (80%) were Caucasian (n=31),
and 62% (n=24) indicated at least one blood relative receives
care within the same health system. The majority (97%) of
patients (n=38) felt it was very important for their health
system to regularly screen for LS, as “knowledge is power.”
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Additional reasons are that the information can guide health
care decisions (n=14) and provide vital information for at-risk
relatives (n=5). However, patients identified 3 concerns: cost
of screening to the patient (n=4); not wanting to be screened
without a choice (n=3); and possible feelings of anxiety about
learning the LS diagnosis (n=3). About one-third (n=11) felt
LS screening should be standard of care at their health system;
whereas 15% (n=6) would prefer some level of patient choice.
Most (90%) patients (n=36) want their health system to
provide proactive education and support about LS screening,
including patient-friendly written material (n=27), links to
trusted educational videos and web-based resources (n=13),
and assistance from health system staff to further understand
LS or communicate with family (n=11).
Conclusion: Our initial findings provide novel insight into
patient perspectives about the importance for health systems
to regularly screen for LS. Patients’ advice may guide future
implementation of UTS programs to maximize the screening,
diagnosis, and education of individuals with LS and their
first-degree relatives.
P7.02
Identifying Barriers and Facilitators to Participation
in the Kaiser Permanente Research Bank Among
Black Members
Musu Sesay,1 Brandi Robinson,1 Doraina WalkerWilliams,1 Drew Bradlyn1
Kaiser Permanente Georgia, Atlanta, GA

1

Background: Disease burden is prevalent among blacks;
however, research participation and, specifically, genetic
research requiring a biological sample donation can be
challenging, despite the potential benefits. The purpose of
this study was to understand black Kaiser Permanente (KP)
Georgia members’ thoughts on research participation that
includes providing a blood sample for genetic analysis,
completing a health survey, and granting researchers access
to past and future medical record data.
Methods: 35 members were recruited in-person and by
phone to participate in focus groups at two KP Georgia
locations. Two 90-minute focus groups were conducted
in each location. The moderator asked questions, using a
semi-structured interview guide, about research knowledge
and presentation, historical context, trust, and cultural
preferences. Perceptions regarding participation in the KP
Research Bank also were discussed.
Results: 13 members participated in 1 of the 4 focus groups.
The study population was primarily black (85%), nonHispanic (62%), female (92%), and 45 years of age or older
(62%). Participants expressed wanting to “give voice,” have
“black representation” and make a “contribution to their
community” as motivating factors to participate in the focus
group. Participants noted trustworthiness of researcher and
institution, ineffective presentation of research (including
Supplement

lack of “black-to-black” communication), associated risks
and benefits of a study, and data breach concerns as major
barriers to participation. Participants noted the need for
education on research subject matters, desire for effective
treatments, trust in KP, diversity, and return of research
results (personal or group) as facilitators to participating
in research. Most participants expressed interest in
participating in genetic research if conducted by KP (given
their trust and confidence in KP), data are de-identified,
information is used only for its intended purposes, and the
requested biological samples are collected the same day
as recruitment or scheduled conveniently with their next
clinic visit. They prefer in-person recruitment and review of
consent documents for participation.
Conclusion: Black KP Georgia members are interested in
participating in research to make a difference, despite their
reservations about historic matters of distrust. Members
hope researchers can provide ongoing communications to
keep them aware of the difference their contributions in
research are making.
P7.03
Implementing an In-Clinic Recruitment Strategy
to Increase Diversity in the Kaiser Permanente
Research Bank
Brandi Robinson,1 Doraina Walker-Williams,1 Musu
Sesay1 Marni Segall1 Drew Bradlyn1
Kaiser Permanente Georgia, Atlanta, GA
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Background: The Kaiser Permanente (KP) Research
Bank is committed to establishing a national biobank
that represents KP’s richly diverse membership and the
communities we serve. National recruiting efforts are
primarily web- and email-based and may unintentionally
limit diverse participation due to reliance on those methods.
KP Georgia implemented an in-clinic recruitment strategy
to increase the number of racial and ethnic minorities who
consent to participate in the KP Research Bank.
Methods: We implemented an in-clinic recruitment strategy
in 9 KP Georgia medical centers with a high proportion of
members from racial and ethnic minority groups. Research
staff recruited members 1–2 days per week, at tables located
near the main entrance of each center. Modest giveaways
(eg, pens, lip balm, hand sanitizer) and recruitment flyers
were placed on tables to promote the study. Members who
approached the recruitment table were asked if they wanted
to learn more about the study. If the member expressed
interest in learning more, recruiters provided background
information about the KP Research Bank and answered any
questions. Members who agreed to participate consented
electronically using an iPad.
Results: Over the course of 167 recruitment days, 5269
members approached one of our recruitment tables. Of those,
37% (n=1938) consented to participate in the KP Research
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Bank. In comparison, approximately 1% of KP Georgia
members recruited via email consented to participate in
the KP Research Bank. Approximately 62% (n=1194) of
members who consented in-clinic were racial or ethnic
minorities. Common member questions included: “How is
my information protected?” “What will my blood be used
for?” and “Have you participated?” When members expressed
concerns about participation due to historical cases of research
abuses, recruiters listened to the members’ concerns, provided
information about the measures to protect participants, and
discussed the importance of diverse representation in research.
Conclusion: Although costly and more intensive than email
recruitment, initial results indicate that in-clinic recruitment
is an effective strategy to consent racial and ethnic minorities
to participate in the KP Research Bank. Engaging in face-toface conversations about the past and future of research was
essential to our success in recruiting members from minority
populations.
P7.04
Member Attitudes
Toward
Biobanking Participation

Research

and

Musu Sesay,1 Brandi Robinson,1 Doraina WalkerWilliams,1 Drew Bradlyn1
Kaiser Permanente Georgia, Atlanta, GA
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Background: Participation in biobanking research may be
impacted by a variety of factors, including race/ethnicity,
age, distrust of researchers, privacy concerns, and the
potential for personal or community benefit. This study
aimed to determine the importance of specific factors in an
individual’s decision to participate in biobanking research.
Methods: A convenience sample of approximately 10,000
adult (≥18 years of age) Kaiser Permanente (KP) Georgia
members were invited to complete a survey of attitudes
regarding participation in biobanking research. The survey
was organized into categories reflecting cultural preference,
knowledge and understanding, mode of presentation, trust,
and perceptions of research. Item content was developed
based on existing literature and themes identified in formative
focus groups with KP Georgia members.
Results: 400 members completed the survey (varying item
response rates of at least 75%). Participants were primarily
white (55%), non-Hispanic (85%), female (66%), and 45
years of age or older; nonwhite participants were primarily
black (88%). The majority had been a KP member for 5
or more years (56%), held at least an associate’s degree
(60%), and had previously participated in research (40%).
Compared to whites, significantly more nonwhites considered
it important to be informed about a research study in person
(29% vs 44%; P<0.05) by a known/trusted person (52% vs
66%; P<0.05) and to help others (75% vs 86%; P<0.05), but
were less likely to participate if employers/health insurers
could use their information against them (96% vs 88%;
www.aurora.org/jpcrr
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P<0.05). Compared to whites, nonwhites agreed, though not
significantly, that researchers could use their information to
answer important health questions (99% vs 100%; P>0.05).
They were also likely to participate in research asking for
blood samples (87% vs 82%; P>0.05) or completing health
surveys that include sensitive information about drug use and
sex (93% vs 91%; P>0.05). However, they were less likely
to participate in research with the potential for unauthorized
access to personal data (73% vs 68%, P>0.05).
Conclusion: Participants are interested in participating in
research to help answer important health questions, but
nonwhite participants might not if it violates their privacy
or can be used against them for employment or health
insurance purposes.

progress in the build of the application. The result was a tool
called Access Portal.
Results: The KPRB Access Portal became available to Kaiser
Permanente researchers in January 2018 and to external
researchers in August 2018. It is being used to coordinate
scientific review, community review, data feasibility review,
and biospecimen feasibility review of research proposals.
Conclusion: We are now using the Access Portal to
coordinate research proposal reviews and provide feedback
to researchers. In addition, use of the Access Portal allows
the KPRB to gain further understanding of the submission
process and make improvements as needed, as well as to
identify gaps in policy, procedures, and technical readiness.

P7.05
Development of an Access Portal to Coordinate
Biobanking Research Applications for the Kaiser
Permanente Research Bank

METHODS, DESIGNS, AND ANALYTICS
TOOLS

Suzanne Gillespie,1 Alan Bauck,1 Terry Chinn,2 Renee
Trinidad,3 Inga Wager2
Kaiser Permanente Northwest, Portland, OR; 2Kaiser
Permanente Northern California, Oakland, CA; 3Kaiser
Permanente Southern California, Pasadena, CA
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Background: The Kaiser Permanente Research Bank
(KPRB) is one of the most population-diverse biobanks
in the United States. Eight geographically distinct Kaiser
Permanente regions participate in the KPRB, which contains
collections of blood, saliva, and patient data for more than
350,000 individuals. Participants consent to broad use of
their biospecimens, electronic health record data, survey
data, and genomic data for health research. KPRB reviews all
research submissions by performing scientific, communityimpact, and organizational-risk assessments. In addition,
KPRB staff review proposals for data and biospecimen
feasibility to ensure that the research can be conducted with
the resources available and within the projected timeframe.
To ensure consistency, monitor researcher requests, and track
the process, the KPRB implemented an online workflow tool.
Methods: The KPRB Data Coordination Core worked
with stakeholders to document the requirements for an
online workflow tool and identified 21 predefined criteria
that broadly fell into the categories of value, risk, and cost.
Those criteria led to the selection of a Kaiser Permanente
Information Technology (KPIT) team that specializes in
business process management (BPM). The KPIT BPM
team leverages software to automate, monitor, and optimize
business processes to increase efficiency and reduce costs. The
KPIT BPM team worked with stakeholders to document the
workflow using IBM’s Blueworks Live©, then used an agile
approach to achieve consensus, improve the process model
through prototypes, and validate what had been developed.
This allowed the stakeholders to refine their ideas and see
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All-Cause Mortality Production Table From the
National Death Index
Sundeep Basra,1 Monica Ter-Minassian,1 Alphonse
Derus,1 Eric Watson,1 Michael Horberg1
Kaiser Permanente Mid-Atlantic States, Rockville, MD
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Background: The Kaiser Permanente Mid-Atlantic States
(KPMAS) virtual data warehouse (VDW) derives its death
data from databases sourced from the Social Security
Administration, the KPMAS tumor registry, and Clarity.
However, more complete information on vital status and
cause of death was needed. KPMAS obtained data from the
National Death Index (NDI) on select members. We present
the matching algorithm and quality control steps used to
produce a researcher-ready production member death table.
Methods: All members submitted to NDI were enrolled
between 2005 to 2017 and had a date of last contact (identified
by an outpatient vital encounter) prior to 2017. We submitted
12 NDI-required identifying fields, on 1,036,449 members,
except for race, state of birth, and marital status. We used the
NDI-recommended algorithm to determine the best match,
of the multiple matches returned by NDI. We evaluated
each field for percentage matched. For a specific matching
classification where social security number is missing (class
4), we compared match scores by race and gender. We also
compared NDI to the VDW for both vital status and death
date for well-matched and poorly matched records.
Results: NDI returned 372,865 (36%) possible matches,
663,061 (64%) records not matched to the NDI database,
and 522 (<1%) rejected records. The total number of resulted
death dates from NDI’s best score-matching algorithm was
38,861. The fields of the well-matched records were more
than 95% matched, except for middle initial. Class 4 scores
differed significantly by gender and race (Kruskal-Wallis
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P<0.0001). Member death dates had an exact match between
NDI results and the VDW for 27,150 deaths but did not
have an exact match for 1628 deaths. There were 10,083
additional deaths from NDI results that were not present in
the VDW death data. We found 870 of the poorly matched
records had death dates exactly matching VDW.
Conclusion: NDI data can substantially improve the overall
capture of deaths. The death dates available in the VDW
appeared to be mostly concordant with NDI dates. However,
we recommend investigating further quality control measures
to ensure the accuracy of NDI’s best-match algorithm.
P13.02
Developing a Toolkit to Calculate Morphine
Equivalents and Identify Nonclassified Drugs for
Opioid Research
Phillip Crawford, Morgan J. Fuoco, Ladia AlbertsonJunkans,2 Arvind Ramaprasan,2 Reesa Laws,1 Mary
Ann McBurnie1
1

1

Kaiser Permanente Northwest and Hawaii, Portland,
OR; 2Kaiser Permanente Washington, Seattle, WA

Documentation for using the toolkit also was created.
Results: Using these methods, a process was developed
to make the determination of MEQs a less time-intensive
procedure. Working with text-based unstructured strength
data is a step in the implementation that could be targeted for
additional automation.
Conclusion: Developing a toolkit of resources and
procedures for computing standardized MEQs can
reduce analyst burden, variation in MEQ definitions, and
misclassification of computed MEQs.
P13.03
Measuring the Cost of Caring for Children With a
Chronic Health Condition: Design and Description
of the Study Population in the r-Kids Study
Joanna Bulkley,1 Alexandra Varga,1 John Dickerson,1
Phillip Crawford,1 Katherine Vaughn,1 Lisa Croen,2
Eric Fombonne,3 Brigit Hatch,4 Beth Waitzfelder,5 Yihe
Daida,5 April Lee,4 Maria Massolo,2 Frances Lynch1
Kaiser Permanente Northwest, Portland, OR; 2Kaiser
Permanente Northern California, Oakland, CA; 3Oregon
Health & Science University, Portland, OR; 4OCHIN, Inc.,
Portland, OR; 5Kaiser Permanente Hawaii, Honolulu, HI
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Background: The opioid epidemic is a high priority for
many researchers, policymakers, and communities across
the United States. Exposure is a primary indicator of risk
of addiction, overdose, and death due to opioids. Morphine
equivalents (MEQ) are used to standardize variations
across drugs to assess the total amount of opioids to which
a person has been exposed; however, currently available
tools for calculating MEQs have limitations. A standardized,
comprehensive approach for computing MEQs is needed. We
built on the previous work of a multicenter study of patients
prescribed opioids for chronic pain to develop a toolkit with
the capacity to process opioid prescribing information from
diverse systems and sources and provide a more uniform
approach calculating MEQs.
Methods: The toolkit itself was a combination of data, macro
programming, and process. Data included in the toolkit
was a study-compiled MEQ dataset that included data from
multiple sources. Macro programming was used to compare a
user’s predefined opioid data against the MEQ dataset. This,
in combination with user input at key points, accomplished
the 6 main steps: 1) identify perfect MEQ matches based on
National Drug Code or active ingredient and form matching;
2) identify mid- and high-quality active ingredient and form
matches (acceptance/rejection based on additional user
review and research; 3) identify gaps in a user’s MEQ data by
identifying low-quality or nonmatches that require additional
user research and/or parsing of text-based strength data; 4)
accept user feedback via importable Excel data files that write
the data to the local dataset for use in local analysis; 5) when
needed, use the Centers for Disease Control and Prevention
formula for calculating MEQ; and 6) conditionally accept
the drug and MEQ data to build out the parent MEQ dataset.

Background: While all families experience financial and
time costs related to caring for their child’s health, families
of children with autism spectrum disorder (ASD) or other
chronic health conditions may face a higher burden.
Understanding this economic burden is crucial for designing
effective policies to support families.
Methods: Using the electronic health record, we identified
children between 3 and 16.5 years with ASD, asthma,
or neither (GenPop) from 3 Kaiser Permanente regions
(Northwest, Hawaii, Northern California) and several health
clinics in the OCHIN network. We oversampled racial and
ethnic minorities, and matched asthma and GenPop groups to
the age and gender distribution of the ASD group. Guardians
completed an online survey 3 times, 4 months apart. The
survey was comprised of the Family Economic Impact
Inventory (measuring financial, time, and employment costs
of caring for a child’s health), and established instruments
measuring the child’s quality of life (Pediatric Quality of
Life Inventory [PedsQL] and Strengths and Difficulties
Questionnaire [SDQ]) and symptom severity for children
with ASD (Social Responsiveness Scale [SRS]) or asthma
(PROMIS asthma scale). We also assessed parenting stress
and parent physical and mental health. All materials were
provided in English and Spanish.
Results: 1461 families enrolled in the study (564 ASD, 468
asthma, 429 GenPop). The study children were predominantly
male (79%), with a mean age of 9.1 years, and ethnically
diverse (43% non-Hispanic white; 21% Hispanic; 35%
non-Hispanic Asian, black, Native Hawaiian, or other race/
ethnicity). Children in the asthma group were less likely to be
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white (39%) compared to ASD and GenPop groups (45% and
46%, respectively; P=0.003). The majority of respondents
were female (86%), had a college degree (62%), and were
married/partnered (79%). ASD group respondents were
less likely to be employed (73%) than those in the asthma
or GenPop groups (both 80%; P=0.023); 49% of GenPop
families had a monthly household income pf >$6000,
compared to 40% for both the ASD and asthma groups.
Conclusion: The r-Kids study recruited a large diverse
sample. Planned main analyses will examine differences in
financial, time, and employment-related costs among study
groups. Additional analyses will focus on the impact of
family characteristics, ASD severity, employer policies, and
caregiver strain on family costs.

laws regarding adolescent health care and to engage
key stakeholders, including institutional review offices,
health care providers who specialize in care of adolescent
populations, and, if applicable, legal and privacy
departments. Researchers also should be prepared to modify
their study to comply with privacy requirements.
P13.05
Agile Research: Sprinting Through Development
of a National Network Website
Morgan J. Fuoco,1 Reesa Laws,1 Matt Hornbrook,1
Kim Funkhouser,1 Mary Ann McBurnie1
Kaiser Permanente Northwest, Portland, OR
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P13.04
Human Subjects Considerations in Human
Papillomavirus Vaccine Research in Adolescents
Gabrielle Gundersen,1 Aruna Kamineni1
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Background: State privacy laws can present unique
human subjects considerations when conducting human
papillomavirus (HPV) vaccine research in minor adolescents.
Washington state privacy laws permit 13–17-year-olds
to consent to their own mental health, substance use,
and reproductive health care. For care related to sexually
transmitted infections (STIs), the minimum age for consent
is 14 years. At Kaiser Permanente Washington (KPWA), an
integrated health care system, HPV vaccination is considered
an STI service and is confidential between 14–17-year-olds
and their health care provider. Information about this type of
care cannot be disclosed to parents without the adolescent’s
consent.
Methods: In 2018 we sought to conduct a study to understand
barriers to HPV vaccine series completion among KPWA
members. Human subjects review and approval for this
research was more complex than anticipated due to issues
of parental consent and assent for minors 14–17 years of
age, since HPV vaccination raises privacy concerns. We had
originally planned to interview parents of 9–13-year-olds and
individuals 14–19 years of age, but we learned we could not
approach 14–17-year-olds for their assent to participate in the
study without risking disclosure of their HPV vaccination
information to their parents without their consent.
Results: After numerous discussions with the KPWA
institutional review office and consultations with KPWA
legal and privacy departments, we modified our approach
strategy and interview plans. We were ultimately approved to
interview parents of 11–17-year-olds and young adults 18–19
years of age.
Conclusion: Conducting HPV vaccine research in minor
adolescents necessitates allocating additional resources
and allowing sufficient time to understand state privacy
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Background: Agile, developed in 2001 in response to
traditional waterfall methodology, is an iterative development
methodology that is premised on the following 4 values:
individuals and interactions, working software, collaboration,
and responding to change. Agile values smaller "sprints" of
work, each yielding a small functional product. Originally
developed to serve the software world, agile methodologies
have recently been introduced into other sectors like health
care and research. Adapting the agile processes to fit into
research environments is a way to balance the reduction in
federal funding, tighter timelines, and budget constraints.
As part of a national research network, we implemented
agile methodology to develop a website to support study
activities, including study data collection and management,
training and incentive tracking, committee appointment and
task management, document management and distribution,
institutional review board submissions and documentation,
and network staff directory management.
Methods: Two of the core values of agile are iteration and
change. The implementation of agile in a research setting
has required both iteration and rapid feedback for processes
refinement. Our implementation has included: workflow
coordination between technical directors and developers;
sprint planning, execution, and review; and continual
task distillation and adjustment. Flexible work processes
have allowed quicker product changes to meet additional
requirements.
Results: Generally, the technical directors spend about
2 weeks gathering requirements, writing user stories,
developing workflows, and working with the UX developer
to develop wireframes. Then, the product moves into
development. Initially, we had 4 weeks of development
with a week of quality assurance. However, after our sprint
retrospective, we decided to divide the work into even smaller
sections and have shorter sprints. We also refined how we
gather requirements for user stories, work collaboration, and
processes for documentation. In 3 months, we have been able
to specify and build an initial version of the website that would
likely still be under construction using waterfall methodology
The agile environment has allowed all team members to offer
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creative solutions to problems that may not be possible under
a waterfall approach.
Conclusion: Agile methodology lends itself to collaboration,
flexibility, and creativity. Agile offers a way to incorporate
the constant associated with research into streamlined
development.

PATIENT, CLINICIAN & HEALTH SYSTEM
ENGAGEMENT
P14.01
Feasibility of Electronically Collecting PatientReported Data From Lower-Income Parents to
Integrate and Coordinate Clinical and Community
Health Care
Adam Cook,1 Jennifer Savage,2 Samantha Kling,2 Holly
Harris,2 Michele Marini,2 Jacob Mowery,1 Shawnee
Lutcher,1 Lisa Bailey-Davis1
Geisinger Health, Danville, PA; 2Penn State University,
State College, PA
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Background: Electronic integration of complementary
health services from clinical and community settings may
benefit high-risk populations. Parents of economically
disadvantaged newborns participate in up to 7 preventive
care visits from pediatric primary care providers (PCPs) and
Women, Infant, and Children (WIC) nutritionists in the first
6 months of life. In response to stakeholders’ concern about
conflicting messages and support for an integrated approach,
this study describes the feasibility of engaging parents,
clinicians, and community nutritionists through electronic
data collection and sharing for coordinated care.
Methods: WIC-eligible parents and infants who received
care at Geisinger Health were recruited, provided consent,
and randomized to intervention or control. The intervention
included 1) collecting parent-reported practices via Early
Healthy Lifestyles tool; 2) integrating responses into the
electronic health record (EHR) to inform care; 3) sharing data
between clinic and community settings (care coordination
opportunities); and 4) coordinating care (interaction with
shared data). Data sources included the EHR and WIC data
management system. Data were independently coded by 2
study team members for the intervention parent-child dyads.
Means and standard deviations are reported.
Results: Caregiver-infant dyads (N=131) attended 459
(3.50 ± 1.03 per dyad) PCP and 296 (2.26 ± 0.97 per dyad)
WIC visits. Parents completed the Early Healthy Lifestyles
risk assessment prior to 53% of PCP visits (1.86 ± 1.15 per
dyad), and these data were integrated into 100% of infant
EHRs. These data were shared with WIC following 100%
of PCP visits and 50% of the time a WIC visit followed a
PCP visit. Thus, there were 1.76 ± 0.81 per dyad PCP-to-WIC
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care coordination opportunities. When this happened, WIC
coordinated care at 67% of opportunities (1.18 ± 0.85 per
dyad). Data were shared with the PCP following 67% of
WIC visits (1.5 ± 0.95 per dyad), and 59% of the time a PCP
visit followed a WIC visit. Thus, there were 0.89 ± 0.78 per
dyad WIC-to-PCP care coordination opportunities. When
this occurred, PCPs coordinated care at 44% of opportunities
(0.39 ± 0.58 per dyad).
Conclusion: Electronically integrating care is feasible;
however, between-participant variability in real-world
visit sequence limited care coordination opportunities.
Parent input was available for most visits to inform patientcentered care. Workflow integration enabled PCP data
sharing, while partial integration limited WIC data sharing.
WIC nutritionists were more likely than PCPs to interact
with shared data to coordinate care.
P14.02
Determining Whether Opioid Prescription Patterns
and Demographics Impact a Clinician’s Willingness
to Respond to an Opioid-Related Survey
Zijun Shen,1 Farah Refai,1 William Isenberg,1 Amol
Navathe,2 Mitesh Patel,2 Rebecca Pepe,2 Kit Delgado,2
Joshua Liao,3 Xiaowei (Sherry) Yan1
Sutter Health, Walnut Creek, CA; 2University of
Pennsylvania, Philadelphia, PA; 3University of
Washington, Seattle, WA
1

Background: We surveyed 451 clinicians from emergency
departments (ED) and urgent care (UC) clinics in February
2019 across Sutter Health, a large health care system in
Northern California, on their opioid-prescribing behavior and
patterns. Clinicians received an email from their local medical
director with an explanation of the survey and a link to the
questionnaire on SurveyMonkey. Survey responses were
collected over a period of 8 weeks, with weekly reminders to
nonrespondents. In this study, we seek to understand whether
a clinician’s opioid prescribing pattern and/or demographic
characteristics impact survey response.
Methods: One year of baseline electronic health record
(EHR) data from June 2017 to May 2018 was used to
capture clinicians’ opioid prescription patterns, represented
by opioid prescription rate, and basic demographic
characteristics. Multivariate logistic regression was used to
estimate the association between opioid prescription pattern,
clinician demographics, and response rate.
Results: The overall response rate was 55.7% (n=251), with
response rates for UC clinicians significantly higher than for
ED clinicians (69.9% vs 45.9%). Nurse practitioners and
physician assistants were more likely to respond compared
to physicians (73.7% vs 54.0%). Among ED clinicians,
51.2% of females and 43.5% of males responded, whereas
among UC clinicians, 66.3% of females and 74.7% of males
responded. UC clinicians had higher response rates than ED
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clinicians for all levels of years of medical practice (ED:
28.9% for <10 years, 44.2% for 10–20 years, 49.6% for >20
years; UC: 76% for <10 years, 68.4% for 10–20 years, 70%
for >20 years). Neither prescription patterns nor demographic
characteristics were associated with response rate for ED
clinicians. UC clinicians who had practiced greater than 20
years were less likely to respond (odds ratio: 0.19, 95% CI:
0.03–0.97) compared to those who practiced for less than 10
years. Opioid prescription patterns were not associated with
response rates for either UC or ED responding clinicians.
Conclusion: UC clinicians had significantly higher response
rates compared to ED clinicians. Our study reveals that
opioid prescription patterns and demographic characteristics
do not have an impact on UC and ED clinician response
rates, providing validation that information collected from
responding clinicians is likely not biased.
P14.03
What Motivates People With Migraine to Participate
in Research: A Qualitative Analysis of MindfulnessBased Stress Reduction for Migraine
Heather Law, Andrew Avins, Alice Pressman
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Background: Migraine is one of the most common
neurological disorders in the United States and is ranked
among the top 20 causes of disability worldwide. Given the
common side effects of pharmaceutical migraine treatments,
a substantial number of headache sufferers use integrative
medicine to provide symptom relief. Mindfulnessbased stress reduction (MBSR) is an 8-week classroombased intervention that combines meditation and yoga;
increasing evidence has demonstrated its effectiveness for
a variety of pain-related and functional disorders. As part
of a randomized controlled feasibility trial of MBSR for
migraine, we conducted a single focus group to learn about
participants’ experiences in the study.
Methods: We conducted a 2-arm, parallel-comparison
randomized controlled feasibility trial of MBSR versus
usual care for 60 migraine patients at a large not-forprofit health network in Northern California. The 7 focus
group participants all completed the MBSR intervention
and all aspects of the study data collection, including 4
headache diaries and questionnaires over a 1-year period.
The focus group was audio-recorded and transcribed
verbatim. Qualitative data were analyzed with the constant
comparative method in order to develop a grounded theory.
Results: Participants (n=7) reported the following themes:
1) strong preference for integrative medicine and natural
methods; 2) enjoyed being part of a group intervention;
3) would not have tried mindfulness on their own; 4)
experienced a decrease in frequency and intensity of
migraines; and 5) less anxiety and depression.
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Conclusion: The focus group was a qualitative exploration
of how people with migraine experience the possible benefits
and hindrances of participating in a feasibility trial of MBSR
for migraine. It was evident that the participants were grateful
for the opportunity to be a part of the study and receive the
MBSR intervention. MBSR had not only improved their
migraines but improved the participants' overall sense of
well-being. These findings along with quantitative outcomes
data will be used to inform a future fully powered trial. More
research is needed to better understand what motivates people
with migraine to participate in research studies as well as
what types of individuals are more likely to join clinical trials
involving integrative medicine.
P14.04
Introduction of a Knowledgebase to Support a
Learning Health Care System
Nico Pronk,1 Andrew Alexander,1 Richard Paskach,1
Santhosh Anand,1 Hannah VanLith,1 Lauryn Davin1
HealthPartners, Bloomington, MN
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Background: The development and exchange of knowledge
is critical to the success of a learning health care system.
HealthPartners Institute chartered a project to implement
a knowledgebase for the HealthPartners system to collect,
share, and preserve scholarly materials produced throughout
HealthPartners. Although there is currently oversight and
tracking of research across HealthPartners, the publication
listings and citations didn’t give users an easy way to
search and find publications, education materials, or quality
improvement results. In addition, those listings didn’t make
results available in a concise manner to those external to
HealthPartners. By capturing knowledge in a format that
is easily accessible, searchable, and includes reporting
functionality, these data are better leveraged by the broader
organization and community.
Methods: Implementation requirements included a
knowledgebase and user interface to search content to
understand information related to general learning, research,
and quality improvement at HealthPartners, as well as results
of previous quality improvement and research projects.
Connecting HealthPartners staff to previous initiatives with
links to publications, project summary reports, curriculum,
etc also was a requirement. Additionally, interfacing with
existing citation software to capture scholarly materials,
and analysis of metadata on HealthPartners’ use of the
knowledgebase (areas of interest and number of searches on
a subject), were required.
Results: The knowledgebase has brought into focus the
value of this information for the broader organization. The
deployment of this powerful software demonstrates the
“products” of HealthPartners Institute in ways that haven’t
been seen before. The knowledgebase allows users to have
access to publications, profiles, and centers right at their
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fingertips. Google Analytics are used to measure the usage
of publications online and in social media, and custom
analytics are used to capture search keywords to better
understand users and their interests.
Conclusion: The implementation of a knowledgebase has
been challenging; however, the immediate benefits are already
being realized by HealthPartners Institute: a comprehensive
look into the scholarly products of the institute, which in
turn demonstrates the value of having an embedded research
institute within the enterprise; availability of knowledge
for care delivery division to support our learning health
care system; and greater visibility of researchers within the
organization and externally.
P14.05
Effect of Navigation Services
Engagement and Activation

on

Patient

Rebekah Angove,1 Kathleen Gallagher,1 Eric Anderson1
Patient Advocate Foundation, Hampton, VA

1

Background: Patient engagement takes many forms. It
encompasses patients being able to define and share their care
goals, gather information to make informed choices, engage
in shared decision-making with providers, navigate the health
and insurance systems, be proactive in their health and care,
and expand their advocacy to advise the wider system or
community. Success in any (or all) of these activities requires
skilled communication, confidence, self-efficacy, and selfadvocacy skills. All of these can be learned or strengthened
through training and practice. There is anecdotal evidence to
support that many components of patient navigation facilitate
the development of these patient engagement skills that we
know to be crucial, yet the impact of patient navigation on
these aspects of patient engagement has yet to be robustly
measured.
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Methods: Patient Advocate Foundation delivers navigation
and case management services to patients battling lifethreatening and chronic illness. Surveys were administered to
all patients served by Patient Advocate Foundation in 2019,
both before and after navigation services were provided, to
assess the impact of navigation on patient engagement and
activation across a variety of domains. These domains include
health education, navigation, communication, self-advocacy,
and eHealth literacy.
Results: While data collection is still ongoing through
December 2019, 200 paired responses have been collected.
Preliminary population-level results indicate navigation
services reduce general distress and increase confidence in
navigating the health care system. Once data collection is
complete, matched pair analysis will be done, along with a
subanalysis of presenting issues.
Conclusion: Understanding how navigation services impact
patient engagement and activation is key to ensuring that
these services are meeting the needs of patients and provide
evidence for the continued investment by systems and
payers. It also will support the identification of opportunities
to naturally embed enhanced engagement activities within
patient navigation structure and workflow as well as help
engineer navigation services that address emergent issues and
provide long-lasting effects.
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